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ABSTRACT 
Evidence is presented for DNA delivery to cultured HepG2 
hepatoma cells via the endocytotic pathway, under the direction 
of insulin, in a soluble system of transfection leading to 
stable gene expression. Serum albumin treated at pH 5.5 and 
20°C for 48-60h with the water-soluble carbodiimide N-ethyl-N'-
(3-dimethylaminopropyl) carbodiimide hydrochloride has been 
found to produce positively charged N-acylurea albumin capable 
of binding different types of DNA in a reaction which is at 
least partially electrostatic in nature (Huckett et al, 1986). 
N-Acylurea albumin, synthesised at an albumin to carbodiimide 
mole ratio of 1 : 500, resulting in the attachment of 27 N-
acylurea moieties per albumin molecule, was covalently 
conjugated to insulin by glutaraldehyde cross-linkage in order 
to produce a macromolecule, insulin-[N-acylurea albumin], with 
the facilities f or both DNA transport and receptor binding. The 
resultant conjugate, purified by gel filtration through Sephadex 
G-100, was characterised in terms of molecular size, charge 
properties and insulin content by polyacrylamide gel 
electrophoresis, agarose gel electrophoresis and immuno-dot-
blotting respectively. The conjugated protein was shown by gel 
band shift and nitrocellulose filter binding assays to bind DNA 
non-specifically in a reversible reaction which occurs rapidly, 
is dependent upon protein concentration and the ionic strength 
of the medium, and involves at least two types of intermolecular 
interaction. Furthermore, the conjugate was shown by 
competitive displacement of [ '25I ]insulin to bind specifically 
and particularly avidly to the HepG2 insulin receptor. When the 
expression vectors ptkNEO and pAL-8 which incorporate the neo 
gene were complexed to the conjugate in an in vitro transfection 
procedure using HepG2 cells, G418 resistant clones developed at 
frequencies of 2.0 - 5.5 X 10-5 , possibly dependent upon vector 
promoter. Subsequently, a 923bp PstI fragment within the neD 
sequence was identified by Southern transfer in genomic DNA 
extracted from transfected cell populations which had been grown 
on a G418 regime through several subculture passages over a 
period of 44 days. 
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~ DNA UPTAKE BY LIVING CELLS - AN HISTORICAL PERSPECTIVE 
1 .1.1 GENETIC TRANSFORMATION AS A NATURAL PHENOMENON IN 
BACTERIA 
In 1928, Griffith published the now classic observation that 
cells of Diplococcus pneumoniae could be heritably altered by 
association with a cell-derived "transforming principle". 
Sixteen years later this transforming substance having the 
potential for genetic interaction was identified as 
deoxyribonucleic acid, DNA (Avery et al, 1944). Within the next 
three decades the phenomenon of bacterial transformation -
recognised as the uptake and integration into a recipient cell 
chromosome of DNA fragments released into the environment by 
death of a donor bacterium - had become widely identified as a 
natural mechanism of genetic recombination in certain 
eubacterial genera (Hotchkiss and Gabor, 1970; Notani and 
Setlow, 1974). During the same period the phenomenon came to be 
exploited extensively as a means of genetic analysis, especially 
in the important Gram positive model bacterium Bacillus subtilis 
lacking conjugation and transduction mechanisms (Dubnau et al, 
1967). Techniques were developed to enhance transformation in 
responsive bacterial types. Commonly, nutrients in the growth 
medium were minimised, and the cell population allowed to reach 
a state of semi-starvation. This kind of treatment was found to 
induce in the cells a particular state of receptivity to DNA 
termed competence, which was later recognised as a protein-
signalled event involving the production. of specific cell 
surface receptors for the binding of DNA and its transport to 
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the cell interior (Mandelstam et ai, 1982). 
1.1.2 CIRCUMVENTION OF NATURAL BARRIERS TO TRANSFORMATIONAL 
CHANGE IN BACTERIA 
By the early 1970s transformation had been shown to occur 
naturally in prokaryotes other than eubacteria. For example, it 
was demonstrated in the cyanobacterium (blue-green alga) 
Anacystis nidulans by Shestakov and Khyen (1970) and in the 
actinomycete Thermoactinomyces vulgaris by Hopwood and Wright 
(1972). Furthermore, more extreme methods were being developed 
at that time to provide conditions conducive to transformation 
in organisms found earlier to be completely resistant to the 
process. Ironically, included among those previously 
untransformable types was the Gram negative model bacterium 
Escherichia col i . However, in 1970, Mandel and Higa reported 
that E. coli cel ls pretreated with calcium chloride at low 
temperature became more permeable and were capable of taking up 
both linear and circular forms of bacteriophage DNA.* Later, 
using a similar method, Cohen et al (1972) demonstrated the 
uptake of circularised bacterial plasmid DNA by E. coli. 
Events such as these caused a shift in the definition of 
transformation to include the cellular entry and expression of 
DNA regardless of whether 4chromosomal integration and 
recombination followed. They also set a precedent for a spate 
of technical advances in transformation technology. Numerous 
variations on the calcium chloride treatment approach were 
published, many of them directed towards improving the 
efficiency of transformation for a particular bacterial strain. 
In addition, high transformation efficiency mutant strains 
(usually nuclease deficient) were sought and isolated -
* Note: The uptake of naked viral DNA by a cell was regarded as 
a specific category of transformation and was termed 
transfection. 
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especially in E. coli - for application with calcium chloride 
procedures. Many such methods are still in common usage, 
particularly for the induction of recombinant plasmid uptake 
(Maniatis et ai, 1982; Hanahan,1985) (section 1.1.4). 
1.1.3 GENETIC TRANSFORMATION IN EUKARYOTES 
As interest in bacterial transformation developed, increasing 
numbers of worker s turned their attention to the possibility of 
naked DNA mediating comparable transformations in higher 
organisms. 
Much of the early work was both ambitious and crude. It 
involved the injection of DNA from the tissue of one animal into 
the body of a whole animal of the same species but different 
phenotype. The pioneering work in this area of experimentation 
is that of Benoit et al (1957) who noted significant physical 
alterations after treating Pekin ducks with DNA extracted from 
those of the Kaki Campbell type. Working along the same lines, 
Martinovitch et al (1961) obtained changes in feather colour 
associated with gross morphological abnormalities following the 
injection of chicken embryos with DNA administered via the 
venous system. The chicken embryo experiments were followed up 
with observations of individuals of the next generation, and it 
was noted that i n addition to the colour modifications they 
carried an apparently novel type of haemoglobin (Martinovitch et 
ai, 1962). A degree of reproducibility was achieved in this 
particular work , and numerous modified offspring were obtained 
as a result (Mar tinovitch et ai, 1961). Possible confirmation 
of the transformations shown by Martinovitch was provided by 
various reports of the appearance of feather colour changes as a 
consequence of whole blood injections from one type of fowl into 
another (Kushner, 1957; Stroun et ai, 1962). Since avian 
erythrocytes are nucleated those experimental results are likely 
to be indicative of DNA interaction. Further in this regard, 
Leroy et al (1964) noted alterations in feather pigmentation 
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when guinea fowl erythrocyte nuclei were lysed and injected into 
Rhode Island Red fowls. 
In general, however, attempts to reproduce transformations using 
gross DNA treatments such as these met with a high level of 
failure (Benoit, 1960) and a large number of papers were 
published to this effect. Attempts to extend the transformation 
phenomenon to other animal taxa were also fairly unsuccessful 
(Billet et ai, 1964). 
Considerably more elegant experiments were set up by workers who 
turned to cell culture systems to look for transformation in 
terms of the transfer and expression of specific genetic 
markers. Two examples, both involving mammalian cell culture, 
will illustrate this point. Kraus (1961) demonstrated that bone 
marrow cells taken from sickle cell anaemia patients which lack 
the ability to produce the SA chain of haemoglobin may have that 
ability conferred upon them by incubation with DNA from normal 
bone marrow cel l s homozygous for haemoglobin. In experiments of 
parallel design , Szybalska and Szybalski (1962) grew mutants of 
a human cell line deficient in the enzyme inosinate 
pyrophosphorylase and treated them with extracts of DNA prepared 
from enzyme-positive cells of the same line. The appearance of 
enzyme-positive genetically transformed cells resulted from this 
procedure, transformation occurring at a frequency of 1 event 
per 4 X 104 cells in the presence of 150~g DNA/mI. 
The pathway and mechanism of DNA uptake in successful 
transformations such as those quoted above was unknown, although 
attempts had already been made and continued to be made to 
follow the fate of DNA from the exterior environment, across the 
cell membrane, into the interior of the cell, and even from 
organ to organ. For example, Gartler (1959) showed that Earle L 
cells took up a small amount of [3H]-homologous DNA in intact 
polymerised form, with a smaller amount being degraded by the 
cells. The same results were obtained when DNA labelled with 
bromodeoxyuridine was used (Gartler, 1960). Sirotnak and 
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Hutchinson (1959 ) used [32p ]-labelled DNA to show that its rate 
of uptake by L12 10 cells growing intraperitoneally was very 
rapid, maximal in 3 minutes, and Tsumita and Iwanaga (1963) 
demonstrated that 80-90% of [3H]-DNA injected into mice 
intravenously disappeared from the blood stream in 10 minutes 
compared with only 20% of hydrolysed [3H]-DNA in the same 
period. The fate of [~]-DNA in germinating barley seeds was 
studied extensively by Ledoux and coworkers. In one series of 
experiments it was shown that a 30 minute incubation of the 
endosperm region of the seedlings with labelled DNA was 
sufficient for the DNA to become localised in the nuclei of the 
root cells, some distance away (Ledoux, 1965). 
In reviewing the field of DNA uptake by living cells, Ledoux 
(1965) offers speculations on mechanism which appear especially 
insightful from present day perspective. At a time when modern 
cell biology was in its infancy, and before receptor-mediated 
endocytosis was a recognised phenomenon, he suggested the 
importance of a kind of indiscriminate pinocytotic process in 
which selectivity of molecular uptake could be provided by 
specific site attachment in the cytoplasm. At the same time he 
did question whether transformation is, in fact, a natural 
process in eukaryotes. 
In concluding h i s review, Ledoux states: 
"We have a l ready good indication of the possibility of DNA 
uptake by l iving cells; there seems to be little doubt 
concerning the existence of such a process, at least in 
certain cel l types. Many positive results have already 
been obtained for cells growing in suspension .... 
.... concerning DNA uptake by tissues and organs, we are on 
much less certain ground, not because contradictory results 
have been obtained, but mainly because the results are 
still fragmentary and the results not numerous." 
His final commen t is particularly perspicacious: 
"It also a ppears more and more evident that the isolated 
cases of transformation reported in the literature should 
not be considered too lightly as they could indicate the 
appearance of a new dimension in molecular biology." 
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By the end of the 1960s the evidence for DNA uptake by 
eukaryotic cells had been significantly consolidated by the 
publication of a number of detailed studies (Ayad and Fox, 1968; 
Ledoux and Huart, 1968,1969; Laval et ai, 1970). Then, in 1971, 
a piece of work by Merril and coworkers emerged in which it was 
reported that the specific bacterial gene sequence coding for 
a-D-galactose-1-phosphate uridyl transferase, incorporated into 
the DNA of transducing phage Lambda, could be taken up and 
expressed by human fibroblasts isolated from a patient with 
congenital lack of the enzyme. This work was seen to be of key 
significance, not only because the incorporated gene was 
bacterial in or i gin yet stably inherited and expressed in a 
mammalian system, but also because the gene was provided to the 
system in purified form in multiple copies for the first time. 
The paper was the subject of a major editorial comment in the 
issue of Nature in which it was published. The following 
phrases from the editorial reflect the importance put on the 
work: 
"The experiments reported by Merril, Geier and 
Petricciana .... will be of the greatest and most startling 
interest to all biologists .... they will have very far 
reaching implications indeed." 
Those "far reaching implications" began to be realised almost 
immediately, for as the type of work reported by Merril's group 
developed, it met and ultimately amalgamated with radical new 
technical advances in nucleic acid chemistry and molecular 
biology which, in turn, allowed exponential growth of the field 
in a quite unprecedented manner . 
1 . 1 . 4 DEVELOPMENT OF THE NEW RECOMBINANT DNA TECHNOLOGY 
Advances in molecular biology from the mid-1970s to the present 
time represent the growth of a technology of dramatic 
proportions and have led to a considerable information explosion 
in the field of biochemical genetics. This has come about 
largely because a number of individually · powerful techniques has 
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been integrated to form an array of compatible tools having the 
potential to tackle and solve a wide variety of gene transfer 
problems. Key components in this manifold instrumentarium 
include 
- enzymes for the precise fragmentation and ligation of DNA 
molecules; 
- methods for the separation and sequence identification of 
DNA fragments, and 
- a variety of nucleic acid vectors, viral or plasmid in 
origin, into which DNA fragments of interest can be 
inserted accurately and which can be replicated in a host 
cell, thereby cloning the introduced sequences of foreign 
DNA. 
Manipulation of the DNA during the overall cloning process takes 
place alternately within and without cell structures. The 
original viral or plasmid vector structure is produced in 
cultured cells, then extracted and biochemically modified by the 
insertion of appropriate DNA sequences before reintroduction 
into a host cell for replicative proliferation. The host cell 
used at this stage is rarely the exact cell type of origin; in 
the case of bacterial plasmids, the most versatile of vectors, 
the cloning is usually implemented in a well characterised 
bacterial host, the one most often chosen being "that workhorse 
of Molecular Biologists, E. coli" (Glover, 1985). Introduction 
of the newly designed plasmid into the host is by 
transformation. Thus the transformation methodology discussed 
above in section 1.1.2 is yet another device in the overall 
repertoire of techniques, and one of considerable importance. 
Subsequent to this cellular step the cloned plasmid, now in 
considerable quantity, is retrieved by extraction for 
experimental use. 
It is this controlled recombination of known and defined DNA 
sequences in vitro together with the produce ion of multiple 
copies of the recombinant DNA in vivo which gives the new 
technology its powerful experimental thrust. 
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DNA sequences which lend themselves to cloning include control 
regions as well as structural genes per se. Moreover, these may 
be either prokaryotic or eukaryotic in nature, even though 
carried on plasmid structures and replicated in bacteria. It is 
therefore not surprising that, as recombinant DNA technology has 
evolved, the prospect of specific gene transfer and expression 
in eukaryotic cell systems has become a realistic one. 
Currently, major interest is being shown in this area of 
manipulative genetic practice, and numerous approaches are being 
developed with varying degrees of applicability and success. 
Some of the central aspects of present day gene transfer 
technology as applied to eukaryotic systems are reviewed below 
in section 1.2. 
~ CURRENT STATUS OF EXPERIMENTAL GENE TRANSFER TO EUKARYOTES 
1 . 2 . 1 PLASMID VECTORS USED IN EUKARYOTIC CELL EXPRESSION 
Plasmid vectors designed for gene transfer and expression in 
eukaryotic cells must fulfil a number of functions and are 
constructed accordingly. Firstly, the plasmid must carry an 
appropriate replication origin in order to be capable of 
propagation in a bacterial host. Secondly, there must be 
present on the plasmid a selective marker such as a gene coding 
for antibiotic resistance as a means of plasmid maintenance 
during bacterial host replication. Both of the aforementioned 
characteristics are features of some naturally occurring 
plasmids. A third component, a suitable "test" gene, often 
called a reporter gene, must be built into the plasmid structure 
for the monitoring of gene expression in the recipient 
eukaryotic cells. While the test gene itself may be either 
prokaryotic or eukaryotic in origin, the fourth component, 
consisting of promoter and possibly also enhancer elements for 
the initiation and control of test gene transcription, is 
necessarily eukaryotic in action and is taken from a viral 
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genome in many instances. This promoter sequence is usually 
inserted upstream from the test gene as an adjacent flanking 
region. A fifth functional sequence involved in the processing 
of the transcripts must be added to the plasmid structure in 
order to ensure that efficient translation takes place. Such a 
sequence includes, for example, a section controlling 
polyadenylation of mRNA, and is placed so that it flanks the 
test gene in a downstream position. It is frequently taken from 
the same viral source as the promoter region. Introns for the 
control of mRNA splicing may be included in this portion of the 
plasmid as well. 
Many eukaryotic expression vectors are based on the plasmid 
construct pBR322 (Bolivar et al, 1977) which bears an origin of 
replication from pMB1, similar to that of the natural E. coli 
plasmid colE1-K30, as well as the gene for ampicillin resistance 
(ampR) coding for a B-lactamase which is part of the transposon 
Tn3 from the Salmonella paratyphi plasmid R1, and genes coding 
for tetracycline resistance (tetR) taken from the Salmonella 
panama plasmid pSC101. Inactivation of one of the two 
antibiotic resistance gene sequences by insertion of foreign DNA 
provides an excellent means for insertion selection. In order 
to increase the usefulness of pBR322 further in this respect, 
Bolivar and coworkers have deleted a number of endonuclease-
sensitive sites so that a large number of restriction enzymes 
cut the plasmid only once and a small number cut it only twice. 
An additional advantage of using pBR322 is that its nucleotide 
sequence has been fully determined (Sutcliffe, 1979). One much 
used family of expression vectors incorporating the origin of 
replication and ampR from pBR322is the prototype pSV2 and its 
many derivatives, in which the control sequences are provided by 
Simian Virus 40 (SV40) (Mulligan and Berg, 1980). 
There are two fundamental types of expression vector in use in 
eukaryotic cells. The first type is designed and used to 
estimate transient expression shortly after uptake, while the 
second type is suited for the detection of expression following 
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stable integration into therecipent cell genome. Short term 
expression as demonstrated by the former is often used to 
estimate important experimental parameters such as the efficacy 
of a particular promoter in the cell line under investigation as 
a preliminary to applying the latter. 
Transient expression vectors incorporate test genes coding for 
products distinguishable experimentally - as either RNA or 
protein - from those of the recipient cell. Activity of the 
test gene can be assayed, therefore, within hours of entry, at a 
stage when the plasmid vectors are not yet integrated into the 
host cell chromatin. At this point the plasmids which have been 
assimilated are often linked into large concatemers termed 
transgenomes (Scangos and Ruddle, 1981) and the level of 
expression is very high. However, transgenomes lack functional 
centromeres and are soon lost from the cell population, so that 
the expression peaks 24 - 72 hours after uptake of the DNA. 
Specialised genes from bacterial sources are well suited to use 
as reporters, since the recipient eukaryotic organisms lack the 
gene and provide a null background against which the assay can 
be conducted. Two which are commonly used are cat and lacZ 
which respectively encode the enzymes chloramphenicol 
acetyltransferase (Gorman et al, 1982) and B-galactosidase (Hall 
et al, 1983). A test gene which has become much used in plant 
systems recently (Jefferson et al, 1987) is the B-glucuronidase 
(GUS) coding sequence from the uidA locus of E. coli; the enzyme 
causes hydrolytic cleavage of a wide variety of B-glucuronides 
of which many are available commercially as spectrophotometric, 
fluorometric and histochemical substrates. 
By contrast, stable expression vectors carry genetic markers 
whose products, albeit generated at low levels, allow selective 
survival of the recipient cells in culture. The test of their 
presence is thus a relatively long term process and integration 
of plasmid into the genetic apparatus of the recipient cell is 
necessary so that continuous de novo synthesis of gene products 
occurs. The eukaryotic tk gene coding for the enzyme thymidine 
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kinase (TK) has been used a great deal as a test gene in stable 
expression vectors, one of the first such vectors to be designed 
being based on the pBR322 construct (Enquist et ai, 1979). The 
selection system? invented by Szybalska and Szybalski (1962) and 
developed by Littlefield (1964) for application in early genetic 
studies (section 1.1.3), requires the use of HAT culture medium, 
which contains hypoxanthine, aminopterin and thymidine. In this 
medium aminopterin blocks the pathway leading to the essential 
purine intermedi ate inosine monophosphate (IMP) as well as the 
conversion by methylation of the pyrimidine dUMP to dTMP, 
thereby creating dependence upon extraneous sources of purines 
and thymidine. The hypoxanthine included in the medium can be 
used as a source of purines since it is phosphorylated by the 
enzyme hypoxanthine-guanine phosphoribosyl transferase to form 
IMP. Similarly , the thymidine present can be phosphorylated by 
the TK enzyme. As a result, cells which are tk+ survive in the 
HAT mepium while those which are tk- do not. A disadvantage of 
the system is t hat the selective advantage of tk uptake can only 
be seen in recip ient cells which are mutants deficient in the 
expression of TK (Wigler et ai, 1977). 
By comparison with tk, the bacterial gene neoR is a far more 
universally applicable test of stable integration as it is a 
dominant marker which does not require a genetically deficient 
recipient cell for expression to be observable (Colbere-Garapin 
et ai, 1981). Selection using neoR can be applied, therefore, 
to almost any cell type. The gene neaR, borne in the natural 
state on the transposon TnS, codes for the aminoglycoside 3'-
phosphotransferase Type II (APH(3')-II) and confers resistance 
to the antibiotic neomycin upon bacterial cells which carry it. 
Neomycin itself interferes with the action of prokaryotic but 
not eukaryotic ribosomes, but an analogue to it, G418 
(Geneticin), is effective against eukaryotic animal ribosomes 
while still being inactivated by the APH(3')-II enzyme. 
Clearly, then, animal cells bearing and expressing the neaR gene 
can survive in culture medium containing . inimical levels of 
G418. Comparable selection of plant tissues carrying the neaR 
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gene can be made using a growth regime which incorporates 
kanamycin (Rogers et ai, 1986). 
1.2.2 CURRENT METHODS FOR THE INTRODUCTION OF DNA INTO 
EUKARYOTIC CELLS 
The methods utilised for the transfer of genetic material into 
eukaryotic cells at the present time are extremely varied. 
Almost without exception, however, they involve either the 
active insertion of DNA into cells or the active uptake of DNA 
by cells via specific mechanisms that are at least partially 
understood. Th i s is in contrast with the apparently passive 
cellular incorporation of DNA by unknown means under conditions 
of straightforward incubation as described by workers such as 
Szybalska and Szybalski (1962) and Merril et al (1971) referred 
to in section 1.1.3. Some of the current methods are simple in 
concept; others are based on highly contrived strategies. 
Overall, the appeal of these techniques lies in the relatively 
high frequencies of gene transfer, genomic integration and 
ultimate expression which result from their application, and the 
consequently good reproducibility levels. 
During the course of development of this field of work, common 
use of viral DNAs in early transfer studies led to adoption of 
the term transfection to describe the process of gene delivery 
to eukaryotic cells, and today this term may be used whether the 
DNA being transferred is viral in origin or not. While the term 
transformation is still used validly for the same process and 
the phenotypic expression which results from it, it is likely 
that those workers who avoid its use in favour of transfection 
do so in order to avoid confusion with the alternative and 
highly specific meanings attached to the word transformation in 
the fields of bacterial genetics and oncology respectively. 
This thesis draws upon a wide range of work in which, variously, 
each of the two terms is used to describe the introduction of 
DNA into eukaryotic cells; therefore transfection and 
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transformation are used interchangeably to convey this meaning 
in the sections which follow . 
Two broad categories of transfection methodology exist. In the 
first, the DNA of interest is introduced to the cells in the 
unprotected state (naked DNA transfer). In the second, the DNA 
is packaged in some way inside a membranous coating of 
non-nucleic acid material prior to cell contact 
(vehicle-mediated DNA transfer). 
Naked DNA Transfer 
An extensive range of methods exists for transfer to recipient 
cells of DNA which is unprotected. Despite the potential for 
exposure of the DNA to a variety of biochemical hazards during 
the transfection process, these methods are the most commonly 
used, probably because they are relatively simple. In many 
instances the DNA is in solution, and it is the solution which 
is delivered into the cell interior. In other cases the DNA is 
precipitated to form a granular suspension to which recipient 
cells are exposed, or the precipitate is taken a step further 
and coated on to particulate support material prior to solid 
phase delivery. 
Micropuncture 
Microinjection. The first injection of substances into cells 
using glass micropipettes was reported early in this century 
(Barber, 1914), and in a classic piece of work some years later 
the technique was used under darkfield illumination with cells 
in tissue culture (Chambers and Fell, 1931). In the modern 
version of the method, a glass microcapillary with a tip 0.2 -
1 .O~m in diameter is directed spatially by a mechanical 
micromanipulator during phase contrast microscopic observation 
of the cells to be injected, and samples . of 1 - 2 X 10-11 ml are 
transferred to the cells by positive and negative air pressure 
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control exerted by a syringe connected to the capillary 
(Diacumakos, 1980; Graessman and Graessman, 1983). Up to 1000 
cells can be injected per hour (Mueller et ai, 1980). The 
degree of precision is such that injected material can be placed 
in specific subcellular locations within the recipient cell, 
including the nucleus (Diacumacos et ai, 1970; Diacumacos, 
1980). Puncturing of the nuclear membrane does not lead to cell 
death (Diacumakos, 1980) and, in general, cultured cells are 
affected only mildly, if at all, by the intrusion of the syringe 
and the introduction of modest volumes of material into the 
intracellular space (stacey, 1980). 
Many microinjection studies have dwelt upon the effects of 
inserting specific proteins and RNA species into cells. 
However, microinjection of primary genetic material into cells 
has been exploited extensively and has included the 
transplantation of nuclei (Graessman, 1970) and chromosomes 
(Diacumakos et ai, 1970), as well as the transfer of purified 
DNA (Graessman and Graessman, 1976; Palmiter et ai, 1982). 
Microinjected DNA species are efficiently expressed; following 
intranuclear injection, transient expression levels are 50 -
100%, and significant stable expression as shown by 0.1 - 30% 
transformed colonies is achieved (Graessman and Graessman, 1983; 
Celis, 1984). 
As Diacumakos (1980) has pointed out, the advantages of the 
method include its directness - the immediate examination and 
monitoring of treated cells - and the requirements for few cells 
and small amounts of material to be transferred. Graessman and 
Graessman (1983) consider that a distinctly attractive aspect of 
the method is that opportunity is open to the investigator to 
choose and vary the site of inoculation within the cell. They 
make the additional comment that every tissue culture cell line 
tested has proven suitable for microinjection, including 
suspension cultures, as these can be bound to a substrate for 
the duration of the procedure. In spite . of these positive 
features, the method has been criticised on the grounds that it 
14 
is laborious (Loyter et al, 1975), requires particular skill 
(Tao et al, 1987 ) and is applicable to only small numbers of 
cells, thereby l imiting the types of analysis which can be 
employed within the system (Celis et al, 1980). These various 
features of the microinjection approach have been reviewed and 
evaluated by Celis (1984) in relation to a number of other 
transfer methodologies. Clearly the strongest applications of 
the microinjection technique lie in precise studies of single 
cells or small populations of cells which lend themselves to the 
use of highly sensitive assays such as those employing 
immunofluorescen t, autoradiographic, histochemical or virus 
plaque measurements. 
Laser Micropuncture. Tao et al (1987) have described a 
technique of direct gene transfer into cultured cells using 
laser microsurgical procedures in an ultramodern variation of 
the microinjection method. As in manual microinjection, the 
cells can be visualised and the perforation directed, although 
the entry 'of DNA and its positioning within the cell cannot be 
precisely controlled. The suggested mechanism of action is that 
of puncturing of the cell surface followed by rapid self-sealing 
of the hole, with DNA being taken up from the medium in the 
intervening period, presumably by a process of diffusion. 
The third harmonic 355nm wavelength from a short-pulsed Quantel 
model YG481a neodymium-ytrium-aluminium garnet laser was focused 




10nsec duration obtained by electronic shutter 
Pulse energies were in the range 23-67~J. Cells were 
and the laser beam targeted by employing a motorised 
microscope stag e coordinated with a video camera, TV monitor and 
computer. One thousand cells were irradiated per hour - a 
treatment rate comparable to that of experienced workers using 
the manual microinjection method (Mueller et al, 1980). Using 
human HT1080-6TG fibrosarcoma cells and the plasmid pSV2neo as a 
model system, between 1 in 8 X 104 and 1 in 3 X 103 cells 
demonstrated expression of the neo gene at a plasmid DNA 
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concentration of 12~g/ml. 
The authors make the point that although the manual 
microinjection method yields higher frequencies of DNA uptake 
and stable transformation in mammalian cells, it has worked only 
poorly in isolated plant protoplasts. They suggest that the 
laser method could be of importance in the genetic manipulation 
of plants and other types of cells for which similar 
difficulties have been encountered previously. 
Eiectroporation . Electroporation - sometimes termed 
electropermeabi l ization - is the reversible electrical breakdown 
("poration") of cell membranes brought about by high voltage 
electrical pulses (Neumann and Rosenheck, 1972; Serpersu et ai, 
1985). When cells are electroporated in the presence of DNA, 
its transfer int o the cells is actively facilitated via a 
mechanism which is now known to be at least partially 
electrophoretic (Winterbourne et ai, 1988). The production of 
holes, while quantitatively controllable, is random and 
therefore lacks the spatial precision of the microinjection 
procedure; on the other hand, large numbers of cells can be 
punctured and DNA-treated simultaneously. The method has been 
applied to a wide variety of cell types including mammalian cell 
lines (Potter et ai, 1984; stopper et ai, 1987), yeast 
sphaeroplasts (Karube et ai, 1985), plant protoplasts (Fromm et 
ai, 1986) and intact prokaryotes (Taketo, 1988). There have 
been recent reviews on specific applications (Shigekawa and 
Dower, · 1988; Morikawa et ai, 1988). 
Cells are treated in a cooled discharge chamber, 1 - 3ml in 
volume, fitted with twin parallel platinum electrodes connected 
to a pulse generator. During pulse treatment the cells are 
suspended in low ionic strength (low conductance) buffer made 
isotonic with nonionic molecules; after pulse treatment and 
prior to further culture, cells are transferred to a higher 
ionic strength medium containing magnesium and calcium ions for 
20 minutes or so at 37°C to allow membrane resealing (stopper et 
16 
al, 1987). In a typical procedure using mouse L cells and a 
plasmid carrying the selective marker gene neo, expression of 
the transferred gene was optimal when the cell concentration was 
3 X 10 5/ml, the plas~id concentration 1~g/ml, the temperature 
4°C, the field strength 10kV/cm, the duration of the pulse 
5~sec, the number of pulses 10 ~nd the interval between pulses 1 
minute. These conditions yielded one neo transformant per 
thousand cells (stopper et al, 1987). 
A commercially produced apparatus for electroporation is now 
available which claims transfection efficiencies for mammalian 
cells even higher than those of stopper and coworkers, although 
not for all cell types (Bio-Rad Laboratories, Bio-Radiations 
Bulletin No. 61EG, 1986). This apparatus is being used 
extensively as an alternative to calcium-induced plasmid 
transformation of bacteria; the resultant transfer efficiencies 
are greater (Taketo, 1988). 
Perforation by High Velocity Microproiectiles. An innovative 
method for DNA delivery by micropuncture, namely the use of a 
particle gun capable of firing tungsten microprojectiles into 
plant cells through cellulosic cell walls, has been reported by 
Klein et al (1987). The gun is a simple barrel down which a 
cylindrical nylon projectile, 5mm in diameter and 8mm long, is 
accelerated by firing pin detonation of a gunpowder charge. The 
tungsten particles, 4~m in diameter, are suspended in 1 - 2~1 of 
water and spread ~n the front surface of the nylon projectile. 
On detonation, the particles accelerate with the nylon 
projectile and continue moving towards the target cells through 
a 1mm aperture in a steel plate designed to stop the nylon 
projectile itself. The tungsten microprojectiles have an 
initial velocity of 430m/sec. 
Cells in the form of 1cm2 pieces of Allium cepa (onion) 
epidermis - approximately 2000 cells per piece - were used as 
targets and placed 10 - 15cm from the end of the firing device. 
When the tungsten particles in suspension were coated with 
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precipitates of either TMV RNA or p35S-CAT plasmid prior to 
bombardment, expression resulted. 
In common with electroporation, the advantages of this method 
are its rapidity, resulting from the simultaneous delivery of 
genetic material to many cells, and the high frequencies of 
transformation observed. An additional point in its favour is 
that cell culture or cell suspension is unnecessary; whole 
tissues can be subjected to the procedure without pretreatment. 
The possibility exists that by using the technique on 
meristematic tissue or embryogenic callus, the problems 
attendant on genetically transforming graminaceous 
monocotyledonous plants might be circumvented, current 
approaches involving regeneration of whole plants from altered 
protoplasts or Agrobacterium tumefasciens infection being beset 
by serious limitations. The authors point out that for such 
development to be feasible the process must be refined so that 
smaller cells than those of onion epidermal tissue can be only 
just penetrated. More recent work demonstrates that a degree of 
sophistication has been achieved in this respect: the method has 
been applied in the transformation of chloroplast genomes in 
Chlamydomonas (Boynton et ai, 1988) and mitochondrial genomes in 
Saccharomyces (Johnston et ai, 1988) by the bombardment of 
monolayers of the respective cells types, both of which are 
smaller than those of onion epidermis. 
It is interesting that Klein and coworkers make no comment on 
the use of animal tissue as target material. Suitably 
monolayered cel l s in whole tissue form are certainly not as 
commonplace in animals as they are in plants. It is also 
possible that the method, being particularly aggressive, would 
cause serious trauma in animal cells, although conditions of 
bombardment could perhaps be further modified to overcome such 
difficulties. 
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Membrane Disturbance by Mechanical Abrasion 
One group of workers has developed the idea of loading 
macromolecules into mammalian cells in culture by mechanically 
inducing general wounding of the plasma membrane, thereby 
opening up the cell interior to normally impermeant substances. 
McNeil et al (1984) first reported this approach in a technique 
termed scrape-loading in which washed cells are scraped from the 
culture surface with a rubber policeman in the presence of the 
macromolecule of interest, resuspended further in culture 
medium, replated, then allowed to recover and spread. In an 
attempt to eliminate the cell suspension step with its 
concomitant requirement for replating and growth prior to 
further experimentation, the method has been refined in a 
variation called bead-loading (McNeil and Warder, 1987), which 
causes grazing of the upper surface of attached cells in situ. 
In the bead-loading technique the culture medium of the cell 
monolayer is washed off and replaced by a small volume of a 
solution of the macromolecule to be loaded, glass beads 75 -
500~m in diameter sprinkled on to the cells, and the layer of 
beads , caused to roll across the cells by rocking 3 - 6 times. 
After rinsing the beads and the exogenous molecules away, the 
bead-loading step is complete, and fresh medium is then added to 
allow growth to continue. The method is therefore exceedingly 
straightforward, requiring little expertise and only the most 
simple of tools . Moreover, variations in bead size and degree 
of agitation al l ow for adjustments to be made according to the 
fragility of the cells under study and the extent of loading 
desired. However, the authors have shown that increased 
abrasion and loading is always gained at the expense of cell 
viability. 
Successful transformation of cells with genes borne on plasmids 
has been achieved using the scrape-loading method, with both 
transient and stable expression being noted (Fechheimer et al, 
1987), but no reports are yet available indicating a similarly 
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successful use of bead-loading for DNA transfer. 
Use of Chemical Facilitators 
Polycations. When DNA is added to the culture medium in which 
mammalian cells are growing, its occasional uptake into the 
cytoplasm and nucleus (Kraus, 1961; Szybalska and Szybalski, 
1962) is found to be enhanced to measurable levels in the 
presence of certain polymeric cationic compounds. Examples of 
such cationic facilitators are diethylaminoethyl-dextran 
(DEAE-dextran) (McCutchan and Pagano, 1968), polyornithine 
(Farber et ai, 1975) and 1 ,5-dimethyl-1,5-diazaundecamethylene 
polymethobromide (Polybrene) (Isa and Shima, 1987). The 
mechanism of facilitation remains obscure, but seems likely to 
relate to complex ionic interactions in which the positively 
charged cations act as a bridge between the anionic nucleic 
acids and negative charges on the cell surface, thereby creating 
a physical link between the DNA and the membrane (Isa and Shima, 
1987). 
While cationic facilitators have been used widely to effect 
increased uptake of viral nucleic acid (McCutchan and Pagano, 
1968), including supercoiled covalently closed circular forms 
(Sompayrac, 1981), transfer efficiencies have not been 
particularly impressive. Furthermore, in the case of selectable 
marker gene transfer, permanently altered cell lines have not 
been achieved using these methods (Gorman, 1985), although 
recent work by Isa and Shima (1987) suggests that DNA transfer 
followed by stable expression is possible using a cationic 
facilitator (Polybrene) in conjunction with dimethylsuphoxide 
(DMSO). 
Calcium Phosphate. More successful chemically facilitated 
transformations by far have been .demonstrated using calcium 
phosphate to precipitate DNA molecules on to mammalian cell 
surfaces. This technique was initially developed to detect the 
infective potential of viral DNA (Graham and van der Eb, 1973) 
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but has been used extensively since in a wide variety of 
mammalian genetic studies requiring the transfer of gene 
sequences from one cellular source to another. 
The technique draws upon simple equipment, is applicable to most 
cells in monolayer culture and some cells in suspension, and can 
be used to produce either transient gene expression or stable 
transformation in a consistent manner. The fact that its 
efficacy does not depend upon membrane aggression, but rather 
leaves the cell surface intact, gives the method added appeal . 
On these grounds it has proved to be an extremely popular means 
of gene transfer to mammalian cells, and has been quoted as the 
most widely applied method (Vainstein et ai, 1983; Gorman, 
1985). The transfer frequencies obtained vary a great deal 
according to the recipient cell line. Tao (1987) quotes 1 - 5 
transformants per 105 - 107 cells as a general value. One often 
quoted disadvantage lies in these only moderate frequencies 
(Strain and Wyllie, 1984; Tao, 1987; Tsao, 1987); another in the 
abnormally high levels of calcium and chemical adjuvants 
required. While this latter factor has in the past been the 
subject of some general suspicion and criticism (Tao, 1987), it 
has only recently been shown that calcium perturbation during 
the calcium phosphate procedure may lead to distinct genetic 
effects, namely heritable alterations in both the tumorigenic 
and malignant behaviour of transfected neoplastic cells (Kerbel 
et ai, 1987) and abnormal transcriptional activation (Pine et 
ai, 1988). Based on this evidence, use of the method may 
seriously decline, especially in studies where investigation of 
gene expression is the primary object. 
The method involves the mixing of the DNA of interest with 
calcium chloride followed by gradual introduction of the mixture 
to phosphate ions in order to produce a fine coprecipitate of 
DNA and calcium phosphate. When this suspended precipitate is 
added to cell cultures it binds to the plasma membranes readily, 
and over the next several hours of incubation the DNA may be 
taken up into the cells and ultimately expressed. There are 
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many relevant factors to be considered in using the technique 
and consequently many versions of the basic protocol. Some of 
the more important parameters affecting efficiency have been 
examined and reviewed by Graham et al (1980). They include cell 
type, cell density, carrier DNA concentration and molecular 
weight, size of the coprecipitate particles and time of exposure 
of cells to particles. Two , particular methodological variations 
subsequently proven to be the ones most commonly used have been 
described in detail by Gorman (1985). A further variation which 
utilises whole chromosomes rather than DNA fragments has been 
outlined by Srinivasan and Lewis (1980). 
By employing fl uorescent dye-stained DNA and tracing its pathway 
into the cell, Loyter et al (1982) have shown that the DNA-
calcium phosphate complexes enter cells by an endocytosis- like 
process, and that the DNA, for the most part, becomes trapped 
within degradat i ve vacuoles. Vainstein et al (1983) have argued 
that these find i ngs explain respectively why cells such as mouse 
L cells with a high level of endocytic activity are well suited 
to transformation by DNA-calcium phosphate coprecipitates and 
why the observed transformation frequencies for all cells are 
--------
never very high. In this regard it is significant that 
transformation levels are raised in the presence of chloroquine, 
a drug with lysosomotropic activity (Luthman and Magnusson, 
1983). 
other additives which are observed to increase the frequency of 
gene uptake and expression after DNA-calcium phosphate treatment 
have been reported. For example, sodium butyrate has been shown 
to increase the expression of transferred DNA several-fold 
(Gorman et al, 1983), especially if the cells are shocked with 
15% glycerol first (Gorman, 1985); the butyrate appears to 
enhance the transcriptional activity of plasmids bearing SV40, 
polyoma and papilloma virus control regions in particular. 
Addition of dimethylsulphoxide (DMSO) to cells at the end of the 
coprecipitate treatment period also has ~een shown to improve 
transfer and expression efficiency (Srinivasan and Lewis, 1980). 
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(This effect of DMSO has been noted above in relation to 
polycation-induced DNA transfer.) In a detailed study of the 
uptake and stability of SV40 DNA after calcium phosphate 
transfection of CV-1 cells, Strain and Wyllie (1984) conclude 
that the mechanism of action of agents such as glycerol and DMSO 
remains enigmatic, but may involve the conferral of greater 
stability on the transferred DNA intracellularly rather than the 
mere alteration of its rate of entry into the cell. 
Vehicle-Mediated DNA Transfer 
A number of methods have been developed for the transfer to 
mammalian cells of DNA which is enclosed in a protective 
covering. In each of the methods the covering is a membrane of 
natural or artificial origin which offers distinct advantages to 
the DNA being carried. The membrane may serve the purpose of, 
firstly, enclosing large numbers of DNA molecules '(gene copies) 
in each vehicular unit; secondly, protecting the DNA molecules 
from attack by serum or cell-secreted nucleases prior to cell 
entry, and thirdly, attaching to and either fusing with or being 
taken up by the target cell, via natural or contrived 
mechanisms, thereby allowing intracellular unloading of the DNA 
to take place in a manner which bypasses the normal permeability 
barrier of the cell membrane. The various experimental 
approaches employing membranous DNA carriers are presented 
below. 
Protoplasts as Carriers 
DNA present in bacterial cells, including multiple cloned 
sequences carried on plasmids, can be transferred to mammalian 
cells directly and very effectively if the cells are converted 
to wall-less protoplasts and the protoplasts brought into c lose 
contact with the recipient cells by fusion techniques. The 
charm of the method lies in the fact that the DNA of interest 
never leaves its natural cytoplasmic environment and therefore 
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does not have to be extracted or purified at any stage. This 
saves time and effort and, more importantly, eliminates 
procedures and conditions liable to cause -nicking and shearing 
of the DNA. 
Protoplast fusion was developed initially by Schaffner (1980) 
for the introduction into mammalian cells of SV40 DNA cloned in 
E. coli. The technique was extended by Sandri-Goldin et al 
(1981) using cloned DNA sequences from herpes simplex virus type 
1 (HSV1), including the thymidine kinase (tk) gene, and these 
same authors subsequently reviewed the general methodology 
(Sandri-Goldin et al, 1983). More recent work reports 
significantly successful use of protoplast fusion as a method of 
choice in permanently transferring the genes cat and neo, 
incorporated into respective plasmids, to human haematopoietic 
cells (Tsao et al, 1987). 
Three steps are involved in the procedure: the transformation of 
and subsequent production and amplification in an appropriate 
bacterial host of plasmids carrying the gene or genes of 
interest; the removal of cell wall material from the whole 
bacterial cells by lysozyme digestion in order to create 
protoplasts, and fusion of the resultant protoplasts to 
recipient eukaryotic cells in culture. The bacterial strains 
used as carriers in experiments involving mammalian cell 
recipients have been mostly mutants of E. coli- HB101, 1106 and 
DH-1 - while those employed as carriers in the genetic 
manipulation of higher plant cells have been variants of 
Agrobacterium tumefasciens (Sandri-Goldin et al, 1983). The 
recipient mammalian cell lines used have been many and varied, 
and have included 3T6 mouse fibroblast cells, Vero cells (from 
African Green Monkey kidney) and human HeLa cells (Schaffner, 
1980; Sandri-Goldin et al, 1981) as well as human leukaemia K562 
cells (Tsao et al, 1987). Plant work has included the use of 
cells from the drug-producing Vinca rosea as recipients 
(Hasezawa et al, 1981). 
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The actual binding process between the two cellular elements is 
brought about by pelleting the protoplasts on to recipient cell 
monolayers or by pelleting a mixture of protoplasts and cells, 
then overlayering the close- packed mixture with concentrated 
(approximately 50%w/v) polyethylene glycol (PEG) for 2 - 4 
minutes before washing and incubation. It is not known for 
certain whether PEG treatment brings about true fusion and 
therefore the formation of hybrid cells on any significant 
scale; the work of Hazezawa et al (1981) suggests that while 
some fusion does occur, the PEG treatment is most active in 
promoting endocytotic uptake of the protoplasts by the much 
larger recipient cells. What is clear, in spite of uncertainty 
in this regard, is that genetic material carried by the 
prokaryotic element is released into the eukaryotic partner and 
stably expressed at high frequency (Sandri-Goldin et ai, 1983). 
Fusogenic agents other than · PEG which may permit mass 
conjunction of cells are DEAE-dextran and inactivated Sendai 
virus, and these have been used variously in cell fusion 
technology (Poste and Nicolson, 1978) . More recently, electric 
field mediated fusion (Zimmermann, 1982) and laser-induced 
fusion (Wiegand et ai, 1987) have been put forward as further 
options. 
Erythrocyte Ghosts as Carriers 
In this methodology the plasma membranes (ghosts) of mature, 
enucleate mammalian erythrocytes are partially emptied of their 
normal cytoplasmic constituents (largely haemoglobin) and loaded 
with a macromolecule of choice during hypo-osmotic haemolysis. 
The resultant erythrocyte carriers are then fused with 
appropriate recipient cells using inactivated Sendai virus or 
PEG so that the ghosts' contents are donated to the cells. 
This technique was originally described by three different 
groups and was referred to variously as a means of 
macromolecular injection (Furusawa et ai, 1974), microinjection 
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(Schlegel and Rechsteiner, 1975; 1978) and ultramicroinjection 
(Loyter et ai, 1975), although the concept involved here must be 
carefully distinguished from that of mechanical microinjection. 
Celis et al (1980) have made a valuable comparison of the two 
kinds of microinjection, while in a later review, Celis (1984) 
refers to erythrocyte- ghost-mediated transfer without invoking 
the term microinjection at all. 
In general the method has been used for the transfer of proteins 
or small particles (Loyter et ai, 1975), tRNA (Schlegel and 
Rechsteiner, 19 78) and mRNA (Boogaard and Dixon, 1983). It has 
been used only rarely for DNA (Iiono et ai, 1983; Wiberg et ai, 
1983), apparentl y because large, unwieldy molecules like DNA 
cannot be loaded into erythrocytes easily by the available 
procedures (Cel i s et ai, 1980; Celis, 1984). 
The greatest importance of erythrocyte vector technology to DNA 
transfer techniques lies in its historical relationship to the 
following two methods which are based on similar principles. 
Reconstituted Animal Virus Envelopes as Carriers 
The idea of using inactivated Sendai virus to induce 
erythrocyte-cell fusion in the unloading of erythrocyte carriers 
has been taken even further by Loyter and colleagues (Vainstein 
et ai, 1983). Using as a basis a previously reported method for 
reconstructing Sendai virus envelopes from constituent molecules 
(Hosaka and Shimizu, 1972), they have developed a means of 
employing these reconstituted structures as DNA carriers. 
Sendai virus belongs to the paramyxovirus group. Its membranous 
envelope bears an F glycoprotein responsible for virion-cell 
binding. Such an envelope therefore provides both the facility 
for containment and intrinsically fusogenic properties when put 
into contact with cells bearing the appropriate receptors. 
In essence the method involves the dissolution of intact virions 
by the action of a detergent (Triton-X 100 or Nonidet P-40), the 
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removal by centrifugation of the detergent-insoluble 
nucleocapsid material, the reconstitution of the membrane in the 
presence of the DNA of interest during removal of the detergent 
by dialysis, and , finally, the digestion of exterior DNA by 
DNAse. The resultant reconstituted Sendai virus envelopes 
(RSVE) comprise viral phospholipids and two glycoproteins 
including F. For fusion to take place, it is essential that 
recipient cells bear sialic acid residues on cell surface 
glycoproteins or glycolipids. Since such sialoglycoproteins and 
sialoglycolipids are, in fact, present in a wide range of animal 
cell lines Vainstein and coworkers have dubbed the RSVE "an 
almost universal fusogenic syringe". 
Transfer of SV40 DNA and the HSV tk gene has been shown to occur 
in a broad range of cell lines, some of which have previously 
demonstrated resistance to transformation by DNA-calcium 
phosphate complexes. Loyter's group suggest that, in theory, 
the RSVE method should be as efficient as intact animal viruses 
in the transfer of functional DNA molecules. They concede, 
however, that in order to reach such a goal, significant 
improvements would be necessary, especially in the steps 
involved in trapping DNA inside the envelope structures. 
Liposomes as Carriers 
Liposomes are laboratory-produced mono- or multilamellar 
vesicles in which the vesicular boundary layers are ordered 
assemblages of amphipathic molecules, largely phospholipid in 
nature, fully compatible with aqueous environments on both their 
internal and external surfaces and stable in water-based 
solutions for considerable periods. Liposomes can be 
manufactured by a number of methods, some of which allow 
efficient trapping of water-soluble high molecular weight , 
solutes. They are therefore potentially advantageous as 
carriers of important biological macromolecules. Their use in 
this respect was first reported by Grego~iadis and Buckland 
(1973), who used murine cells lacking invertase and accumulating 
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sucrose in a sucrose-rich medium as a model for storage disease, 
and showed that by incubating the cells with liposomes loaded 
with invertase the condition could be alleviated. 
Several of the properties of liposomes which are important 
experimental parameters in carrier technology can be varied at 
will: size can be adjusted from a radius of approximately 12nm 
for the smallest monolamellar vesicles to several ~m for 
multilamellar types; negative or positive surface charges may be 
imposed by the incorporation of charged amphiphiles, and 
fluidity of the bilayer manipulated by alteration of its 
phospholipid composition. As a result, liposomes offer the 
worker an unusually versatile delivery system. Within the last 
decade, starting with the work of Mukherjee et al (1978) on 
liposome-mediated chromosome exchange, this approach has 
extended itself readily to specific application in purified DNA 
transfer. 
Liposomes generally fall into one of three categories according 
to structure and size, factors which in turn are dependent upon 
the method of preparation. Multilamellar vesicles (MLV) arise 
when a film of phospholipid supported on the inner wall of a 
glass vessel is hydrated with vigorous agitation. Small 
unilamellar vesicles (SUV) are produced when a suspension of MLV 
is extensively sonicated. Neither MLV nor SUV lend themselves 
to DNA entrapment for two major reasons: the effective internal 
volume is small in both cases, and the physical rigours 
encountered during preparation lead to significant fragmentation 
of nucleic acids introduced into the aqueous phase for 
incorporation. On the other hand, large unilamellar and 
oligolamellar vesicles (LUV), which bound a relatively large 
aqueous volume, can be ,made to capture DNA very successfully if 
physically mild methods of manufacture are chosen from the 
variety available. 
One method of LUV preparation which has been found applicable to 
DNA incorporation is an injection technique originally proposed 
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by Deamer and Bangham (1976) in which lipid dissolved in diethyl 
ether is injected into an aqueous phase warmed to a temperature 
at which the ether vaporises, thereby inducing liposome 
formation. When DNA is the solute for encapsulation, the 
aqueous solution is heated to 60°C and the ether solution 
injected very slowly and consistently at rates of 0.1 -
2.0ml/hr. The result is a population of liposomes having 
diameters of 0.2 - 0.5~m and a capture efficiency of 8 - 14~1 
DNA solution/~mole of lipid (Cudd and Nicolau, 1984). 
Reverse-phase evaporation (REV), first described by Szoka and 
Papahadjopoulos (1978), gives rise to liposomes of similar size 
and holding capacity as the ether injection method, and is 
considered to be the most suitable and convenient preparative 
procedure if DNA is to be encapsulated (Straubinger and 
Papahadjopoulos, 1983). Aqueous buffer containing the nucleic 
acid of interest is mildly sonicated or extensively vortexed 
. with a larger volume of diethyl ether containing dissolved 
phospholipid. This produces a stable water-in-oil emulsion in 
which the hydrophobic lipid tails project into the ether and the 
hydrophilic head groups enclose aqueous droplets. The ether is 
then evaporated off under reduced pressure, a process which 
reverses the phases, the lipids reverting to normal bilayer 
configuration and trapping the DNA solution previously 
surrounded by lipid head groups. Careful control of conditions 
during the formation of the original emulsion is essential if 
the DNA is to remain intact; the relevant parameters have been 
reviewed by Straubinger and Papahadjopoulos (1983) and eudd and 
Nicolau (1984). 
Free, untrapped DNA is often separated from the liposome 
fraction by gel exclusion chromatography, differential 
centrifugation, or flotation on discontinuous polymer gradients 
(Straubinger and Papahadjopoulos, 1983). In addition, liposomes 
of varying size may be passed through a polycarbonate filter to 
produce a population of uniformly sized vesicles without loss of 
material (Cudd and Nicolau, 1984). 
29 
The close physical association between DNA-carrying liposomes 
and recipient cells which is essential for delivery of the DNA 
occurs naturally during incubation of the two populations in 
physiological medium, particularly avidly if the liposomes are 
rich in negatively charged phospholipid (for example, 
phosphatidylserine) and cholesterol (Straubinger and 
Papahadjopoulos, 1983). Following binding, the liposomes are 
carried into the cell interior by endocytosis (Straubinger et 
al, 1983). It appears that liposomes do not fuse with the host 
cell plasma membrane unless induced to do so by the 
incorporation of viral fusogens into the lipid bilayer of the 
liposome structure or by polyethylene glycol perturbation 
(Struck et al, 1981). Based on the infectivity of liposome-
carried SV40 DNA, it appears that the application of PEG (44%w/v 
for 90 sec) is advantageous in that it enhances effective 
delivery by a factor of 10, as does the addition of DMSO (25%v/v 
for 4 min), while glycerol (15 - 35%v/v for 4 min or more) is 
even more effective, enhancing delivery 100 - 200-fold (Fraley 
et al, 1981). On the other hand, one of the beauties of 
liposome-mediated delivery is that it can occur successfully 
without the agency of any such toxic fusogen. 
Liposomes have been utilised for various genetic transactions. 
Some of the earl y experimental models were primarily for the 
purpose of demonstrating the feasibility and advantages of gene 
carriage and transfer by liposomes and employed only bacterial 
systems. One example of this approach is the work of Fraley et 
al (1979) in which the liposome encapsulation of pBR322 prior to 
transformation of E. coli was shown to make the process DNase 
resistant. However, there have been many reports of 
liposome-mediated transfections of eukaryotic cells, including 
plant protoplasts (Lurquin and Sheehy, 1982) and cultured murine 
L cells (Schaefer-Ridder et al, 1982). The efficiency of DNA 
delivery has been correlated to vesicle phospholipid composition 
and incubation conditions (Fraley et al, 1981) as well as to the 
type of liposome used and the stage of tne cell cycle at the 
time of transfection (Nicolau and Sene (1982a). Nicolau and 
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Sene (1982b) have reviewed liposome-mediated DNA transfer and 
expression in eukaryotic cell systems. 
Retroviruses as Carriers 
Molecular cloning of functional mammalian genes in animal 
viruses and expression of the cloned genes in infected cells is 
an avenue of gene transfer which has been exploited only very 
recently. However, it is showing particular promise in a number 
of specific directions, notable progress having been made in 
studies of gene regulation, especially during embryonic 
development, as well as in studies directed towards corrective 
gene therapy. Consequently, viral structures have become 
important tools in these areas of biological research (section 
1.2.3). A number of viral types have been used in these 
endeavours, incl uding DNA viruses such as simian virus 40 
(Mulligan et al , 1979; Gruss and Khoury, 1981) and vaccinia 
virus (Mackett et al, 1982). Recently, the RNA togavirus known 
as Sindbis virus has been suggested as a useful vector (Xiong et 
al, 1989). Mos t attention has been given, however, to the group 
of RNA viruses known as the retroviruses, and current work 
utilising virus particles as gene vectors is almost exclusively 
focused on this viral family. 
The viruses which belong to the Retroviridae are unusual 
enveloped plus-strand RNA viruses which infect dividing cells in 
a range of animals including primates. The viral RNA, together 
with 50 - 100 molecules of reverse transcriptase, is packaged 
into the virus core. On cellular infection, the viral genome 
undergoes conversion from single-stranded RNA to double-stranded 
DNA, and in this form it is inserted into the genome of the host 
as a proviral sequence where it remains as a permanent genetic 
feature. There, the provirus is regularly replicated, 
transcribed and translated to produce viral RNA and proteins 
which are assembled and released as new virions, acquiring 
envelopes as they are budded outwards from the host cell plasma 
membrane. Virion production is usually at a chronic level, and 
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although under certain conditions retroviruses may be 
cytopathic, they are generally not so and the host cells are not 
killed; on the contrary, cellular growth may be potentiated 
(Bishop, 1978; Mason et ai, 1987). 
All retroviruses have a small genome (8-10kb) with a similar 
genetic organization. Even those which are self-contained with 
respect to infection and replication functions carry just a few 
essential structural genes, namely gag, pol and env, encoding 
the core proteins, reverse transcriptase plus associated 
enzymes, and envelope proteins respectively. These act in 
conjunction with control regions which, in the proviral genome, 
form long terminal repeat sequences (LTRs) flanking the 
structural genes on both sides (Mason et ai, 1987; Varmus, 
1988). 
Many retroviruses are acutely tumorigenic as a result of the 
incorporation of oncogenic recombinant sequences of cellular 
origin into their own genomes at some stage in the past. A 
classically studied example is Rous Sarcoma Virus (RSV), 
causative of sarcomatous growths in birds, which bears the 
oncogene src in addition to the viral genes gag, pol and env. 
RSV is, however , an exceptional oncogenic retrovirus in that it 
is genetically complete and therefore replication competent. 
All others known have oncogenes substituted for viral structural 
gene sequences; there is consequent loss of the normal 
complement of trans-acting gene products, and the viruses are 
replication defective. In nature, the molecular components 
required for the replication and integration of such a defective 
virus are complemented in trans by a non-oncogenic 
replication-competent helper virus. Such a system allows a 
large proportion of the defective viral genome to be dispensed 
with, as the only cis-acting sequences which must be retained 
intact if the viral life-cycle is to continue are the LTRs, the 
sites for the priming of reverse transcription and a packaging 
signal sequence, all of which are situated in the terminal 
regions of the provirus . Certain naturally occurring oncogenic 
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retroviruses demonstrate this potential for genomic plasticity 
by showing extreme degrees of genetic depletion and substitution 
(Pimentel, 1986). 
The first infective retrovirus constructs containing 
artificially introduced non-retroviral genes were designed and 
reported by Shimotohno and Temin (1981) and Wei et al (1981). 
In the latter case, a recombinant genome carrying the cis-acting 
LTR and closely adjacent regions and the src oncogene of Harvey 
murine sarcoma virus (Ha-MuSV), together with the thymidine 
kinase (tk) gene of herpes simplex virus-1 (HSV-1) linked to it 
in a downstream position, was constructed in bacteriophage 
Lambda, cloned, and used to transform mouse NIH3T3 fibroblasts 
by calcium phosphate transfection procedures. On superinfecting 
the transformed fibroblasts with a helper-independent retrovirus 
- Moloney murine leukaemia virus (Mo-MuLV) - new individual 
retrovirus were isolated. These pseudotypes were shown to be 
infective towards NIH3T3 cells, a single virion being capable of 
expressing both the src and tk genes. While the new retroviral 
sequence src-tk was non-productive (replication-defective) it 
could be rescued into virus particles at high titre by, again, 
infection with a helper-independent retrovirus. It was found to 
be a single RNA species 4.9 kilobases long. 
In creating a fully infective but non-replicative dual gene 
function retrovirus of this nature, the stated purpose of Wei 
and coworkers was the creation of a unique means of gene 
transfer which would be a most useful tool in the genetic 
a~alysis of src and other retroviral genes, especially other 
oncogenes. In addition, the mode of preparation of the virus 
was seen as a model system for understanding how the natural and 
spontaneous generation of oncogenic retroviruses might have 
occurred during evolutionary history. 
By contrast, later workers saw the powerful potential of 
retroviral vectors in broader terms. For example, Willis et al 
(1984) have pinpointed the general advantages of retroviral gene 
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delivery over transfer by other methods applicable to animals. 
They comment in particular on the 100% efficiency of the process 
of cellular entry by retroviruses. They mention also that cell 
types recalcitrant to calcium phosphate-mediated DNA transfer 
may be retrovirally infected, and that, uniquely, a single copy 
of the transferred genetic sequence is integrated into the 
recipient cell genome, simplifying studies of its organisation 
and expression. Miller et al (1984) have made similar points, 
drawing attention to the capacity of the retroviral structure 
for genomic flexibility. 
The growing perception that retroviruses carrying oncogenes are 
naturally occurring and highly evolved eukaryote gene vectors, 
combined with t h e realisation of the extreme order of efficiency 
with which retroviruses are capable of infecting cells, have 
jointly been the key to an even more broadly based insight: 
that of the possible use of retroviral vectors as agents of 
therapeutic gene transfer to cell lines and, ultimately, to 
whole animals including humans (Robertson, 1986; Varmus, 1988). 
Natural retroviral mechanisms have now been expropriated by 
clinical invest i gators with vector designs of their own, and 
this aspect of retroviral development has advanced enormously in 
the last few years, albeit encountering unforeseen difficulties 
on the way. It is discussed further in section 1.2.3. 
1.2.3 APPLICATIONS OF GENE TRANSFER TECHNOLOGY 
The deliberate insertion and integration of functionally active 
genes into eukar yotic cells has broad-ranging and enormously 
important practical relevance in molecular biology, as well as 
in the many fields of applied science which draw upon its 
technology: medicine, agriculture and industry. The extensive 
array of transformation methodologies reviewed in section 1.2.2 
and the continuous emergence of new ones in themselves attest to 
this. Outlined briefly below are the areas of research in which 
radical advances have been made that are directly attributable 
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to the facility for experimental gene transfer. 
Gene Expression 
Extremely fine analysis of the mechanisms by which gene 
expression is regulated has been possible as a result of the 
transfer of precisely engineered combinations of structural 
genes and control region components to recipient cells in which 
expression can be monitored. In fact there is almost no current 
biochemical research in the area of gene regulation which does 
not employ gene insertion techniques. This type of work has 
involved much use of expression vectors carrying assayable 
bacterial genes (section 1.2 . 1) fitted with various arrangements 
of eukaryotic regulatory elements, and measurement of their 
genetic activity on delivery to cultured cells (Johansen et al, 
1984; Rosenthal, 1987). Important advances such as the 
identification of the roles of cis-acting promoter and enhancer 
DNA sequences in the regulation of transcription has come about 
almost entirely because of this kind of approach (Maniatis et 
al, 1987). Furthermore, headway has been made in understanding 
how location-specific and temporal expression is controlled by 
these elements, as for instance in the study by Elshourbagy et 
al (1987) of the expression of the human apolipoprotein A-IV 
gene according t o tissue type. Just how functionally versatile 
such elements may be is also emerging as a key concept, as for 
example in the bidirectional control of a gene pair by a shared 
enhancer (Nickol and Felsenfeld, 1988). 
Protein structure-Function Relationships 
The insertion of structural genes and gene fragments into a 
foreign or homologous cell system for the contrived production 
of the coded protein has become an important means of protein 
structural analysis. One of the early examples of this approach 
is the cell surface expression of the influenza haemagglutinin 
glycoprotein, an integral membrane protein, following host cell 
infection with a viral vector (SV40) carrying a cloned DNA copy 
35 
of the original RNA gene (Gething and Sambrook, 1981). A 
comparable study by Rose and Bergmann (1982) involved cell 
surface secretion of vesicular stomatitis virus glycoprotein. 
Procedures such as these have opened the way to detailed study 
of both viral and non-viral genes and their products which would 
be inaccessible t o genetic analysis at their natural loci. 
There are many i nvestigations in which the use of site-directed 
mutagenesis or c h emical modification for the production of minor 
structural alterations, alternatively the insertion of foreign 
nucleotide sequences into the gene for the production of hybrid 
proteins, allows dissection of the molecular domains of the 
protein in terms of structure, function and biosynthesis. In 
one example, observations of intermediate filament formation in 
hamster lens and HeLa cells transfected with modified hamster 
vimentin and desmin genes has established the roles played by 
terminal regions of the proteins in intermediate filament 
assembly (van den Heuvel et al, 1987). 
Physiological Processes 
As more mechanisms of cellular physiology become understood in 
terms of peptide and protein activity, the use of gene transfer 
techniques to a i d in further elucidation is increasing. One 
field which lends itself to this approach is that of 
neuropeptide processing (Thomas and Thorne, 1988). 
Cellular Differentiation 
Hierarchies of cellular differentiation have been elucidated by 
the introduction of clonal markers into primitive stem cells. 
In the majority of studies of this kind, the haematopo i etic 
system has been used as a model, neo has been used as the gene 
marker, and retroviral vectors have been the means of marker 
insertion. The gene transfer step is accomplished in vitro, but 
only as a preliminary to reestablishment in vivo, this type of 
investigation being the first to employ gene delivery to intact 
animals (Cline et al, 1980). In a feasibility study in mice in 
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which foreign genetic material was introduced into pluripotent 
haematopoietic stem cells (the progenitors of all blood 
tissues), Mulligan and coworkers (Williams et al, 1984) 
pinpointed the particular usefulness of retroviral vectors for 
work of this kind: the stem cells to be transfected represent 
only 0.01% of the bone marrow population, and have not been 
defined morphologically, thus making a highly efficient method 
of gene transfer essential. Subsequent work by Mulligan's group 
(Dzierzak et al, 1988) has utilised the method to analyse 
lineage-specific gene expression. Dick et al (1985) employed 
this same approach to monitor cell lineages in some detail, and 
made clever additional use of the retroviral gene transfer 
mechanism: progeny from individual stem cells were unequivocally 
identified by their unique proviral integration site on the 
chromosome. 
Developmental studies comparable to these have been made 
possible using preimplantation embryos as gene recipients, gene 
insertion usually being accomplished either by analogous 
retroviral protocols (Rubenstein et al, 1986) or microinjection 
(Gordon and Ruddle, 1983). In an ingenious variation, Bosselman 
et al (1989) have combined the two in order to overcome 
difficulties previously encountered in introducing genes into 
early embryonic chickens: they microinjected nonreplicative 
retroviral vectors into stem cells in the unincubated embryo, 
with a considerable degree of success. 
Role of Oncogenes in Carcinogenesis 
Twenty oncogenes have been identified in oncogenic retroviruses 
(Duesberg, 1987). In addition, cellular protooncogenes that 
have been subjected to somatic mutation, amplification or 
rearrangement, thereby creating potential oncogenes, have been 
found in a variety of tumours (Bishop, 1987). Using cell 
culture as a model system, and phenotypic changes such as 
cellular morphology and growth in soft agarose as indicators of 
neoplasticity, oncogenes and putative oncogenes have been tested 
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for their ability to transform primary cell cultures, usually of 
embryonic rodents. The sequences to be tested are most often 
inserted into the cells via plasmid constructs, delivered by 
means of simple methods of transfection such as the calcium 
phosphate-DNA coprecipitate protocol. As a result of this 
approach, many oncogenes have been identified, a huge body of 
information on oncogene expression has been accumulated, and 
important principles derived concerning the way in which 
tumorigenesis is genetically determined. For instance, it is 
now known that although some oncogenes may unilaterally bring 
about cancerous changes (Hjelle et ai, 1988), many others do so 
only in cooperation with a second or third oncogene (Land et ai, 
1983). From a similar experimental base of molecular genetics 
it is also now clear that the products of oncogenes and 
protooncogenes are most frequently growth factors or growth 
factor receptors (Guroff, 1987) and the insight this unifying 
concept allows into the possible mechanism of carconogenesis 
suggests structured ways of further investigating the problem. 
Therapeutic Gene Replacement 
Within the arena of gene transfer, the drive to devise and 
perfect ways of delivering corrective genes to genetically 
defective animals has been perhaps the most persistent. Its 
fundamental operation depends upon the dual availability of the 
facility for gene delivery to whole organisms and efficient 
stable integration. It has therefore relied upon one of three 
approaches: (i) microinjection or retroviral delivery of genes 
to the germ line, (ii) retroviral in vitro transformation of 
somatic cells subsequently transplanted into a recipient animal, 
and (iii) direct in vivo vehicle-mediated transformation of 
somatic tissue via the circulatory system. A possible advantage 
of (i) is that i t results in permanent, vertically transmitted 
therapeutic change. It is typified by the work of groups led by 
Jaenisch and Costantini respectively (Jaenisch, 1988; 
Constantini et ai, 1986). Both (ii) and . (iii) effect change 
which is restricted to the recipient organism, but the potential 
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for experimental control and tissue targeting in these 
procedures appear s to be distinctly advantageous, and the risks 
and costs incurred would be less than for (i), thus making them 
more likely candidates for use in humans. 
Not surprisingly, the haematopoietic system has been envisaged 
as a convenient manipulable system for the development of 
somatic therapy involving retroviral transformation of 
transplantable tissue, and it has been suggested and 
accomplished using bone marrow by a number of laboratories led 
respectively by Mulligan, Miller, Anderson and others who were 
active in establishing the necessary technology for studies of 
blood cell lineages, mentioned above. Working with the bone 
marrow system, Hock and Miller (1986) made an important 
contribution to retroviral therapy in pioneering the design of 
"suicide" infections, using packaging-defective helper viruses 
in conjunction with the replication-defective retroviral vector, 
thereby achieving transformed cells completely lacking any 
residual contaminating viruses. More recently, the same group 
of workers has turned attention to the prospects for therapeutic 
implantation or grafting of genetically engineered skin 
fibroblasts into recipient patients; they have initiated 
investigations by correcting specific medically important gene 
deficiencies in human fibroblast cultures (Anson et al, 1987; 
Palmer et al, 1987), while other workers have undertaken 
fibroblast therapy in murine whole animal models (Selden et al, 
1987). The facility these approaches offer for characterisation 
of the transformed cell line before transplantation is 
particularly appealing. 
Gene therapy via the circulatory system is of continuing 
interest, but less well developed than cell transplantation 
techniques, especially with respect to whole animal trials. Of 
the gene delivery methods developed to date the only ones which 
lend themselves to circulatory use are those involving 
vehicle-mediated transfer, and the sugge$ted approach closely 
resembles that of vehicle-mediated drug delivery which has been 
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investigated in some depth over a number of years (Gregoriadis, 
1977; 1984). Many studies have been devoted to the potential 
these delivery systems have for tissue-specific targeting via 
modifications of the vehicular membrane, particularly the 
inclusion of appropriate antibodies into liposomes (Gregoriadis 
and Meehan, 1981; Peeters et ai, 1988), but few have 
demonstrated targeted DNA delivery by vehicular means. One 
which has, but only with a cell culture model, is the work of 
Gitman et al (1985) which showed the targeted delivery of SV40 
DNA, via Sendai virus envelopes incorporating insulin, to virus 
receptor-depleted hepatocytes. Other studies have dwelt upon 
the potential of certain tissues to be used as targets. For 
example, Smirnov et al (1986) have suggested that denuded areas 
of blood vessel walls might make a useful target for liposome 
and erythrocyte carriers. Using similar thinking but a viral 
vector approach, Anderson's laboratory is currently looking at 
the transducibility of endothelial cells, on the basis that the 
immediate contact the endothelium has with the circulating blood 
makes it an attractive in vivo target tissue for retrovirally 
delivered genes (Zwiebel et ai, 1989). 
A distinction must be made between extracellular targeting of 
genes to specific cells or tissues and intracellular targeting 
of genes to homologous sites within the chromosome. The latter 
is crucially important if precise gene correction is to be 
achieved, yet most methods of gene insertion used at the present 
time lead to uncontrolled and illegitimate recombination events 
in mammalian systems (Kato et ai, 1986), while retroviral gene 
transfer is a system of naturally controlled random insertion 
(Dick et ai, 1985). Moreover, there is evidence that although 
DNA may be targeted to sites of homology at high frequency under 
certain conditions (Thomas et ai, 1986), the result may be the 
production of mutation in the cognate gene (Thomas and Capecchi, 
1986). Targeted recombination is therefore an area of great 
importance within the field of gene therapy; it continues to 
produce interesting results from systems in which attempts are 
made to represent the genetic environment more normally than 
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previously (Adair et ai, 1989), and may lead to more prolific 
investigations in the near future. 
Transgenic Animals and Plants 
The introduction of foreign genes into the germ line and 
successful expression of the transferred gene has led to genetic 
manipulation of animals on a major scale. In a review of the 
subject, Jaenisch (1988) gives details of the techniques 
employed. They can be summarised broadly as follows: (i) 
injection of recombinant DNA into the pronucleus of a fertilised 
egg; (ii) retroviral gene transfer to pre- and post-implantation 
embryos, leading to some germline transformation, and (iii) gene 
transfer by a variety of methods into embryonic stem cells 
established in vitro from explanted blastocysts, followed by 
reintroduction of the transformed cells into a host blastocyst 
for colonisation and contribution to the germ line. "Transgenic 
technology" (Jaenisch, 1988) clearly provides a model system for 
many areas of study, contributing to advances being made in 
areas of endeavour already discussed above. In addition, 
however, the real possibility exists of generating transgenic 
animals of commercial importance. Extension of the technology 
from the common murine model (Palmiter et ai, 1982) to rabbits, 
sheep and pigs has been accomplished (Hammer et ai, 1985), and 
it seems likely that such strategies as the harvesting of 
medically important proteins from the milk of transgenic cows 
might well be implemented in the near future, as has been shown 
feasible and successful in mice (Simons et ai, 1987). 
In the plant world, transgenic individuals are rather more easy 
to produce than in the animal kingdom, a situation which is 
leading to a massive increase in the scope of plant molecular 
biology, as well as commercial investment in it. Transgenic 
plants have been produced by DNA injection into floral tillers 
(De la Pena et ai, 1986), but more commonly by simple 
transfection of somatic protoplasts, cells and tissues 
subsequently allowed to develop into new plantlets via the 
41 
production of callus and differentiated tissue in culture (Jones 
et al, 1985; Rogers et al, 1986). As with transgenic animals, 
many fundamental genetic studies have made progress as a result 
of the technology (Willmitzer, 1988); in addition, transgenic 
plants are now being designed for horticultural and agricultural 
use (De Block et al, 1987). 
1.2.4 THE NEED FOR NEW APPROACHES 
The plethora of methodologies available for the introduction of 
genes into cells, tissues and whole organisms does not yet mean 
that a suitable technique exists for every possible purpose. 
Simple transformation techniques for genetic studies of cells in 
vitro are well developed, and perhaps require little 
augmentation. However, the complex requirements of in vivo 
transformation are only just being realised, and are certainly 
not met by anyone approach. This is amply illustrated by the 
fact that human gene therapy is still thwarted by biological 
obstacles, not merely slowed down by the difficulties being 
encountered in attempting to resolve the ethical problems 
involved. Table 1.1 summarises the important limitations 
besetting each of the major gene transfer methods at the present 
time. It shows that while techniques for the delivery of naked 
DNA are the ones most useful for cell culture work, they are not 
suitable for application to whole animal systems since they 
involve protocols which are inappropriate or too aggressive; the 
only gene transfer methods which mimic natural conditions 
sufficiently closely to be useful in vivo are those involving 
vehicle-mediation, of which the retroviral mechanism alone is 
efficient enough for serious practical consideration. 
The work described in this thesis is concerned with the 
development of a new approach to gene delivery, that of transfer 
of soluble naked DNA across the plasma membrane by receptor-
mediated endocytosis. The work presented constitutes a study of 
the feasibility of this approach, modelled in vitro, but its 
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Table 1.1 Negative factors restricting applicability of 
current gene transfer methods 
* Perturbations of gene expression have been documented 
for the calcium phosphate procedure (Kerbel et al, 1987; 
Pine et al, 1988) (section 1.2.2). 
[ lliI ] 
[ D) Serious limitation to applicabi lity of method moderate or partial limitation 
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potential does lie beyond cell culture systems; the possibility 
exists for its use in the targeted delivery of genes to 
mammalian cells in vivo via . the circulatory system, without the 
involvement of vehicle-mediation. 
~ GENE TRANSFER BY RECEPTOR-MEDIATED ENDOCYTOSIS 
1 .3.1 CONCEPTUAL FOUNDATION OF THE THESIS 
This thesis is based upon the idea that the efficiency and 
specificity of internalisation afforded by the process of 
receptor-mediated endocytosis (Goldstein et al, 1979) might be 
exploited for the targeted delivery of genes to mammalian cells 
in a directed manner. Implicit in the idea is the suggestion 
that if DNA in the naked state could be bound to a soluble 
protein ligand recognisable by its cognate receptor at the 
plasma membrane surface, it would be carried into the cell 
interior. This concept has been put forward previously by 
Pastan and coworkers (Cheng et al, 1983) in a communication 
reporting the development of a method for covalent attachment of 
DNA to protein. By contrast, non-covalent reversible binding of 
DNA to protein was envisaged here in the belief that it might 
offer advantages in the cytoplasm in the event of successful 
transfection. 
At the outset of the work it was known that the complexing of 
DNA to protein in a non-covalent manner is possible if the 
protein is first modified to a condition of extreme basicity by 
reaction with certain water-soluble carbodiimides. During the 
course of earlier investigations using carbodiimides to couple 
proteins to various small mblecules, it had been observed that 
control proteins treated with carbodiimide in the absence of a 
second molecule gave rise to products capable of binding 
negatively charged materials including DNA. This type of 
interaction is explained by the addition of positively charged 
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N-acylurea carbodiimide moieties at side chain carboxyl groups 
of aspartate and glutamate residues (Timkovitch, 1972), and the 
formation of tenaceous salt bridges between these groups and 
ionised phosphodiester backbone regions of DNA. 
The proposed approach thus involved the preparation of a 
modified protein which could act as both receptor specific 
ligand and DNA carrier. It was modelled using insulin as the 
protein of choice. On account of its small size, limited number 
of modification sites and crucial conformation-dependent 
receptor binding role, it was thought that insulin itself should 
not be carbodiimide treated; instead it should be cross-linked 
to bovine serum albumin (BSA) which has a capacity for extensive 
carbodiimide modification (Table 1.2) and could be converted to 
its N-acylurea derivative prior to coupling. In this way a 
conjugated protein would be created in which the receptor 
binding and DNA binding functions were relegated to separate 
surfaces on one macromolecule. The conceptual design of this 
conjugate is il l ustrated in Figure 1.1. 
Table 1.2 Relative potentials of insulin and 
albumin for carbodiimide modification 
TOTAL NUMBER 
PROTEIN/ MOLECULAR OF Asp & Glu 
PEPTIDE SOURCE WEIGHT RESIDUES 
INSULIN pig, cow 5700 4 * 
(monomer) human 
ALBUMIN cow 68000 97 ** 
* (Smith, 1972) 
















Figure 1.1 Binding interactions of a conjugate consisting of a 
small polypeptide ligand such as insulin covalently cross-linked 
to N-acylurea albumin 
The ligand component retains its facility for specific receptor 
binding. The N-acylurea albumin component, produced by 
carbodiimide modification of serum albumi~bears numerous 
positively charged N-acylurea moieties ( ~ ) in place of 
acidic amino acid side chain carboxyl groups (aspartate and 
glutamate residues) and readily interacts electrostatically with 
negatively charged DNA phosphodiester backbone ( () ). 
I, insulin; A-CDI, N-acylurea albumin; a and B, insulin receptor 
subunits. 
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1.3.2 SERUM ALBUMIN 
Serum albumin is one of the major proteins of the vertebrate 
circulatory system, maintaining continuous contact with 
extracellular surfaces. It is a resilient, multifunctional 
protein which provides buffering and protection to other, more 
sensitive, molecular components of the organism. In addition, 
it plays more specific roles such as the solubilisation of long 
chain fatty acids, the binding of bilirubin and toxins, and 
ultimately the provision of amino acids to peripheral tissues by 
its own degradation. 
The primary structure of serum albumin was established by Brown 
and coworkers (Brown, 1978); its conformation and active sites 
have been investigated by Peters and colleagues (Peters and 
Reed, 1978). The bovine serum albumin molecule is composed of 
582 amino acid residues and has a molecular weight of 68500; 
other serum albumins show slight variations. Serum albumins are 
prolate ellipsoids in shape, 14.1 X 4.2nm in size, consisting of 
, 
three domains in linear sequence. The domains are very similar 
to one another, and are essentially a triply repeated series of 
loop structures which have arisen during evolution by gene 
duplication (McLachlan and Walker, 1977). The domains have 
developed differences of hydrophobicity and net charge, and 
ligand binding is domain specific. In human serum albumin, the 
first domain binds indole compounds and mixed disulphides, the 
second domain binds bilirubin, and the third domain binds long 
chain fatty acids. 
Serum albumin is very soluble in aqueous solvents and shows 
exceptional stability in solution, resisting extreme conditions 
which would denature most other proteins. For instance, it is 
particularly heat tolerant, withstands the action of agents like 
6M urea which tend to disrupt hydrogen bonds ~ and requires a 
concentration of trichloroacetic acid (TeA) as high as 30%w/v 
for precipitation. Its ruggedness and stability, combined with 
the fact that it is readily available and inexpensive, make it a 
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popular choice when a model protein is sought for laboratory 
procedures. Furthermore, it is an important reference standard 
in protein assays because it is one of the few common 
polypeptides free of carbohydrate. It is widely used to protect 
low concentrations of other molecules (for example, enzymes, 
antigens and antibodies) from denaturation, and to prevent their 
adsorption to g l ass vessels. It is a convenient blocking agent 
in western-type blotting techniques. 
Serum albumins have been put to a number of specialised uses. 
For example, they have found widespread application as carriers 
for haptenic mol ecules in the preparation of antibodies. A 
variety of proteins has been employed for this purpose, but 
serum albumins and keyhole limpet haemocyanin (KLH) remain the 
ones of choice. A major reason is that conjugates prepared with 
human, bovine and rabbit serum albumins are far more soluble 
than those prepared with other inexpensive proteins such as 
~-globulin and egg albumin; the latter frequently precipitate 
out during synthesis (Erlanger, 1980). Serum albumins have also 
become much used as carrier molecules for drugs, the 
pharmacological potential of albumin's humoral role adding 
further advantage to the ease with which conjugated derivatives 
can be prepared. Current methodology includes the massive 
polymerisation of albumin into microspheres from which drugs may 
be released gradually and continuously (Tomlinson and Burger, 
1985). 
In the work described in this thesis, bovine serum albumin was 
chosen to act as a dual purpose carrier in accordance with the 
model proposed in Figure 1.1. Carbodiimide modification of the 
albumin to produce an N-acylurea albumin was undertaken in order 
to render the p r otein capable of DNA binding and carriage, while 
its covalent conjugation to insulin was undertaken so as to 
facilitate targeting and insertion of the complex into cells 
bearing insulin receptors. 
Throughout the work, references to albumin signify bovine serum 
48 
albumin (BSA). 
1.3.3 INSULIN AND THE INSULIN RECEPTOR 
In most vertebrate species insulin is a major anabolic 
polypeptide hormone, secreted by the B-cells of the pancreas, 
which is capable of eliciting a remarkable array of biological 
responses. It is an attractive choice of proteinaceous molecule 
for use as a model in the work described here because it binds 
to specific plasma membrane receptors on a wide range of target 
cells, following which the endocytotic uptake of the 
insulin-receptor complex and its temporary sequestration in the 
endosomal apparatus occurs rapidly and inevitably (Bergeron et 
al, 1985; Sonne, 1988). The insulin receptors are abundantly 
embodied in the membranes of liver, fat and muscle cells, and 
significantly represented in a number of other tissues such as 
blood and brain (Cahill, 1971); there are few cells which lack 
them completely (Rosen, 1987). 
Insulin was the first functional protein to be sequenced, a 
major analysis by Sanger and coworkers (Ryle et al, 1955) now 
considered to be classic. Insulin is composed of 51 amino acids 
residues in two peptide chains, A and B, linked by two 
disulphide bridges and containing a third intrachain bridge. It 
has a molecular weight of 5700. Its full primary structure is 
given in Figure 1 . 2. 
Crystallisation studies by Schlichtkrull (195Ga; 195Gb) 
established that the presence of zinc was required for insulin 
crystal formation: two zinc molecules for every six molecules of 
insulin. Meticulous X-ray crystallographic analysis by Hodgkin 
and her colleagues subsequently led to the elucidation of the 
tertiary structure. of the zinc-insulin complex (Blundell et al, 
1971; 1972). It was shown to be a hexameric configuration 
comprising a trimer of dimers in which the zinc is required to 
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Figure 1.2 The primary structure of insulin (Ryle et a~, 1955). 
The general structure shown including the disulphide linkages between 
cysteine residues is applicable to a wide range of insulins. 
The specific amino acid sequence shown is for human insulin. 
Variation in porcine insulin: B30 = Ala (Smith, 1972). 
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Figure 1.3 The tertiary structure of insulin (from 
Blundell et ai, 1971; 1972). 
The rhombohedral insulin crystal is a hexamer composed of three 
equivalent dimers related to each other by 3-fold rotation. The 
dimer itself constitutes an - asymmetric unit. Perpendicular to 
the 3-fold crystal axis and intersecting it, there is a 2-fold 
axis of symmetry which relates the two monomers of the dimer and 
neighbouring dimers of the hexamer. 
A. Projection of the complete insulin monomer, including side 
chains, along the 3-fold axis which is perpendicular to the 
plane of the paper. The 2-fold axes lie in this plane and 
are labelled OP and OQ. 
B. The insulin dimer viewed down the 3-fold axis. 
c. The complete insulin hexamer, which constitutes the 
rhombohedral unit cell. There are 2 zinc ions situated 17 
- 1sA apart on the 3-fold axis ( 0 ) and related by the 
2-fold axes. Each zinc ion has bound to it an imidazole 
nitrogen of one of the B10 histidines of each of the 
dimers; thus each zinc has bound to it 3 imidazole rings 
and is coordinated to all 3 dimers. 
Note: the view of the insulin molecule given in Figure 1.4 
is in a direction perpendicular to the 3-fold axis. 
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itself (Figure 1.3). The three-dimensional structure of 
monomeric insulin, which does not crystallise, is inferred from 
that of the hexamer. It is a well defined, relatively 
inflexible globular structure, having a buried core of 
hydrophobic residues and a surface characterised by both polar 
and non-polar regions. The non-polar regions comprise two 
patches of clustered hydrophobic residues, one involved in dimer 
formation, the other in dimer-dimer interactions in the hexamer. 
The biological significance of the different forms of insulin 
has been discussed by Blundell et al (1972). While circulating 
humoral insulin is in dilute solution and considered to be 
monomeric, insulin stored in the pancreas is granulated, with a 
crystal structure showing a cubic or rhombohedral close packing 
of zinc insulin hexamers that closely resembles the insulin 
crystals produced in vitro. The association of monomers in 
storage is considered to decrease the rate of enzymatic 
proteolysis, increase thermodynamic stability and provide a 
convenient concentrated store of the hormone. 
Knowledge of primary and tertiary structural features, 
comparisons of amino acid sequence and biological activity data 
from insulins of different species, and activity measurements 
using chemical analogues, have all combined to provide a basis 
for interpreting insulin structure in functional terms. The 
result has been the definition of a biologically active region 
on the molecule consisting of a cluster of invariant residues 
where receptor binding and other reaction events occur. The 
numerous studies contributing to this structure-function 
analysis have been reviewed in detail by Gammeltoft (1984), who 
has pointed out two important assumptions implicit in the work. 
Firstly, that the form of insulin actively binding to the 
receptor is monomeric, substantiated by the observation that the 
physiological concentration of insulin is 1 0-11 -1 0-9M while the Kd 
of dimerisation is in the region of 10-6M. Secondly, that the 
monomer in solution exhibits the structure inferred from the 
crystal; this assumption is supported by studies of the chemical 
reactivity (Blundell et ai, 1971) and circular dichroism 
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(Blundell and Wood, 1982) of insulin in solution. 
The deduced receptor-binding site (Figure 1.4) includes the 
mainly hydrophilic A chain residues A1 (Gly), A5 (GIn), A19 
(Tyr) and A21 (Asn) and adjacent hydrophobic B chain residues 
B12 (Val), B16 (Tyr), B24 (Phe), B25 (Phe) and B26 (Tyr). The 
same non-polar B chain residues are also involved in dimer 
formation (Blundell et al, 1972), suggesting that receptor 
binding might be analogous to dimerisation, and that the loss of 
non-polar surface residues in the formation of the complex is 
likely to be an important driving force of the reaction. The 
binding forces involved in both types of association have been 
shown to include hydrogen bonding in a a-pleated sheet manner 
between main polypeptide chains and hydrophobic interactions of 
side chain groups (Pullen et al, 1976). The thermodynamic 
behaviour of insulin-receptor interaction (Waelbroeck et al, 
1979) supports Blundell's hydrophobicity concept, but indicates 
that additional binding mechanisms must exist in the 
insulin-receptor complex: the Kd for receptor binding (10-9M) is 
significantly greater than the Kd for dimer formation (10-6M). 
In this regard, Gammeltoft (1984) has suggested the possibility 
of ionic bonding between charged residues in the A chain of the 
insulin binding site and residues at the receptor binding site, 
and Waelbroeck (1982) has provided evidence for a contribution 
to binding by the terminal amino group on the A chain (residue 
A1). Furthermore, the recent finding of Derewenda et al (1989) 
that phenol binds and stabilises helix at the B1-B8 position in 
the insulin hexamer raises the possibility that a tyrosyl side 
chain from the insulin receptor interacts with the same B chain 
N-terminal region. 
That insulin acts at the level of the plasma membrane had been 
suggested by Langley in 1905, but receptors were not identified 
for a further sixty-five years, when a spate of work involving 
receptor-binding assays with radioiodinated insulin was 
initiated by investigators such as Cuatrecasas (1971) and 
Freychet et al (1971). Assays were founded on the principle 
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Figure 1.4 Biologically active amino acid residues of the 
i nsulin molecule (after Gammeltoft, 1984). 
The outlined surface area is involved in receptor binding and 
includes A1 G1y , A5 G1 n , A19 Tyr , A21 Asn , B12 Va1 , B16Tyr , B23G1y , B24 Phe , 
B25 Phe , and B26Tyr • 
Residues B29 Lys and A8 Thr (A8HiS in chicken and fish insulins) lie 
just outside the receptor binding region but may have relevance 
to receptor binding kinetics (Pullen et al, 1976; Cutfield et 
al, 1979) as discussed in section 4.4. 
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can be inhibited by concentrations of insulin or its derivatives 
102 - 105 times higher, whereas it cannot be inhibited in this 
way by other peptide hormones. Interpretation of assay results 
laid emphasis on the dual concept of binding specificity and 
receptor saturability (Roth, 1973). Most assays demonstrating 
the presence of receptors have been conducted on isolated cells, 
membrane fragments or solubilised receptors in vitro, although 
some whole tissues have been used, liver for example (Terris and 
Steiner, 1976), and even whole organisms (Zeleznik and Roth, 
1977). Initially, receptors were defined by their functional 
and kinetic characteristics; physical structure remained 
obscure. In the later 1970s, however, receptors were identified 
by both light and electron microscopy using insulin labelled in 
various ways for visual detection; for instance with ferritin 
(Jarret and Smith, 1974), rhodamine (Schlessinger et al, 1978, 
and 1251 (Bergeron et al, 1979). At the same time, a great deal 
of information about molecular structure began to be revealed by 
means of new biochemical approaches involving methods such as 
affinity labelling, affinity chromatography and specific 
immunoprecipitation. 
The structural concept of the insulin receptor from which a 
current model has been derived (Pessin et al, 1985) was 
independently put forward by Cuatrecasas' research group (Jacobs 
et al, 1980) and Czech and coworkers (Massague et al, 1980) on 
the basis of a variety of biochemical evidence. Confirmation of 
the proposed structure has come since from the cloning and 
sequencing of cDNA for the human insulin proreceptor (Ullrich et 
al,1985; Ebina et al, 1985). The model describes a 
heterotetrameric disulphide-linked integral membrane 
glycoprotein that contains subunits of two types, a and 8, 
giving the structure (a8)2' and suggests that this represents 
the minimum covalent receptor unit. The two a-subunits (M 
r 
125000-135000) are linked together centrally, each flanked by 
and linked to a 8 subunit (M 90000-98000) . The a-subunit r 
carries the insulin recognition site; the 8-subunit includes a 
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Figure 1.5 Minimum covalent subunit structure of the native 
insulin receptor and two major proteolytically cleaved forms 
(model proposed by Pessin et al, 1985). 
Form 1 represents the hypothetical structure of the native 
insulin receptor, which consists of a and B subunits linked by 
disulphide bonds into a heterotetrameric complex. The central 
disulphide bond linking the two symmetrical halves of the 
receptor is extremely sensitive to reductant. Adjacent a and B 
subunits on each flank of the receptor complex are believed to 
the result of cleavage of one continuous polypeptide chain 
during processing. The B subunit is phosphorylated upon insulin 
activation in intact cells or detergent extracts and appears to 
contain one or more tyrosine kinase catalytic sites. The B 
subunit contains a region at about the centre of its amino acid 
sequence which is extremely sensitive to elastase-like 
proteases. Cleavage of one B subunit yields Form 2, while 
cleavage of both B subunits yields Form 3. Forms 2 and 3 are 
often major constituents of the total receptor population in 
isolated membrane fractions. 
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hydrophobic amino acids representing a single transmembrane 
domain that anchors the entire receptor in the phospholipid 
bilayer at the cell surface. The model is depicted in Figure 
1 .5. 
In studies of insulin activity, the presumption is generally 
made that all the biological responses mediated by the hormone 
are initiated in the receptor, and therefore that it is the 
structure and funct i on of this macromolecular complex which 
holds the key to ce l lular signalling mechanisms. In fact it is 
now accepted that the receptor is a multifunctional protein 
involved in hormone binding, transfer of information across the 
plasma membrane , internalisation of hormone for subsequent 
degradation, aut ophosphorylation as well as phosphorylation of 
cellular substrates , and possibly also delivery of message from 
one location to another within the cell interior. The many 
areas of investigation devoted to the elucidation of the 
receptor machinery and its cascade of physiological effects have 
been surveyed recent ly (Rosen , 1987) but are not broadly 
reviewed here. However, the sequel to insulin-receptor 
recognition which is most crucial to the DNA transfer mechanism 
proposed in this thesis - that of endocytotic uptake - is 
enlarged upon in the following section. 
1.3.4 RECEPTOR-MEDIATED ENDOCYTOSIS OF INSULIN 
Insulin is only one of many molecules that have been observed to 
enter cells by means of receptor-mediated endocytosis. Such 
molecules fall into a number of categories and include 
substances extrinsic to the natural life of the cell such as 
toxins and viruses in addition to intrinsic biomolecules like 
hormones, growth factors and transport proteins. There are a 
number of pathways of receptor-mediated endocytosis, but the 
model against which others are usually compared is that of low-
density lipoprot ein (LDL) entry into cells; postulated, verified 
and elaborated by Goldstein, Anderson and Brown in the first 
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clear delineation of the process (Goldstein et al, 1979). 
Differences between specific ligand-directed pathways are found 
both on the cell surface and in the vesicular compartments in 
which the ligands are variously delivered to intracellular 
sites, recycled to the cell membrane, or degraded. 
A broad understanding of endocytotic mechanisms was developed 
during the early 1980s, coincident with the emergence of 
molecular models of receptor structure and function. The two 
areas of invest i gation were clearly mutually reinforcing. 
Pastan and Will i ngham (1985) have reviewed the process of 
receptor-mediated endocytosis in general terms, and a concise 
synthesis is given here. The endo- and exocytotic paradigm is 
outlined in Figure 1.6A. Most cultured cells have a distinctive 
range of receptors in their plasma membranes. Some types of 
receptor (for example, the LDL receptor) appear to exist only 
clustered together in clathrin-coated pits (Figure 1.6B and 
1.6C); others a r e distributed randomly across the membrane 
surface, moving about the membrane and through coated pit sites 
by diffusion. Receptors of this latter type migrate with a 
diffusion constant of 2-8 X 10-10 cm2/sec and pass through a 
coated pit approximately every 3 seconds. In the majority of 
cells in culture, 1% of the membrane surface is occupied by 
coated pits, 500-1000 pits per cell, each coated pit giving rise 
to an intracellular vesicle via membrane invagination every 
twenty seconds or so in a constitutive manner, that is, at a 
rate which is independent of receptor occupancy. Since ligands 
bind to their receptors at high affinity, and receptors are 
endocytosed in such an efficient manner, ligand uptake is 
extemely rapid. Less than a minute after a ligand such as a 
growth factor or hormone is added to a cell, it can be found in 
an intracellular vesicle. The vesicles are called receptosomes 
(Willingham and Pastan, 1980) or endosomes (Marsh and Helenius, 
1980). They are biochemically and morphologically distinct from 
lysosomes, Golgi, or other organelles, and act as agents of 
transport specifically for ligands and their receptors. When 
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A. Diagrammatic summary of the classic morphological pathways 
of endocytosis and exocytosis. 
B. Clathrin-coated pit in fibroblast plasma membrane, drawn 
from a preparation visualised by freeze-fracture, deep 
etching and rotary replication (original photograph 
courtesy of Dr John Heusen, in Keen, 1985). 
C. Models for the packing of clathrin triskelions in 5- or 
6-sided polygon structures of coated pits (Keen, 1985). 
59 
may be low; later, they tend to fuse with one another to form 
structures up to 600nm in diameter in which pH is close to 
neutral. They move by saltatory motion along tracks of 
microtubules. Ultimately, after an independent existence of 
5-60 minutes, they fuse with elements of the Golgi system. One 
type of cell that does not have coated pits and appears not to 
carry out endocytosis is the mature enucleate mammalian 
erythrocyte. However, all other eukaryotic cells exhibit the 
endocytotic process continuously except for interruption during 
mitosis. 
The endocytotic pathway of the insulin-receptor complex in 
particular starts from points of random distribution across the 
cell surface, p r oceeding to coated pit locations accomodating a 
mixture of ligand-receptor types (Maxfield et al, 1978). 
Interestingly, t he coated pit structures have been observed 
clearly only in cultured cells; their involvement in vivo has 
been difficult t o establish (Bergeron et al, 1985). Subsequent 
endosomal processing has been investigated by numerous 
sophisticated biochemical procedures and the large body of 
information resulting from these studies forms the basis of 
reviews by Heidenreich and Olefsky (1985) and Sonne (1988), the 
former dealing with the fate of the receptor, and the latter the 
fate of insulin. These authors have suggested hypothetical 
models which unify as much of the available data as possible. 
The models are described below and summarily represented in 
Figure 1.7. 
Insulin and its receptor dissociate from one another almost 
immediately in the primary endosome. The drop in pH encountered 
there does not influence dissociation itself, but it greatly 
diminishes the reassociation of dissociated ligand, and because 
the rates of association and dissociation are extremely fast, 
free insulin quickly accumulates in the vesicle lumen. Shortly 
after endosome formation, a specific protease, possibly 
activated by low pH, attacks insulin at one or just a few 










I ~ - '. 
, ~ . . 
" ;, 
Figure 1.7 Schematic representation of the fate of occupied 
insulin receptors in target cells (based on Heidenreich and 
Olefsky (1985) and Sonne (1988). 
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not affected, but binding affinity is reduced even further. At 
this stage some intact and "nicked" insulin may be returned to 
the exterior medium by fusion of endosome with plasma membrane. 
The remaining "nicked" insulin is further hydrolysed to amino 
acid status by a protease present in the endosome which is 
active at neutral pH. Almost all of the internalised insulin is 
degraded in this fashion. The breakdown products are rapidly 
released into the extracellular environment; they do not 
accumulate inside the cell. The physiological explanation of 
degradation has been the topic of considerable speculation, and 
is regarded as either (i) that it brings about a rapid quenching 
of the hormone signal, or (ii) that it is an integral part of 
the hormone-receptor mechanism. 
By contrast with insulin, the internalised receptor has one of 
three possible f ates: it may be recycled back to the cell 
surface, degraded, or sequestered undegraded in the cell for 
some time. Mos t receptors enter the recycling route, but the 
relative magnitudes of the three route options are varied in 
order to modulat e the final concentration of total cellular 
receptors, as well as the relative proportions occurring on the 
surface and in t he interior. Downregulation is the term applied 
to the way in which cells exposed to high concentrations of 
insulin bring about a shift to increased receptor degradation 
and reduced receptor recycling while the rate of receptor 
synthesis remains constant; this results in a decrease in the 
number of surface receptors, and in turn leads to decreased 
sensitivity to insulin (Gavin et al, 1974). Even during " 
downregulation, however, receptor degradation never matches or 
exceeds insulin degradation. While the population of undegraded 
intracellular receptors is known to be maintained at a 
numerically significant level, its subcellular location and 
specific functional role is not well defined at the present 
time. Many investigators have suggested a transducing mechanism 
by which the internalised receptors exert biological effects at 
specific subcel l ular sites. Of particular interest in this 
connection is the reported binding of insulin to receptors in 
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nuclear membranes (Vigneri et al, 1978)), and direct action of 
insulin on DNA and RNA synthesis (Goldfine et al, 1985). 
1.3.5 ENDOCYTOSIS OF MODIFIED LIGANDS 
The endocytosis of chemically modified ligands has been 
demonstrated in many instances, but clearly depends upon the 
process of modification leaving the receptor binding site 
functionally intact. In fact, as mentioned in connection with 
the insulin receptor, comparative measurement of the binding 
affinities of a large number of ligand variants chemically 
altered at specific amino acid residues is one means by which 
the receptor-binding region may be mapped. Despite this 
limitation, it has been shown that ligands which have been 
considerably modified by conjugation to other molecules may 
nevertheless undergo successful endocytosis, and this facility 
has been utilised in various ways to contrive transmembrane 
transfer of the carried molecular species into specific cell 
types. The targeted endocytotic delivery of drugs has been 
demonstrated using the principle of covalent attachment of drug 
to hormone, for example daunomycin or ouabain to melanotropin 
(Varga, 1985), and drug to receptor antibody, for example ricin 
A to anti-transferrin receptor (Domingo and Trowbridge, 1985). 
Copolymers of a-1,4-glucosidase, albumin and insulin have been 
shown to be transported into intracellular vesicular fractions 
of cultured muscle cells and to be cleared from the circulation 
of rats in vivo, inferring endocytotic uptake (Poznansky et al, 
1984). Liposomes incorporating antibody to LDL have been 
targeted and endocytosed following non-covalent attachment to 
malondialdehyde-treated LDL (Ivanov et al, 1985); in a similar 
vein, liposomes carrying covalently linked streptavidin have 
been taken up by cells following non-covalent attachment to 
biotinylated B nerve growth factor (Rosenberg et al, 1987). In 
each of these last mentioned studies, however, the liposomes 
were used only to demonstrate the principle of the method, not 
to deliver molecules to the target cells. The potential does 
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exist for the delivery of a broad spectrum of substances, 
including drugs and DNA, by this means. 
In a more extensive investigation, Gitman et al (1985) have 
demonstrated the usefulness of the ligand-receptor system by 
actually delivering ricin A and SV40 DNA to cells via 
reconstituted Sendai virus envelopes. These workers covalently 
linked insulin to the glycoprotein component of the envelope 
before reconstitution, and removed the Sendai virus receptors 
from the recipient hepatoma cells by prior neuraminidase 
treatment. While this type of transfer is not strictly 
endocytotic, since it involves a degree of direct fusion of the 
viral envelopes with the plasma membrane, the work is 
significant in the present context because it illustrates DNA 
transfer via insulin-receptor interactions. The work described 
in this thesis does not involve vehicle-mediation, rather being 
directed towards the delivery to cells of naked DNA in a soluble 
system. In this respect, the work of Poznansky and his 
colleagues, mentioned above, is of comparable importance, since 
they have clearly shown that the use of an albumin carrier 
linked both to insulin and the molecule to be transported is a 
practicable one . 
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CHAPTER TWO 
PREPARATION AND CHARACTERISATION OF N-ACYLUREA ALBUMIN 
AND ITS INSULIN CONJUGATE 
~ INTRODUCTION 
The preliminary stages of the work presented in this thesis were 
concerned with the preparation of a protein macromolecule which 
might act as both DNA carrier and receptor-specific ligand. 
They comprised 
- the synthesis of positively charged N-acylurea derivatives 
of bovine serum albumin (BSA) by treatment of the protein 
with appropriate water-soluble carbodiimides, 
the covalent conjugation of . insulin to unmodified albumin 
and a suitably modified N-acylurea albumin respectively by 
means of glutaraldehyde-induced cross-linkage, and 
the purification and initial characterisation of the 
various protein products resulting from these procedures. 
Carbodiimides are compounds whose general formula is 
R - N = C = N - R' 
where Rand R' may be aliphatic or aromatic (Khorana, 1953). 
There are a number of water-soluble as well as insoluble 
carbodiimides. Carbodiimides react with carboxyl groups to 
produce O-acylisoureas which in turn react with nucleophiles 
such as amino groups. Carbodiimides are capable, therefore, of 
condensing a carboxyl and an amino group. to form a peptide bond 
(Carraway and Koshland, 1972). Additionally, in the presence of 
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diamines, adjacent carboxyl groups may be cross-linked via the 
diamine. Such reactions can be achieved under mild conditions 
and are relatively fast. As a consequence, carbodiimides, 
particularly those which are water-soluble, have been used 
extensively in biochemical coupling reactions (Ji, 1983). For 
example, they have been employed for the synthesis of small 
peptides (Sheehan and Hess, 1955), the production of 
cross-linked hormones for use as tools in receptor binding 
studies (Parsons and Pierce, 1979), the conjugation of toxins to 
cell-specific carrier proteins in order to obtain targeted 
killing responses (Faulstich and Fiume, 1985) and, most 
extensively in recent years, the attachment of weakly haptenic 
molecules to carrier proteins for the enhancement of anti-hapten 
antibody reactivities (Goodfriend et ai, 1964; Bauminger and 
Wilchek, 1980). 
As an alternative to nucleophilic attack generating covalent 
linkages between molecules, carbodiimide activated carboxyl 
groups in the form of O-acylisoureas may undergo internal 
rearrangement to produce stable N-acylurea carbodiimide adducts 
(Carraway and Koshland, 1972; Timkovitch, 1977). This 
transition is illustrated in Figure 2.1. Even under conditions 
favouring nucleophile interaction (low temperature, an excess of 
the amino group donor, and a weakly basic pH at which the amino 
groups are more reactive), N-acylurea derivatives are 
significant by-products of carbodiimide conjugation procedures, 
while under conditions of moderate temperature and low pH which 
suppress coupling they are the predominant products (Carraway 
and Koshland, 1972; Timkovitch, 1977; Davis et ai, 1984). 
Non-conjugative carbodiimide reaction with protein carboxyl 
groups is potentially useful. Riehm and Scheraga (1966) 
employed it in a study of the effect of side chain carboxyl 
group modification on enzyme activity, and Davis et al (1984) 
have suggested detection of complexes formed between receptors 
and their carbodiimide-modified ligands via antisera prepared 
against the appropriate carbodiimide adducts. In the work 
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Figure 2.1 Reaction of water-soluble carbodiimide functional 
groups with pro t ein carboxylic acids under conditions of low pH 
and moderate temperature 





Carbodiimide, either N-ethyl-N'-(3-dimethylaminopropyl) 
carbodiimide (CDI) or N-ethyl-N'-(3-
trimethylpropylammonium) carbodiimide (Me+CDI). 
Protein glutamate residue. 
O-Acylurea protein. 
The tertiary N-acylurea CDI-protein. 
The quaternary N-acylurea Me+CDI-protein. 
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described in the following section of this thesis, the 
carbodiimide induced formation of N-acylurea residues at 
available carboxyl groups on side chains of aspartate and 
glutamate has been exploited puposefully in order to synthesise 
protein derivat i ves which are more electropositive than their 
native counterparts. This has been achieved by employing 
water-soluble carbodiimides in which one of the R groups bears a 
positively charged teriary or quaternary nitrogen function 
(Figure 2.1) and conducting their reactions with protein (BSA) 
under weakly acidic conditions (pH 5.5) at 20°C. Two 
carbodiimides were used: the common N-ethyl - N'-(3-
dimethylaminopropyl) carbodiimide hydrochloride, which has been 
shown to be extremely suitable for carboxyl modification 
(Timkovitch, 1977), and a derivative of it, N-ethyl-N'-
(3-trimethylpropylammonium) carbodiimide iodide. The latter was 
synthesised from the former in the laboratory, and was tritiated 
in the process. Modification of albumin with this carbodiimide 
thus allowed quantitative determination of N-acylurea 
substitution in addition to introducing into the albumin 
molecule a quaternary nitrogen function in place of a carboxyl 
group. 
For the coupling of N-acylurea aibumin to insulin, it was 
important that the N-acylurea protein be rendered free of 
unreacted carbodiimide prior to conjugation and that a 
cross-linking agent reactive towards groups other than carboxyls 
be employed. Accordingly, the modified protein was exhaustively 
dialysed prior ~o the coupling, and glutaraldehyde was made the 
reagent of choice. 
Glutaraldehyde has been used extensively for a multiplicity of 
conjugation procedures. Its mode of action has been the subject 
of much debate, and a definitive explanation is still lacking 
despite an important elucidation of the composition of 
glutaraldehyde solutions and the main features of the chemical 
properties of these by Monsan et al (1975) which has been 
reviewed subsequently (Peters and Richards, 1977). Several 
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products may arise during conjugation, and it is still thought 
likely that a number of unresolved reaction pathways occur 
(Reichlin, 1980). That this is so is seen by Peters and 
Richards to be the basis of the success of glutaraldehyde as a 
non-specific cross-linking agent, and is correlated to the 
existence of a large number of different polymeric forms of 
glutaraldehyde in dilute solution. Commercial reagent ("25% 
glutaraldehyde") has a pH close to 3 and contains a small 
proportion of glutaraldehyde in equilibrium with its cyclic 
hemiacetal in both monomeric and polymeric forms (Figure 2.2A). 
As the pH is increased, however, the glutaraldehyde (a 
dialdehyde) undergoes an aldol condensation with itself followed 
by dehydration, generating a,B unsaturated aldehyde polymers 
(Figure 2.2B) which continue to polymerise as the pH rises 
further until precipitation from solution eventually occurs. 
Despite great variability it appears that most cross-linkages 
are the result of the interaction of the aldehydic groups of the 
unsaturated polymers with reactive groups on the conjugant 
species: E-amino groups of lysine side chains in the case of 
protein-protein coupling. Schiff bases are formed. Since in 
most instances the Schiff base is in conjugation with a double 
bond (Figure 2.2C), resonance stabilisation occurs and the 
linkage is resistant to hydrolysis. Proteins reacted with 
glutaraldehyde thus become partnered in a stable manner through 
a linker which i s itself polymeric and of variable size. 
Apart from simpl icity of use, efficiency of reaction at room 
temperature and controllability of cross-linkage, the added 
advantages of solubility of product and retention of biological 
activity make g l utaraldehyde a favourable choice of coupling 
agent (Reichlin , 1980). These latter features are especially 
advantageous in the production of conjugates for use in 
experiments involving cellular or whole organism processes. It 
is notable also that in work of a physiological nature involving 
protein conjugates, serum albumin is the commonest choice of 
carrier protein (section 1.3.2). Polymerisation of albumin by 
means of glutaraldehyde has been used in the synthesis of 
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Figure 2.2 The structure and reaction of glutaraldehyde and 
related compounds (after Peters and Richards, 1977). 
A. Forms of g l utaraldehyde predominating in"25%" 
glutaraldehyde (pH 3.1) 
B. Forms of g l utaraldehyde arlslng above pH 3 and 
predominat i ng at neutral pH. 
c. Example of glutaraldehyde cross-linkage of 2 proteins by 
the format i on of conjugated Schiff bases between B forms 
and available E-NH2 groups of the protein lysines. 
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microspheres for drug delivery (Yapel, 1985), the preparation of 
albumin-L-asparaginase polymers for anti-tumour treatment 
(Poznansky et al, 1982) and the production of 
albumin-enzyme-antibody complexes for targeted delivery of 
enzyme to cells (Poznansky and Bhardwaj, 1981). More recent 
work by Poznansky et al (1984) along similar lines describes the 
glutaraldehyde conjugation of albumin, a-1,4-glucosidase and 
insulin, and a modification of their method of glutaraldehyde 
treatment was used in the present work. 
Initially reactions were modelled using a relatively crude 
preparation of bovine insulin rendered zinc-free by column 
chromatographic purification. Once reaction conditions and the 
nature of the products had been established, conjugates were 
made using monocomponent porcine insulin of a quality 
appropriate to the experimental cell work to follow. 
2.2 MATERIALS AND METHODS 
2.2.1 MATERIALS 
Crystalline BSA (Product Code No. A-7638), bovine pancreatic 
insulin co-crystallised with zinc (approx. 0.5%) (Product Code 
No. I-5500), ribonuclease A (EC 3.1.27.5) (Product Code No. 
R-4875) and Cytochrome C (Product Code No. C-7752) were obtained 
from the Sigma Chemical Co., st. Louis, Mo, U.S.A. 
Monocomponent porcine insulin (Product No. 7354800) was obtained 
from Novo BioLabs, Novo Research Institute, Bagsvaerd, Denmark. 
Anti-porcine insulin (Catalogue No. 5507-1) was purchased from 
Bio-Yeda, Rehovot, Israel. N-Ethyl-N'-(3-dimethylaminopropyl) 
carbodiimide HCI (Code 800907) was purchased from Merck, 
Darmstadt, Federal Republic of Germany. [3H] Methyl iodide 
(specific radioactivity 85Ci/mmol) was from Amersham 
International, U.K. Visking dialysis tubing (20/32) was from 
Serva Feinbiochemica, Heidelberg, N.Y., U.S.A., and low 
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molecular weight cut-off dialysis tubing (2000) was from 
Spectrum Medical Industries, L.A., U.S.A. Acrylamide, N,N'-
methylenebis-acrylamide, agarose, chemicals for electrophoresis, 
Bio-Gel A-5m, Bio-Gel P-100 and Immun-Blot kit were obtained 
from BioRad Laboratories, Richmond, Ca, U.S.A. Sephadex G-50 
and G-100 were purchased from Pharmacia Fine Chemicals, Uppsala, 
Sweden. All other chemicals were of analytical grade. 
2.2.2 METHODS 
Synthesis of [~H7 N-Ethyl-N'-(3-Trimethylpropylammonium) 
Carbodiimide Iodide 
The quaternary ammonium carbodiimide N-ethyl-N'-(3-
trimethylpropylammonium) carbodiimide iodide (Me+CDI) was 
prepared from N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (CDI) and methyl iodide using the method of 
Kopczynski and Babior (1984) with minor modifications. In order 
to radiolabel the product a proportion of the methyl iodide used 
in the reaction was in the tritiated form. CDI (1.0g, 5.24mmol) 
was dissolved in 2.0ml water and converted to free base by the 
dropwise addition of aqueous sodium hydroxide (20%w/v) until the 
pH of the mixture reached 11-12. The carbodiimide free base 
released (a colourless oil) was extracted into ether (2 X 20ml 
plus 1 X 10ml) and the yellow aqueous phase discarded. The 
pooled ether extract was backwashed with approximately 10ml 
water and the aqueous layer again discarded. The ether extract 
was dried over sodium sulphate for 10min, filtered, ·then 
incubated at 40°C while ether was removed under a stream of dry 
nitrogen until only the syrupy free base remained. This was 
taken up in 15ml dry ether prior to methylation. Methyl iodide 
(0.62ml, 1.42g, 10mmol) and [3H] methyl iodide (SOO~Ci) mixed 
with toluene (0 . 2ml) was added to the ethereal carbodiimide 
solution with stirring. A creamy yellow coloration and the 
initiation of crystallisation were apparent immediately. The 
mixture was kept in the dark at SoC for several hours to allow 
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complete crystallisation. Crystals were separated by filtration 
on a Buchner funnel, washed with dry ether and dried over P20 S 
in vacuo. The hygroscopic product (1.04g, 3.52mmol) had a 
specific radioactivity of 44~Ci/mmol. It was stored desiccated 
in the dark at -15°C. 
Synthesis of N-Acylurea Albumins 
BSA was treated with the two water-soluble carbodiimides CDI and 
Me+CDI to produce N-acylurea CDI-albumin (A-CDI) and N-acylurea 
Me+CDI-albumin (A-Me+CDI) respectively. Albumin to carbodiimide 
mole ratios of reaction were varied widely: 
A to CDI - 1:10,1:50,1:100,1:250,1:500,1:1000 and 1:2000. 
A to Me±CDI - 1 :150 and 1: 500. 
In each case a similar reaction procedure was followed. That 
given below is for a typical treatment of A with CDI at a 1 :500 
mole ratio. 
Aqueous solutions of albumin (14mg, 0.2~mol in 1.3ml) and 
N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide hydrochloride 
(19.17mg, 100mmol, in 1.5ml) were mixed and the pH immediately 
adjusted to 5.5 by the addition of dilute HCI. The resultant 
clear solution was allowed to stand at 20°C for 48-60h in the 
dark, then dialysed exhaustively against saline-EDTA (50mM NaCI, 
0.3mM EDTA, pH 7.0) at 5°C. As in all cases of dialysis the 
tubing was pretreated (Maniatis et al, 1982) and stored under 
sterile conditions. Aliquots of the dialysed product, 
N-acylurea CDI-albumin (A-CDI) were stored at -15°C. 
Protein Determination 
Protein was estimated quantitatively by the method of Lowry 
(1951) using BSA or bovine insulin as standard. 
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Estimation of the Number of N-Acylurea Groups Attached to 
Modified Albumins 
Aliquots (100~1) of [3H] A-Me+CDI of known protein concentration 
were precipitated with an equal volume of cold 60%w/v 
trichloroacetic acid (TCA), filtered through Whatman TF/C 
filters, washed with 2Sml of cold 30%w/v TCA, dried and counted 
for radioactivity in scintillation fluid (Beckman HP/b). 
Determination of Binding Interactions between N-Acylurea 
CDI-Albumin and Gel Filtration Matrices 
Samples of protein (0.6-2.0mg in 1.0ml elution buffer, of known 
A280 ) were loaded individually on to columns (SOml burettes) 
containing Bio-Gel A-Sm (agarose), Bio-Gel P-100 
(polyacrylamide ) or Sephadex G-100 (dextran) and eluted with 
buffer as indicated in Table 2.2. A series of 3ml fractions 
representing the entire protein peak were collected, absorption 
at 280nm measured for each fraction, and recovery of protein 
calculated as follows: 
% recovery = A280 of total recovered protein if in 1 ml X 100 
A280 of ini tial protein load 
Where a protein sample was partially retained on a column, the 
efficiency of removal by an alternative medium was estimated in 
a similar manner: fractions were collected during elution with 
an appropriate buffer, absorption at 280nm measured for each 
fraction, and % recovery calculated. 
Preliminary Purification of Bovine Insulin 
Prior to use in conjugation reactions, zinc-associated bovine 
pancreatic insul in was subjected to gel filtration in order to 
separate the zinc from the peptide. Acetic acid was used as 
solvent and eluant as advised by Steiner . et al (1968) in order 
to ensure, for preparative convenience, that the insulin was 
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maintained in the monomeric form during filtration. Insulin 
dissolved in 10%v/v acetic acid (3.0ml per load, 33mg/ml) was 
filtered through Sephadex G- SO (medium grade) in a 16 X 1100mm 
column using 10%v/v acetic acid as eluant at a flow rate of 
80ml/h. Absorption at 280nm was determined as a continuous 
trace, and 10ml fractions of peptide material collected 
manually. Fractions constituting the main insulin peak were 
pooled and dispensed into glass vials in 3-Sml aliquots. 
Fractions representing tail-end material were similarly pooled 
and dispensed b u t in 10ml aliquots. The insulin solutions were 
frozen in a thin film round the walls of the vials by rotation 
in cold ethanol (-60°C) followed by liquid nitrogen (-19S.8°C), 
and were immediately thereafter set up for lyophilisation. The 
zinc-free insulin product was a fine, fluffy white powder which 
was stored under desiccating conditions at -15°C. Recovery was 
85-90%. 
Conjugation of I nsulin to Albumins 
Insulin was cross-linked to either unmodified albumin or 
N-acylurea CDI-albumin at a 10:1 mole ratio by a development of 
the method of Poznansky et al (1984). The N-acylurea 
CDI-albumin used for this purpose had been prepared at a 1 : 500 
albumin:carbodiimidemole ratio. Insulin (4.2mg, 7.37 X 10-7 
moles, dissolved in 600~l dimethyl sulphoxide (DMSO) at 37°C) 
was mixed with either A or A-COl (Smg, 7.35 X 10-8 moles, in 1ml 
saline-EDTA) at 20°C then diluted with 4.0ml 50mM acetate 
buffer, pH 3.6, and the solution cooled to 5°C. Glutaraldehyde 
(90~l,"2S%" standard reagent) was added and the reaction mixture 
maintained in the cold overnight. Thereafter, crystalline 
glycine (7Smg) was added, dissolved, and allowed to react with 
excess glutaraldehyde for 2.5h at 20°C. The reaction mixture 
was then dialysed exhaustively against 10mM acetate buffer, pH 
4.0, containing 5%v/v DMSO at 5°C. Low molecular weight cut-off 
dialysis tubing was used for this procedure initially. The 
resultant clear, pale straw- coloured solutions were stored in 
aliquots at -15°C. 
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Fractionation of Conjugates 
Conjugates were purified and characterised by gel filtration 
through Sephadex G-100 in a 7 X 1500mm column using 10mM acetate 
buffer, pH 4.0, containing 5%v/v DMSO as eluant at a flow rate 
of 6.0ml/h. Absorption at 280nm was determined as a continuous 
trace. Fractions of 1ml were collected and stored at -15°C for 
up to 8 weeks. For comparative purposes, unconjugated protein 
constituents were characterised using the same column and 
elution conditions. 
SDS-Polyacrylamide Gel Electrophoresis of Proteins 
Albumin, various N-acylurea albumins, insulin and 
insulin-albumin conjugates were analysed for molecular size 
characteristics by SDS-PAGE using a BioRad Protean 160mm cell 
system. Preparation of gels, pretreatment of samples and 
composition of running buffer were according to Laemmli (1970). 
Electrophoresis was at 30mA for 4-5h. 
Agarose Gel Electrophoresis of Proteins 
Albumin, various N-acylurea albumins, insulin and insulin-
albumin conjugates were analysed for comparative electrophoretic 
mobility by separation in 1 .2%w/v agarose gels at neutral pH. A 
BioRad Mini Sub DNA cell system was used; gel dimensions 100 X 
65 X 3mm. Gels were made and run with buffer containing 36mM 
Tris-HCI, 30mM sodium phosphate and 10mM EDTA (final pH 7.5). 
Prior to gel application, protein samples (10-20~g, 3-8~1) were 
mixed with 1/3 the sample volume of loading buffer (50%w/v 
sucrose, 4M urea, 0.1%w/v bromophenol blue, 50mM EDTA, pH 7.5). 
Electrophoresis was at 40V for 3h. 
Visualisation of Proteins in Electrophoretic Gels 
After SDS-polyacrylamide or agarose gel electrophoresis, 
proteins were stained with Coomassie Brilliant Blue (CBB) using 
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one of two techniques according to the solubility properties of 
the particular proteins present. While most proteins, including 
albumin, are appropriately precipitate~ in the methanol-acetic 
acid-water fixation and staining medium iri common use (Weber and 
Osborn, 1969), insulin is soluble in this and must rather be 
fixed and maintained in 12.5%w/v TeA for staining to be 
successful. The insulin staining method given is a version of 
that of Linde et al (1983). 
Gels carrying only albumin or albumin derivatives 
Fixation - 2h in methanol-acetic acid-water (14:1:5, 
v/v/v). 
staining - 18h in O.5%w/v eBB in methanol-acetic acid-
water (5:1 :5, v/v/v). 
Destaining - 2-3 days in several changes of methanol-acetic 
acid-water (5:1 :5, v/v/v). 
storage - in destaining solution. 
Gels carrying insulin or insulin conjugates 
Fixation - 30min in 10%w/v TeA. 
Staining 18h in O.025%w/v eBB in 10%w/v TeA. 
Destaining - several hours in 10%w/v TeA, 5%v/v acetic 
acid. 
storage - in 5%v/v glycerol. 
stained gels were photographed by a combination of incident and 
transmitted white light using Kodak Tri-X Pan black and white 
film (ASA 400) in a single lens reflex camera fitted with a 55mm 
close-up lens and a red filter. 
Identification of Insulin in the Conjugates 
Insulin was detected semi-quantitatively in the conjugate 
fractions by immuno-dot-blotting. Each fraction tested was 
diluted in elution buffer to a concentration of 66ng protein/~l. 
These starting solutions, together with a range of double 
dilutions derived from them, were applied in 1~1 aliquots to 
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nitrocellulose and processed according to the BioRad Immun-Blot 
procedure using 0.05%v/v Tween-20, 20mM Tris-HCI, 500mM NaCI, pH 
7.5 as incubation and washing medium, gelatin (3%w/v) as 
blocking agent, anti-insulin (1/333) as first binding agent, 
protein A-horseradish peroxidase (1/2500) as second binding 
agent, and a freshly prepared mixture of 4-chloro-1-naphthol 
dissolved in ice-cold methanol (2ml, 0.3%w/v) and hydrogen 
peroxide (6~1 ice-cold 30% solution in 10ml buffered saline) as 
colour reagent. 
2.3 RESULTS 
2.3.1 N-ACYLUREA ALBUMINS 
Range of Reaction Conditions 
Bovine serum albumin (A) was modified by means of the two 
water-soluble carbodiimides N-ethy l-N'-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (CDI) and N-ethyl-N'-(tri 
methylpropylammonium) carbodiimide iodide (Me+CDI) which 
respectively incorporate tertiary and quaternary nitrogen 
functions into the albumin structure by substitution at 
available side chain carboxyl group sites. In all modification 
procedures the concentration of albumin in the reaction mixture 
was Smg/ml, and treatment was at pH 5.5 and 20°C. However, it 
was seen to be i mportant to obtain a range of derivatives in 
which the degree of modification varied widely. Such a series 
of derivatives would then provide the basis for subsequent DNA 
binding determinations. Accordingly, reaction mixtures were set 
up in which the number of moles of carbodiimide per mole of 
albumin was var i ed from 10 to 2000. 
Number of Carbodiimide Modification Sites per Molecule 
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Table 2.1 Reaction of [~H]N-ethyl-N'-(3-trimethylpropylammonium) carbodiimide 
iodide with albumin 
A 
+ 
WELLS 1 2 3 4 5 6 7 8 9 10 1112 13 
B 
WELLS 123456 
Figure 2.3 Agarose gel electrophoresis at pH 7.5 of proteins 
and protein derivatives 
Modified proteins were dialysed before application to the gel. 
Protein load, 10-20~g per well. 
A. 1, Cytochrome C; 2, RNAse A; 3, Albumin (A); 4-10, 
N-Acylurea CDI-albumins (A-CDI) prepared at protei - to 
carbodiimide mole ratios of 1:10, 1 :50, 1 :100, 1 :250, 
1 :500, 1 :1000 and 1 :2000 respectively; 11, Albumin (A); 12 
and 13, N-Acylurea Me+CDI-albumins (A-Me+CDI) prepared at 
mole ratios of 1:150 and 1:500 respectively. 
B. 1, Albumin (A); 2, Insulin (I); 3, Insulin-albumin (I-A); 
4, N-Acylurea CDI-albumin (1:500 mole ratio) (A-CDI); 5, 
Insulin (I); 6, Insulin-[N-acylurea CDI-albumin] 
(I-[A-CDI]). 
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ratios, 1 :150 and 1 :500. The use of [3H] Me+CDI served a dual 
purpose: (i) introduction of N-acylurea moieties containing 
positively charged quaternary nitrogen functional groups into 
the resultant modified albumins for later use in DNA binding 
studies, and (ii) determination of the extent of modification 
(Table 2.1). Albumin contains a total of 97 side chain carboxyl 
groups on aspartic and glutamic acid residues. Results show 
that at a mole ratio of reaction of 1:150, 13 of these carboxyl 
groups became substituted, while at a mole ratio of 1 :500 the 
extent of modification was doubled, with 27 carboxyl groups 
becoming substituted. 
Changes in Net Charge on Modification 
Agarose gel electrophoresis of the various carbodiimide modified 
albumins at pH 7.5 shows that their electrophoretic mobilities 
differed from that of the parent albumin; they had become more 
basic (Figure 2.3A). It can be seen that as the A to CDI ratio 
increased from 1:10 to 1:250 the electrophoretic movement of the 
A-CDI product towards the positive pole of the gel decreased 
progressively until it was virtually zero, while at ratios of 
1 :500 to 1:2000 the A-CDI product moved progressively towards 
the negative pole of the gel in the opposite direction to 
unmodified albumin. All these changes indicate increasing 
electropositivity. Modification by the quaternary carbodiimide 
Me+CDI effected relatively greater change of net charge than its 
tertiary counterpart, as demonstrated by a comparison between 
the mobilities of the respective 1:500 products. The 
electrophoretic behaviour of the naturally occurring basic 
proteins cytochrome C and ribonuclease A indicates that their 
net charge values lie in the same range as those of the various 
N-acylurea proteins synthesised. 
Binding to Gel Filtration Matrices 
Since N-acylurea protein derivatives were considered to have 
potential as DNA carriers on account of their charge properties, 
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the corollary existed of their possible electrostatic attachment 
to gel filtration matrix polymers. Therefore, before gel 
filtration procedures were seriously initiated for purification 
of N-acylurea protein conjugates, three different polymer 
matrices were tested for binding interactions. Clearly, the 
matrix most suitable for subsequent use would be the one 
demonstrating least binding with N-acylurea protein. Table 2.2 
summarises the results of tests using gel matrix materials 
composed of agarose (Bio-Gel A-5m), polyacrylamide (Bio-Gel 
P-100) and dextran (Sephadex G-100) for elution of A and A-CDI 
(1 :500). Results show that Sephadex, unlike the two Bio- Gel 
matrices, demonst r ated virtually no binding interaction with 
A-CDI at pH 7.0 (99.5% recovery of protein). Sephadex appeared, 
therefore, to be t he gel filtration medium of choice . When, at 
a later stage of t he work, it became clear that the gel 
filtration of I-[A-CDI] conjugate necessitated the use of a low 
pH elution buffer for the maintenance of conjugate solubility at 
high concentration, investigation into the interaction of 
Sephadex with N-acylurea protein at pH 4.0 was seen to be 
necessary, since under more acidic conditions the modified 
protein would bear an even greater net positive charge . Results 
of these further t ests (Table 2.2) indicate that while a small 
degree of binding was detectable on first passage of A-CDI 
through the matrix at pH 4.0, 100% recovery of protein was 
achieved following each repetition of the procedure, suggesting 
that saturation o f binding sites on the matrix had occurred. 
Ultimately, then, Sephadex G-100 was used for conjugate 
fractionation (Figure 2.6) under the following conditions: (i) 
the same eluant (10mM acetate buffer, pH 4.0, containing 5%v/v 
DMSO) was used fo r all protein separations; (ii) the column was 
always 'pre-conditioned' with A-CDI prior to use in the 
fractionation of A-CDI or its conjugates, and (iii) residual 
bound material was thoroughly removed by washing with 
phosphate-buffered 50mM NaCI, pH 7.6, and the column 
re-equilibrated wi th low pH eluant prior to use with unmodified 
proteins or prote i n conjugates. 
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Table 2.2 Binding interactions between N-acylurea CDI-albumin 
and various gel f i ltration matrices 










pH 7.0 buffer 
pH 4.0 buffer 





a t pH 7.0 
2.0mg sample 
100% recovery 
a t pH 7.0 
1.0mg sample 
100% recovery 
a t pH 7.0 
1.0mg sample 
100% recovery 





at pH 7.0 
1 .1mg sample 
S3% recovery 
at pH 7.0 
Attached protein not 
removed with excess 
2M NaCl; 
fully removed with 
1M acetic acid. 
1 .1mg samples 
99.S% recovery 
at pH 7.0 
(mean of 2 runs: 
99% and 100% 
respectively) 
1.0 - 2.0mg samples 
76% recovery 
at pH 4.0 
100% recovery 
on each repetition 
on same column 
a t pH 4.0 
Attached protein 
quantitatively removed 
at pH 7.6 
phosphate buffered saline (SOmM NaCI). 
10mM acetate buffer, containing S%v/v DMSO. 
phosphate buffered saline (SOmM NaCI). 
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Figure 2.4 is of interest in relation to the results presented 
above: it shows some binding of A-COl and A-Me+CDI to an 
SDS-polyacrylamide gel at the position of the wells, an 
observation which is in keeping with the findings presented in 
Table 2.2. 
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WELLS 
Figure 2.4 SDS-polyacrylamide gel electrophoresis of albumin 
and its carbodiimide derivatives 
12%w/v gel. Modified albumins were dialysed before application, 
and unless stated were stored at -15°C. Protein load 5~g per 
well. 
1, Albumin (A); 2-5, N-Acylurea COl-albumins (A-COl) prepared at 
protein to carbodiimide mole ratios of 1:10, 1 :100, 1 :500 and 
1 :1000 respectively; 6 and 7, A-COl prepared at mole ratios of 
1 :100 and 1 :500 respectively (stored at 20°C for 7 weeks); 8 and 
9, N-Acylurea Me+CDl-albumins (A-Me+CDl) prepared at mole ratios 
of 1 :150 and 1:500 respectively. 
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Pol ymerisa tion 
Size character"istics of N-acylurea albumins were investigated by 
two means: SDS-polyacrylamide gei electrophoresis and gel 
filtration. Results of SDS-PAGE presented in Figure 2.4 
illustrate that (i) N-acylurea albumins appeared to be the same 
size as native albumin except in the case of derivatives 
produced at the highest carbodiimide concentrations (a protein 
to carbodiimide mole ratio of 1:2000 in the case of COl and 
1:500 in the case of Me+CDI), (ii) in the products which did 
appear to be conjugated, the degree of polymerisation shown was 
slight, and (ii) Me+CDI reaction effected conjugation more 
readily than COl, as demonstrated by a comparison between the 
respective 1:500 mole ratio derivatives. Despite these results, 
gel filtration through Sephadex G-100 (Figure 2.6A) showed 
clearly that there was a significant size difference between 
A-COl (1 :500) and unmodified albumin (A). The latter contained 
a small proportion of naturally occurring dimer (small peak ) , 
and it was at a point equivalent to this that the A-COl eluted, 
suggesting that carbodiimide-induced dimerisation had taken 
place. While gel filtration provides a more sensitive analysis 
than SDS-PAGE under the conditions used in these experiments, it 
is possible to combine the findings from both techniques 
constructively. Overall results then suggest that (i) 
oligomeric species somewhat larger than dimers might be formed 
at A:CDI mole ratios of reaction above 1 :500 and at even lower 
A:Me+CDI ratios, but that (ii) the production of large multi-
molecular polymers does not occur under any of the reaction 
conditions used for N-acylurea albumin production . 
UV Absorption 
Figure 2.5 presents ultraviolet absorption spectra of unmodified 
albumin and A-COl (1 :500) at equal concentrations of protein 
(500~g/ml; 7.3~M) . The two proteins exhibit common peaks of 





M- ' cm-' ) . These observations indicate that COl reaction 
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did not interfere with the ring structures of the aromatic amino 
acids responsible for UV absorption. Detection of proteins and 
their N-acylurea derivatives by absorption at 280nm is therefore 
a straightforward procedure requiring no adjustment for 
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Figure 2.5 UV Absorption spectra of albumin and N-acylurea 
CDI-albumin 
Protein solutions, albumin (A) and N-acylurea CDI-albumin 
(A-CDI), each 500Mg/ml in 50mM NaCl, 0.3mM EDTA, pH 7.0. The 
A-CDI was prepared at a 1 :500 albumin to carbodiimide mole ratio 
and exhaustively dialysed after synthesis. 
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stability 
Results presented in Figure 2.4 suggest that maintenance of 
N-acylurea albumins under ordinary laboratory conditions (20°C) 
for an extended period of time (7 weeks) did not affect 
macromolecular integrity by allowing either hydrolytic 
degradation or molecular aggregation. Since albumin and 
N-acylurea albumin solutions were normally stored at -15°C and 
defrosted only for sampling, they were assumed to be stable for 
periods of several months. 
2.3.2 INSULIN-ALBUMIN CONJUGATES 
Composition of Reaction Mixtures 
Insulin was covalently cross-linked to unmodified albumin (A) 
and to N-acylurea CDI-albumin (A-CDI) by reaction with 
glutaraldehyde to provide, respectively, a control conjugate 
(I-A) and a conjugate carrying N-acylurea carbodiimide 
modifications (I- [ A-CDI]). The A-CDI used in the conjugation 
reaction had been prepared at a 1:500 mole ratio, and therefore 
possessed 27 N-acylurea groupings (Table 2.1) and considerable 
electropositivity (Figure 2.3). In order to ensure the 
attachment of several molecules of insulin (mol wt 5700) to each 
molecule of albumin (mol wt 68000) reaction mixtures contained 
an insulin to albumin mole ratio of 10:1 (mole calculations 
based on unmodified albumin input in both cases). 
Molecular Size of Coniugates 
As with N-acylurea albumins prior to conjugation, size 
characteristics of conjugated products were determined by means 
of both SDS-polyacrylamide gel electrophoresis and gel 
filtration. Results of SDS-PAGE of I, A and I-A are presented 
in Figure 2.7. They show that the I-A product was a 
heterogeneous mixture of species ranging in size from only 
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slightly larger than albumin itself to a molecular conglomerate 
which moved very slowly, hardly entering the gel. This high 
molecular weight complex represents a significant proportion of 
the total conjugate population and forms a heavily stained band 
within the overall 'smudge'. Respective gel filtration of I-A 
and I-[A-CDI] through Sephadex G-100 (Figure 2.6) gave rise to 
identical profiles representing a series of conjugates in which 
the very high molecular weight components dominate, forming a 
leading peak which is followed by a shoulder of smaller 
conjugates. Information concerning molecular size provided by 
gel filtration is entirely compatible with that provided by SDS-
PAGE analysis. The two are correlated directly in Figure 2.7 
which shows the electrophoretic mobilities of two gel filtration 
fractions. Fraction 18, representing the main peak (Figure 
2.6), is seen to be equivalent to the discrete high molecular 
weight band on the gel. Fraction 24, representing the shoulder, 
appears to consis t of products of a size range intermediate 
between the largest conjugates and unconjugated albumin. 
Incorporation of Insulin 
Indirect evidence supporting the covalent inclusion of insulin 
within the high molecular weight conjugates resulting from 
glutaraldehyde cross-linkage is provided from two sources: (i) 
SDS-PAGE of I-A reaction mixture containing 46%w/w insulin, 
dialysed in low molecular weight cut-off tubing before 
electrophoresis, indicated a disproportionately faint band at 
the position of unconjugated insulin (Figure 2.7), and (ii) 
Sephadex G-100 gel filtration of similarly dialysed conjugation 
reaction mixtures showed only an insignificant amount of protein 
at the position of unconjugated insulin (Figure 2.6). Direct 
evidence is provided from a third source: immuno-dot-blot 
analysis of gel filtration fractions 16 to 25 (Figure 2.8). 
Results of this analysis demonstrated unambiguously that insulin 
was present in fractions 17 to 25, the highest ratios of insulin 
to total protein being apparent in fractions 18 to 24. 
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Figure 2.6 Gel filtration chromatography of insulin-albumin 
conjugates and their constituent proteins 
Proteins were purified and characterised by gel filtration 
through Sephadex G-100 as described in Materials and Methods. 
Reaction mixtures were dialysed exhaustively prior to loading on 
to the column; reaction mixtures containing insulin were 
dialysed in low molecular weight cut-off (2000) dialysis tubing. 
A. Unmodified insulin (I), unmodified albumin (A) and 
N-acylurea albumin (A-COl). 
B. Insulin-albumin (I-A) and insulin-[N-acylurea albumin] 
(I-[A-CDI]). 
The horizontal bar shows those conjugate fractions containing 
the highest proportions of insulin to total protein as estimated 





Figure 2.7 SDS-polyacrylamide gel electrophoresis of 
insulin-albumin and its constituent proteins 
4%w/v stacking gel; 12%w/v resolving gel. Protein load 10~g per 
well. 
1 and 2, Albumin (A), untreated and alkali digested 
respectively; 3, Zinc-associated insulin (Zn-I); 4, Zinc-free 
insulin (I); 5-9, Insulin-albumin conjugates (I-A): 5, dialysed 
I-A reaction mixture prior to gel filtration; 6 and 7, Sephadex 
G-100 I-A fraction 18, untreated and alkali-digested 
respectively; 8 and 9, Sephadex G-100 I-A fraction 24, untreated 
and alkali-digested respectively; 10, Zinc-free insulin (I); 11, 
Albumin (A). 
Alkali digestion: sample made 0.2M with respect to NaOH, 
incubated at 20°C for 2h, then neutralised with HCI before 
electrophoresis. 
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Figure 2.8 lmmuno-dot-blotting for the identification of 
insulin in gel filtration fractions of insulin-[N-acylurea 
COl-albumin] 
A. Sephadex G-100 gel filtration profile of 
insulin-[N-acylurea COl-albumin] (l-[A-CDI]). 
B. Dot blots (1~1) of fractions 16-25, each normalised to a 
starting concentration of 66ng/~1 and thereafter serially 
diluted to O.5ng/~1. Insulin was detected in the blots by 
successive incubations with (i) anti-insulin, (ii) Protein 
A-horseradish peroxidase, and (iii) a mixture of 
4-chloro-1-naphthol and hydrogen peroxide, which gives rise 




The charge characteristics of insulin-albumin conjugates and 
their component proteins are illustrated in Figure 2.3B. 
Notably, I-A appears to be more acidic than either of its 
constituent proteins, presumably because many of the basic 
lysine E-amino groups contributing to overall charge of the 
native proteins have been utilised in glutaraldehyde 
cross-linkages. A comparable shift towards electronegativity is 
shown in the I-[A-CDIJ conjugate, but since the A-CDI 
constituent prior to conjugation is much more positively charged 
than native albumin on account of its modified aspartate and 
glutamate residues, the resultant conjugate is significantly 
more electropositive than I-A. 
stability 
Results presented in Figure 2.7 indicate that the molecular size 
of conjugates remained unaffected by conditions of mild alkali 
digestion which did cause some degradation of unconjugated 
albumin. This observation confirms the stable nature of the 
covalent glutaraldehyde-based intermolecular linkages holding 
the conjugant species together. In addition, it suggests that 
the tertiary structure of the component proteins might have 
become stabilised by covalent intramolecular linkages. 
2.4 SUMMARY AND DISCUSSION 
Bovine serum albumin has been reacted with water-soluble 
carbodiimides at various mole ratios under conditions known to 
disfavour conjugative protein-protein coupling but to bring 
about substitution of carboxyl groups with N-acylurea 
carbodiimide adducts. It has been shown that N-acylurea 
albumins resulting from this type of modification 
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may undergo dimerisation or even greater degrees of 
oligomer formation, but do not become polymerised into 
large mo~ecular weight complexes (Figure 2.4); 
retain radioactive label on reaction with 
N-ethyl-N'-(trimethylpropylammonium} carbodiimide iodide 
which has been tritiated at one of the methyl groups, 
indicating incorporation of the the trimethylpropylammonium 
moiety into the protein structure (Table 2.1); 
exhibit charge properties which are altered towards greater 
electropositivity in a manner explicable by substitution of 
side chain carboxyl groups with tertiary and quaternary 
amino group functions characteristic of the reacting 
carbodiimide (Figure 2.3A), and 
display a degree of carboxyl group modification, as 
measured by either incorporation of radioactivity or change 
in electrical charge, which is directly related to the 
concentration of carbodiimide in the reaction mixture 
(Table 2.1; Figure 2.3A). 
Reaction of albumin with N-ethyl-N'-(3-dimethylaminopropyl} 
carbodiimide hydrochloride (CDI) was undertaken at seven 
different mole ratios varying from 1:10 to 1 :2000, and it has 
been shown that these conditions effect measurable and 
progressive changes of charge in the products (Figure 2.3A). At 
mole ratios up to 1:250 the degree of charge change brought 
about by each stepped increase in carbodiimide concentration is 
very marked. At mole ratios of 1:500 and above, the changes 
resulting from even larger increases in carbodiimide input are 
relatively minor, suggesting that under these conditions readily 
accessible reaction sites are reaching limiting numbers. It has 
been established from modification with [3H]Me+CDI that 13 
carboxyl groups react at a mole ratio of 1 :150 , while 27 groups 
react at a ratio of 1.:500. It can be tentatively suggested, 
then, that the number of reaction sites existing on the exposed 
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periphery of the albumin molecule under physiological 
(non-denaturing) conditions is in the region of 30 or so. 
Part of the rationale for the use of the two different 
carbodiimides in synthesising N-acylurea proteins was that it 
would be interesting and possibly useful to compare the effects 
of tertiary and quaternary nitrogen groupings on DNA binding 
capacity: it was thought that the quaternary compounds might 
bind DNA more effectively than the tertiary equivalents, since 
they would exert a stronger charge. Although albumin was 
modified with N-ethyl-N'-(trimethylpropylammonium) carbodiimide 
iodide (Me+CDI) at only two different mole ratios, one of them 
(1:500) was selected to provide direct comparison of the product 
with that of A:CDI reaction at the same mole ratio. Results of 
agarose gel electrophoresis have indicated that A-Me+CDI is 
indeed more basic than the equivalent CDI product (Figure 2.3A). 
Of the various N-acylurea albumins prepared and analysed in 
subsequent DNA binding experiments (Chapter 3), the reaction 
products prepared at a 1:500 mole ratio were the ones eventually 
selected for glutaraldehyde cross-linkage to insulin. Choice 
was based upon the fact that these compounds, already shown to 
exhibit a significant degree of modification (Table 2.1) and 
concomitant electropositivity (Figure 2.3), proved to have a 
marked DNA binding capacity (Figures 3.1 and 3.4). Ultimately, 
however, the unfavourable solubility characteristics noted in 
derivatives of the A-Me+CDI product led to the sole use of A-CDI 
as conjugant. 
Glutaraldehyde reaction with mixtures of insulin and unmodified 
albumin or insulin and A-CDI has been shown here to give rise to 
products which 
comprise a heterogeneous population of conjugates ranging 
widely in size, in which the majority are several times 
larger than unconjugated albumin (Figures 2.6 and 2.7); 
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show the covalent incorporation of insulin into their 
structures (Figure 2.8), and 
demonstrate some loss of electropositivity compatible with 
cross-linkage via lysine E-amino groups (Figure 2.3B). 
The glutaraldehyde reaction mixture contained a large excess of 
insulin molecules over albumin molecules (mole ratio of 10:1; 
46%w/w insulin) in order to create the probability of 
cross-linking the proteins in proportions of the same order. In 
synthesising conjugates consisting of three different proteins 
including albumin and insulin, Poznansky et al (1984) have used 
a similar strategy, and appear confident in interpreting 
conjugate composition on the basis of relative molar 
contribution. While such an assumption may not be precisely 
valid, it is clear from several sources of evidence in the work 
presented here (Figures 2.6 - 2.8) that virtually all of the 
insulin in the original mixture became incorporated into 
conjugated species larger than monomeric albumin, thus 
suggesting that heterologous coupling had occurred in 
approximately the proportions planned. On SDS-PAGE (Figure 
2.7), most of the conjugates appeared to occupy a band position 
extremely close to the well of origin and some distance from the 
albumin control: sufficiently immobile to represent a molecular 
weight of several hundred thousand. A complex consisting of 
three albumin molecules combined with thirty insulin molecules 
(molecular weight, 375000) is therefore one speculative example 
out of many possible products. Determinations of precise 
molecular weights and composition were not undertaken; the 
extreme heterogeneity of the conjugate population was a major 
reason for this. 
Having modified albumin with carbodiimide in order to produce 
basic proteins which might be capable of electrostatic binding 
to DNA, and having established that a binding affinity for DNA 
does exist in these compounds (Figures 3.1 and 3.2), the partial 
reverse shift in charge accompanying their glutaraldehyde 
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conjugation to insulin (Figure 2.3) seemed to be a retrogressive 
step. However, it was clear that there existed a significant 
net difference in charge between the I-A control conjugate and 
the experimental I-[A-CDI] (Figure 2.3B), the latter being 
considerably more electropositive. The possibility existed, 
therefore, that some capacity for DNA binding would be shown by 
this conjugate. Its DNA binding potential is reported in the 
following chapter in conjunction with the preliminary and 
subsequent studies of DNA binding by unconjugated albumins. 
Bovine and porcine insulins possess only one lysine residue, at 
position B29 (Smith, 1972). If glutaraldehyde action does in 
fact occur only at lysine side chain amino groups, insulin must 
become bridged to albumin at this one point. The fact that the 
lysine is the penultimate residue in the B chain and is situated 
on the periphery of the molecule (Figure 1.4) suggests the 
probability that normal structure is retained in the major 
portion of the peptide following glutaraldehyde reaction. In 
such a circumstance retention of conformational integrity and 
specific binding affinities would be likely. Residue B29 itself 
is not involved in receptor binding (Gammeltoft, 1984) (Figure 
1.4). These theoretical considerations support the concept of a 
glutaraldehyde-linked insulin-[N-acylurea albumin] conjugate 
acting as an effective cell-specific ligand as well as a DNA 
carrier. Experimental work designed to investigate conjugate-
cell receptor binding is presented in Chapter 4. 
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CHAPTER THREE 
BINDING OF DNA TO N ACYLUREA ALBUMIN AND ITS INSULIN CONJUGATE 
~ INTRODUCTION 
Once the various N-acylurea derivatives of albumin had been 
obtained and purified (Chapter 2), they were subjected to DNA 
binding assays in order for their potential as DNA carriers to 
be determined. The preliminary results of these assays led to 
the choice of N-acylurea albumins prepared at albumin to 
carbodiimide mole ratios of 1:500 being selected for conjugation 
to insulin (Chapter 2). Of the alternatives, N-acylurea 
CDI-albumin (A-CDI) and N-acylurea Me+CDI-albumin (A-Me+CDI), 
the former proved to demonstrate more suitable solubility 
properties (section 2.4), and the resultant conjugate, 
I-[A-CDI], was in turn assayed for DNA binding capacity using 
the same methods. In addition, experiments were undertaken to 
investigate the nature of the binding interactions involved. 
The central importance of protein-DNA binding relationships in 
genetic structures and processes has been brought into sharp 
focus over the past two decades. The formation of protein-DNA 
complexes is now seen to be fundamental to the architectural and 
functional integrity of genetic material; it is only by means of 
the activity of proteins that genetic messages are conserved, 
identified and acted upon during growth, development and 
reproduction. Binding proteins play roles in chromosome 
conformation (Pederson et al, 1986), nuclear scaffolding 
(Newport and Forbes, 1987; Razin, 1987), DNA replication 
(Jackson and Cook, 1986), genetic recombination (Cox and Lehman, 
1987; West, 1988), DNA repair (Sancar and Sancar, 1988), 
regulation of gene expression via transcriptional initiation 
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(Ptashne, 1986; Melton, 1987) and nuclear RNA processing and 
transport (Mariman et al, 1982). The relevance of protein-DNA 
association to such a wide range of core activities in the cell 
has meant that several appropriate binding assays have been 
developed. 
In one of the first investigations leading to successful 
detection and purification of a bacterial repressor, Ptashne 
(1967) used a zonal sedimentation technique, and this approach 
is still employed effectively for the identification of binding 
proteins in experiments which do not demand high sensitivity or 
resolution and for which the protein is relatively plentiful. 
For example, Mignotte et al (1985) have utilised glycerol 
gradients for the characterisation of a single-stranded 
DNA-binding protein having a possible role in mitochondrial 
nucleoid replication, and Kuhn et al (1987) have used sucrose 
gradient analysis of intermediate filament protein interaction 
with supercoiled DNA to advance an argument concerning the 
potential role of vimentin and related filamentous proteins in 
the control of DNA replication and expression . 
Several techniques have been devised for the recovery of 
protein-DNA complexes from crude extracts, and such methods may 
sometimes be used for assay purposes. One is the 
immunoprecipitation of complex with antibody raised against the 
binding protein (Lee and Knipe, 1986). Another with comparable 
applications is DNA affinity chromatography, a method which is 
used mostly for preparative work but which has found occasional 
analytical use (Gaudray et al, 1981). A more recently developed 
technique is that of protein- DNA blotting, in which a mixture of 
proteins separated by polyacrylamide gel electrophoresis is 
bound on to nitrocellulose by blotting, incubated with a 
radioactively labelled DNA probe, washed with varying degrees of 
stringency, and autoradiographed for visualisation of the 
binding proteins. This approach has yet to be refined; its uses 
to date have involved the disadvantage of protein denaturation 
by SDS (Bowen et al, 1980) or low pH (Levinger and Varshavsky, 
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1982). Modifications employing non-denaturing electrophoretic 
systems have not been reported. 
Two techniques much used for the finer analysis of protein-DNA 
binding reactions are the filter binding assay and the 
electrophoretic mobility shift assay respectively, both of which 
are suitable for use with semi-purified or purified protein 
components, and are extremely sensitive. These methods were 
employed in the present work to demonstrate and measure the 
extent of binding of N-acylurea albumin compounds to two forms 
of DNA: linear DNA fragments of heterogeneous sequence from calf 
thymus, and the circular DNA of purified pBR322 plasmid. In 
addition, the filter binding assay was used to investigate 
various parameters of the binding reaction in order to help 
clarify the nature of the forces operating in the protein-DNA 
complex. 
The principle of the filter binding assay rests on the fact that 
proteins, and therefore also protein-DNA complexes, are retained 
by nitrocellulose membranes upon filtration, whereas 
double-stranded DNA fails to be retained in this manner under 
the same conditions. Thus if a binding protein is pre incubated 
with radioactively labelled DNA, filtered through 
nitrocellulose, and the filter washed with buffer and processed 
for counting, the amount of DNA bound may be quantified. The 
assay has been used a great deal for a variety of studies. It 
has been the means of measuring the kinetic and equilibrium 
parameters of the binding interactions of purified proteins with 
DNA (Riggs et al, 1970), as well as the rapid monitoring of 
binding during purification of a binding protein (Johnson et al, 
1980). In a secondary role, it has been used for the detection 
of nuclear binding proteins in crude extracts, and, in 
conjunction with restriction endonuclease cleavage, 
identification of specific fragments of DNA carrying the binding 
sites has been possible (Borgmeyer et al, 1984). However, the 
method has serious limitations as a general detection system as 
it can demonstrate the activity only of high affinity DNA 
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binding proteins (Hennighausen and Lubon, 1987). In the present 
work involving examinination of the binding of synthesised and 
purified N-acylurea proteins to DNA, the filter binding assay 
was found to be particularly precise and versatile, lending 
itself to both quantitative and qualitative use. 
The mobility shift assay, for which the term "band shift assay" 
has been suggested (Varshavsky, 1987), is a more recent 
alternative to the filter binding assay. It is based on 
differences in size leading to separation of protein-DNA 
complexes from free DNA and from each other during gel 
electrophoresis. A version of the technique was originally 
introduced for the separation of nucleosomes formed in vivo 
(Varshavsky et al, 1976), its use for the assay of complexes 
formed in vitro being initiated later by Fried and Crothers 
(1981). Most band-shift assays have employed polyacrylamide gel 
electrophoresis, but agarose gel electrophoresis has been 
introduced recently (Berman et al, 1986; Huckett et al, 1986) 
and was used in the work presented in this chapter. As with the 
filter binding assay, the band shift approach to kinetic studies 
preceded its application to crude nuclear extracts, but its 
usefulness in this latter area has been accented of late, mainly 
because of the extreme sensitivity of the method. Hennighausen 
and Lubon (1987) state that its sensitivity exceeds that of the 
filter binding assay by at least an order of magnitude; 
Varshavsky (1987) has suggested that the exceptional potential 
for sensitivity may be due partly to stabilisation of the 
protein-DNA complexes once they enter a gel; the gel matrix may 
exert a "caging" effect thus decreasing the rate of 
dissociation. However, extreme sensitivity probably exists only 
under optimal conditions, which, for naturally occurring binding 
proteins, include the use of small DNA fragments (less than 
300bp) and buffers of low ionic strength (10mM) (Hennighausen 
and Lubon, 1987; Varshavsky, 1987). In the work reported here, 
the DNA used was of moderately high molecular weight, in keeping 
with the large sizes of the synthesised N-acylurea binding 
proteins, and gels were run under normal buffering conditions. 
100 
The band shift assay was regarded, therefore, as a means of 
generating supportive evidence for binding, not as a primary, 
finely tuned analytical tool. 
In vitro binding assays have generated definitions of some of 
the important conditions required for protein-DNA complex 
formation to take place, and in doing so have pointed to 
possible modes of interaction at the binding site. A 
consistently observed characteristic of protein-DNA binding is a 
marked salt dependency (Record et al, 1976; Karpel et al, 1981; 
Stahl et al, 1984) indicative of electrostatic interaction 
between basic amino acids of the protein and phosphate groups of 
the nucleic acid. Since N-acylurea albumins are modified 
proteins bearing positively charged tertiary amino or quaternary 
ammonium groups attached via a spacer to aspartic and glutamic 
acid side chains, it seemed likely that the formation of salt 
bridges between these groupings and ionised phosphodiester 
backbone regions of DNA would constitute one component of the 
binding response. Therefore the effect of sodium ion 
concentration on N-acylurea protein-DNA binding was 
investigated. Furthermore, since electrostatic binding is 
implicitly charge dependent, the effect of pH on binding was 
also examined. 
Out of protein-DNA binding assays in general have developed 
competition binding assays of various kinds. Many of these are 
for use in identifying binding proteins from crude extracts, and 
are founded on the idea of introducing into the binding mixture 
heterologous DNA fragments (Riggs et al, 19 70; Borgmeyer et al, 
1984) or synthetic alternating copolymer duplexes (Singh et ai, 
1986) which decrease the relative contribution of nonspecific 
protein binding to a specific DNA probe. A less common kind of 
competition assay, but one of relevance in this work, involves 
the use of the polyanion heparin to compete with DNA for binding 
to a specific binding protein as a means of analysing the 
relative contributions and strengths of ionic and nonionic 
components of binding conducted under different conditions 
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(Melancon et ai, 1982). The same strategy was used here to 
study the ion dependency and tenacity of the N-acylurea 
protein-DNA bond in relation to time elapsed after formation. 
Some biochemical techniques directed towards detailed 
sub-molecular analysis of protein-DNA binding interactions, not 
employed in the present investigation, are nevertheless of 
considerable relevance because of the conceptual advances made 
as a consequence of their use. "Footprinting", by which precise 
binding site sequences in the DNA may be mapped, applicable both 
in vitro (Hennighausen and Lubon, 1987) and in vivo (Jackson and 
Felsenfeld, 1987) , has proved to be one of the more important of 
these methodologies for the study of the specific contribution 
of DNA to the binding reaction. It is now known that DNA is 
recognised by binding proteins in a non-specific or specific 
manner. Proteins binding non-specifically show poor base 
sequence recognit i on but may bind preferentially to 
double-stranded or single-stranded forms of DNA. This category 
includes the DNA melting proteins such as gene 32 protein of 
bacteriophage T4 (Jensen et ai, 1976) and bovine pancreatic 
ribonuclease (Jensen and von Hippel, 1976); also some proteins, 
like recA, which bind both single-stranded and duplex DNA but in 
different modes (West, 1988). Many regulatory proteins which 
act at specific genomic target sites also exhibit general 
affinity for other regions of DNA. Thus the binding to DNA of 
RNA polymerase hol oenzyme from E. coli (Melancon et ai, 1982) 
and catabolite gene activator protein (CAP) from E. coli (Weber 
and Steitz, 1984) are interactions which include non-specific 
responses, even though the more characteristic binding 
activities are highly site-specific. 
Detailed investigations into the protein components of binding 
have dwelt upon those proteins involved in site-specific 
interactions. They have included genetic studies of mutant 
proteins defective in DNA binding (Hecht et ai, 1983), and X-ray 
crystallographic analyses of DNA binding proteins such as Lambda 
Cro (Anderson et al, 1981), CAP from E. coli (McKay and Steitz, 
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1981) and Lambda repressor (Pabo and Lewis, 1982). Such 
approaches eventually led to the proposition of a common model 
for the physico-chemical interactions occurring at the binding 
sites of naturally evolved site-specific protein-DNA complexes 
(Pabo and Sauer, 1984). Evidence for the validity of this model 
has come more recently from X-ray crystallography of a 
co-crystal of the DNA-binding region of the repressor protein of 
coliphage 434 and the short (14bp) sequence that the protein 
recognises (Anderson et al, 1985), as well as studies of the 
interactions of protein-engineered 434 repressor variants 
(Wharton and Ptashne, 1985). It has also found general support 
from sources such as electron microscopic visualisation of 
protein-DNA complexes (Stasiak et al, 1981; Kuhn et al, 1987) 
which has been an alternative means of 3-dimensional image 
reconstruction (Egelman and Stasiak, 1986). 
The model of interaction between DNA binding proteins and DNA is 
briefly as follows: The binding protein is usually a dimer or 
tetramer with symmetrically related subunits which carry a 
characteristic motif of two a-helices linked by a tight turn. 
One of the a-helices protrudes from the surface of the molecule. 
The complete protein thus has two or more projecting a-helical 
regions. The angles at which these helices are borne, their 
distance apart and their diameters (including side chains) are 
such that they fit neatly into successive major grooves along 
one face of double stranded DNA in B conformation, thereby 
acting as backbone clamps from which amino acid side chains can 
contact the edges of the base pairs in the groove. 
Electrostatic attraction stabilises the complex in a 
non-specific manner, while further stabilisation as well as 
specificity (recognition) is provided by hydrogen bonding and 
van der Waals interactions. The entire binding protein may 
contact the DNA on one side only, as in Cro (Anderson et al, 
1981) and CAP (McKay and Steitz, 1981). Alternatively it may 
include a flexible region which wraps around the double stranded 
helix thus making contact on both sides, as in the case of 
Lambda repressor (Pabo et al, 1982) and RecA (Egelman and 
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stasiak, 1986}. 
The general model appears to hold for many known examples, and 
homology among DNA binding proteins suggests even wider 
applicability (Sauer et al, 1982). While the model is directed 
towards an explanation of specificity, the elements it contains 
are fully compatible with non-specific binding. In this 
respect, the N-acylurea protein-DNA interaction, despite being 
based on synthetic protein constructs, might usefully be 
compared against it. 
3.2 MATERIALS AND METHODS 
3.2.1 MATERIALS 
Highly polymerised calf thymus DNA (Product Code No. D-1501), 
deoxyribonuclease I (EC 3.1.21.1) (Product Code D-5025), 
ethidium bromide (Product Code E-8751) and heparip (Product Code 
H-3125) were obtained from the Sigma Chemical Co., st. Louis, 
Mo, U.S.A. Plasmid pBR322 DNA and endonuclease-free DNA 
polymerase I from E. coli (EC 2.7.7.7) were from Boehringer 
Mannheim GmbH, Penzberg, Western Germany. [Methyl, 1 , ,2,_3H] 
thymidine 5'-triphosphate (specific radioactivity 97Ci/mmol) was 
purchased from Amersham International, U.K. Sephadex G-50 was 
from Pharmacia Fine Chemicals, Uppsala, Sweden; nitrocellulose 
filter discs (Type HA, 25mm diameter, 0.45~m pore size) were 
from Millipore Corporation, Bedford, Mass, U.S.A., agarose was 
from BioRad Laboratories, Richmond, Ca, U.S.A., and 
scintillation fluid (type HP/b) was from Beckman-RIIC Ltd., High 
Wycombe, U.K. All other chemicals were of analytical grade. 
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3.2.2 METHODS 
Shearing of Calf Thymus DNA 
Calf thymus DNA approximately 12kb in size was prepared by 
passing a solution of DNA (0.1mg/ml) in 0.1SSC (SSC, 0.15M NaCI, 
0.015M trisodium citrate) through a 25G-Yale syringe needle six 
times. Sheared DNA solutions were stored at -15°C. 
Labelling of Calf Thymus and pBR322 DNAs 
Sheared calf thymus DNA and the plasmid pBR322 were each 
labelled by the nick translation protocol (Rigby et ai, 1977) in 
the presence of [methyl,1' ,2,_3H] thymidine 5'-triphosphate and 
subsequently purified by the spun column method using Sephadex 
G-50 (Maniatis et ai, 1982). The products were stored at -15°C. 
Specific activities: 6.0 X 106 - 1.0 X 107 cpm/~g TCA-
precipitated DNA. 
Protein Determination 
Protein was estimated quantitatively by the method of Lowry 
(1951) as mentioned in section 2.2.2. 
Band Shift Assay 
This assay, comprising agarose gel electrophoresis of 
protein-DNA and N-acylurea protein-DNA mixtures, was conducted 
as previously described (Huckett et ai, 1986). Unlabelled 
pBR322 DNA was incubated with protein at 20°C for 30min as 
indicated in the legend to Figure 3.2, samples mixed with 1/3 
volume of loading buffer (50%w/v sucrose, 4M urea, 0.1%w/v 
bromophenol blue, 50mM EDTA, pH 7.5) and analysed in 1.2%w/v 
agarose gels made and run with buffer containing 36mM Tris-HCI, 
30mM sodium phosphate and 10mM EDTA (final pH 7.5). A BioRad 
Mini Sub DNA cell system was used; gel dimensions 100 X 65 X 
3mm. Electrophoresis was at 40V for 3h. Gels were stained 
105 
after electrophoresis with ethidium bromide (EB) using 
conventional methodology (Maniatis et al, 1982), illuminated 
wi th transmi tt"ed UV light (300nm), and photographed using Kodak 
Tri-X Pan black and white film (ASA 400) in a single lens reflex 
camera fitted with a 55mm close-up lens and UV and red filters. 
Nitrocellulose Fi l ter Binding Assay 
This assay was conducted essentially as previously described 
(Huckett et al, 1986) with modifications being made according to 
the requirements of individual experiments. All assays were 
carried out at 20°C. 
For a straightforward assay, mixtures containing [3H]calf thymus 
DNA or [3H]pBR322 DNA and protein as indicated in the figure 
legends, in a final volume of 200~1 assay buffer, were incubated 
for 30min, then f i ltered through nitrocellulose discs and rinsed 
with 2.0ml of the same buffer. The nitrocellulose filters were 
wetted in rinse buffer prior to use. Filtration and washing 
were conducted us i ng a Millipore single glass filter holder 
under weak, constant Venturi suction. Finally, filters were 
air-dried and counted for radioactivity in scintillation fluid. 
In the initial stages of the work, the buffer used for 
incubation and washing was 100mM NaCI, 50mM Tris-HCI (pH 7.5), 
5mM EDTA (assay buffer 1). Once it was realised that the 
binding reaction i s sensitive to ionic strength, the buffer was 
changed to 50mM NaCI, 10mM Tris-HCI (pH 7.5), lmM EDTA (assay 
buffer 2). For b i nding experiments involving insulin-albumin 
conjugates, the buffer was modified yet again to 50mM NaCI, 20mM 
Tris-HCI (pH 7.0) , lmM EDTA (assay buffer 3), in order to 
provide sufficient buffering at pH 7.0 to accomodate additions 
of conjugate in the form of stock solution at pH 4.0. Also, in 
some experiments, the DNA samples were isotope diluted. The 
variations employed for each particular experiment are made 
clear in the figure legends. In all other respects the ordinary 
assay procedure remained the same. 
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To investigate the effect of ionic strength on binding, 
protein-DNA complexes were allowed to form in the normal manner 
during a 30min incubation in assay buffer, then the incubation 
mixtures adjusted to Na+ concentrations ranging from 2SmM to 
1 .OM either by dilution with water or by the addition of 4M NaCI 
made up in appropriate buffer. Final total volume of each 
mixture after Na+ adjustment was 200~1. Solutions were 
incubated for a further 10min before filtration. The filters 
were presoaked and subsequently rinsed with buffer which had 
been Na+ adjusted to match the final incubation medium. 
To investigate the effect of pH on binding, a series of special 
buffers was prepared for use with the assay which ranged from pH 
4.0 to pH 10.0. In each buffer the total final concentration of 
Na+ was adjusted t o BOmM by the addition of NaCI as appropriate. 
Each buffer was used as incubation medium and washing medium in 
place of a regular assay buffer. 
pH 4.0 SOmM acetate buffer (sodium salt) 
pH 5.0 SOmM acetate buffer (sodium salt) 
pH 6.0 SOmM phosphate buffer (sodium salt) 
pH 7.0 SOmM phosphate buffer (sodium salt) 
pH B.O SOmM barbital buffer (sodium salt) 
pH 9.0 SOmM glycine-NaoH buffer 
pH 10.0 SOmM glycine-NaOH buffer 
To investigate the temporal susceptibility of the binding 
interaction to anion competition, protein-DNA complexes were 
allowed to form in the normal manner in assay buffer, then, at a 
period of either 30sec or 30min after initial mixing, varying 
amounts of the polyanion heparin added in the form of freshly 
made up standard solution (O.1~g/~1 in assay buffer) to give 
final total assay volumes of 200~1. Mixtures were incubated for 
a further 30sec before filtration. 
107 
3.3 RESULTS 
3.3.1 RELATIONSHIP BETWEEN CARBODIIMIDE MODIFICATION OF PROTEIN 
AND CAPACITY TO BIND DNA 
The entire series of N-acylurea CDI-albumins prepared at protein 
to carbodiimide mole ratios ranging ,from 1:10 to 1:2000 (section 
2.2.2) was evaluated by means of the nitrocellulose filter assay 
for ability to bind both sheared calf thymus DNA and pBR322 DNA. 
Results, shown in Figure 3.1, demonstrate that while unmodified 
albumin and lightly carbodiimide-treated N-acylurea albumins 
could not bind DNA, N-acylurea albumins prepared at protein to 
carbodiimide mole ratios of 1:250 and greater were able to bind 
DNA. Albumins in this category had already been shown to carry 
more than 13 N-acylurea moieties per albumin molecule (Table 
2.1) and to exhibit significant electropositivity as a result 
(Figure 2.3). The first N-acylurea albumin in the mole ratio 
series which significantly bound both calf thymus (linear) and 
plasmid (circular) DNA was the 1:500 derivative (Figure 3.1), 
previously shown to have N-acylurea groupings at 27 sites per 
molecule (Table 2.1). On the basis that this derivative 
appeared to provide reliable DNA binding with least 
modification, N-acylurea albumins prepared at protein to 
carbodiimide mole ratios of 1:500 were deemed most suitable for 
conjugation to insulin. 
The capacity of proteins to bind DNA once they have been 
converted to N-acylurea derivatives is illustrated by 
alternative means in Figure 3.2, which shows the result of DNA 
gel electrophoresis following incubation of pBR322 DNA samples 
with varying amounts of proteins. Retardation of migration 
resulting from the complexing of plasmid to protein (the band 
shift effect) was apparent only in the case of N-acylurea 
protein incubations. Band shift analysis of albumin and 
N-acylurea CDI-albumin (1:500) is presented in Figure 3.2A. In 
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CDI- TREATED ALBUMIN SAMPLES 
Figure 3.1 Binding of DNA to N-acylurea albumins prepared with 
N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide hydrochloride at 
protein to carbodiimide mole ratios varying from 1:10 to 1:2000 
DNA binding was assayed by the nitrocellulose filter technique 
using buffer 1 (high ionic strength). Each assay mixture 
contained 10ng DNA and 8.8~g protein. 
A. [3H]calf thymus DNA (6.5 X 104 cpm per assay) with the 
complete range of N-acylurea albumins. 
B. [3H]pBR322 DNA (7.6 X 104 cpm per assay) with the complete 
range of N-acylurea albumins. 
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Figure 3.2 Band shift assay of binding interactions between 
proteins and DNA 
Samples of pBR322 DNA were incubated with protein at 20°C for 
30min prior to agarose gel electrophoresis. Each incubation 
mixture contained pBR322 DNA and protein as indicated, in a 
final volume of 10~l buffer (50mM NaCI, 20mM Tris-HCI (pH 7.0), 
1mM EDTA). 
A. pBR322 DNA, O.33~g per well. 1, pBR322, no protein; 2, 
pBR322 plus albumin (4.0~g); 3 and 4, pBR322 plus A-CDI 
(4.0~g and 8.0~g respectively); 5, pBR322 plus cytochrome C 
(4.0~g). 
B. pBR322, 0.45~g per well. 1, pBR322, no protein; 2 and 3, 
pBR322 plus I-A (2.0~g and 3.3~g respectively); 4-8, pBR322 
plus I-[A-CDI] (0.4~g, 1 .O~g, 1 .66~g, 2.66~g and 3.3~g 
respectively). 
Conjugates were added in the form of purified stock solutions 
(pooled Sephadex G-100 fractions, as shown in Figure 3.3). 
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band shift, particularly in relation to the supercoiled form of 
the plasmid, while at 8~g A-COl the plasmid was fully bound and 
the resultant complex virtually unable to enter the gel. In 
contrast, unmodified albumin and the basic protein cytochrome C 
were without effect on pBR322 DNA migration under the same 
electrophoretic conditions. A comparable analysis of 
insulin-albumin conjugates is presented in Figure 3.2B. In the 
presence of 0.45~g pBR322 DNA, band shift became observable at 
1 .O~g I-[A-CDI] among the supercoiled plasmid population, and at 
1.66~g I-[A-CDI] significant retardation of both supercoiled and 
nicked circular forms was seen as continuous smudging of the 
DNA, while at higher levels of the same conjugate the complex 
was quite unable to migrate. I-[A-CDI], being particularly 
large and yet heterogeneous in size, appeared to bring about 
dramatic band-shifts of variable dimensions, thus giving rise to 
more "blurring" than did A-CDI. Like unmodified albumin, I-A 
was without effect on pBR322 mobility. Insulin was similarly 
without effect (result not shown). 
3.3.2 DNA BINDING CAPACITY OF INSULIN-ALBUMIN CONJUGATES 
FRACTIONATED BY GEL FILTRATION 
Purified conjugates obtained by gel filtration through Sephadex 
G-100 (Figure 2.6) were assayed for DNA binding activity by the 
nitrocellulose filtration technique. Figure 3.3 illustrates 
typical binding interactions of pBR322 DNA with the various size 
species of I-A and I-[A-CDI] obtained by fractionation during 
the purification procedure. Each assay mixture contained 1.5~g 
conjugate. At this level of protein the DNA present in the 
assay mixture (10ng) is not limiting (Figure 3.4B). The 
capacity to bind DNA was demonstrated by I-[A-CDI] but not by 
I-A. While all fractions of I-[A-CDI] underwent significant 
binding, binding was lowest for the very large polymers and 
there was a reproducible trend for the binding capacity of the 
larger species of conjugate to be inversely proportional to 
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Figure 3.3 DNA binding capacity of insulin-albumin conjugates 
fractionated by gel filtration 
DNA binding was assayed by the nitrocellulose filtration 
technique using assay buffer 3. Each assay mixture contained 
4.5ng [3H]pBR322 DNA (3.0 X 104 cpm), 5.5ng unlabelled pBR322 
DNA and 1.5~g protein conjugate. 
Absorption at 280nm of I-A and I-[A-CDI] (---); DNA bound by 
I-[A-CDI] (light hatching); DNA bound by I-A (heavy hatching). 
The horizontal bar indicates those fractions pooled for use in 
binding and transfection experiments. 
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reflection of the reduction in the ratio of surface area to 
weight that accompanies polymerisation. Maximal binding was 
achieved and maintained over a range of the more moderately 
sized species (fractions 21 - 24). 
On the basis of (i) DNA binding capacity (Figure 3.3), (ii) 
insulin content (Figure 2.8) and (iii) concentration (Figures 
2.6 and 2.8), I-[A-CDI] fractions 19 to 23 inclusive were pooled 
to provide an I-[A-CDI] stock solution for use in all 
experiments requiring purified conjugate. Fractions of I-A were 
pooled in an equivalent manner. stock solution concentrations 
ranged from 0.38 to 0.42~g protein/mI. 
3.3.3 PARAMETERS OF BINDING 
The Effect of Protein Concentration 
The interactions of DNA with albumins and insulin-albumin 
conjugates at varying concentrations of protein are shown in 
Figure 3.4. Results confirm that only N-acylurea derivatives 
undergo binding. Total DNA per reaction mixture was 10ng in all 
cases. The amount of DNA bound increased linearly with 
increasing protein until a point of saturation (equilibrium) was 
reached; beyond this point no more DNA could be taken up into 
the protein-DNA complex. 
Figure 3.4A illustrates the binding of [3H]calf thymus DNA (6.5 
X 104 cpm) and [3H]pBR322 DNA (7.6 X 104 cpm) to N-acylurea 
CDI-albumin and N-acylurea Me+CDI-albumin respectively, each of 
the two proteins having been carbodiimide-modified at a 1:500 
mole ratio. Results indicate that A-Me+CDI, which was fully 
saturated with DNA at an input of 0.05~g protein, was able to 
enter into a more tenaceous binding relationship than A-COl, 
0.10~g of which had to be present for saturation point to be 
reached. Thus the observed equilibrium constant (K ) was 
obs 
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Figure 3.4 Binding of DNA to N-acylurea proteins at varying 
protein concentration 
DNA binding was assayed by the nitrocellulose filtration method. 
A. Each assay mixture contained 10ng [ 3H]pBR322 DNA (7 . 6 X 104 
cpm) or 10ng [ 3H]calf thymus DNA (6.5 X 104 cpm) and 
protein as indicated, in assay buffer 2. Modification of 
albumin was at a protein to carbodiimide mole ratio of 
1 : 500. A-CDI with pBR322 (.) and calf thymus DNA (0 ) ; 
A-Me+CDI with pBR322 (.) and calf thymus DNA (0); albumin 
control with either DNA (6). 
B. Each assay mixture contained 4 . 5ng [ 3H]pBR322 DNA (4.5 X 
104 cpm) and 5.5ng unlabelled pBR322 DNA together with 
protein as indicated, in assay buffer 3. Each protein 
conjugate was added as purified stock solution (Figure 
3.3) . I- [A-CDI], (.); I-A control ' ( 0 ) . 
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with the expectation that the quaternary nitrogen functions 
present in the N-acylurea moieties of A-Me+CDI would give rise 
to a higher af·finity for DNA than exhibited by A-CDI, which is 
characterised by tertiary nitrogens. That A-Me+CDI is more 
positively charged than its A-CDI counterpart has already been 
noted (Figure 2.3A). However, it is interesting to observe that 
in spite of its apparently higher affinity for DNA, A-Me+CDI 
showed a lower overall DNA binding capacity: at saturation it 
carried less DNA than did A-CDI. The explanation for this is 
not immediately clear, but could be related to a reduction in 
the number of available binding sites as a result of 
conformational constraints. 
Results shown in Figure 3.4A also indicate that pBR322 DNA was 
bound more effectively than sheared calf thymus DNA by both 
N-acylurea albumins. This could be explained simply by the loss 
of particularly small or large fragments of calf thymus DNA 
during the filtration and washing procedures of the assay. 
Alternatively, it could be explained by a higher N-acylurea 
protein binding affinity for circular (particularly supercoiled) 
forms of DNA, or a more efficient spatial accomodation of this 
form of DNA on the protein surface, or both. The results of 
band shift assay (Figure 3.2) indicate that from a mixture of 
supercoiled and nicked circular forms of plasmid, the former was 
indeed selectively bound by N-acylurea proteins. 
Of interest in relation to both of the above sets of findings is 
the observation that the interaction of pBR322 DNA with A-CDI 
was the only one leading to virtual exhaustion of free DNA in 
the incubation mixture (7.2 X 104 cpm bound). 
Results presented in Figure 3.4B illustrate the binding of 
isotope diluted [3H]pBR322 DNA (4.5 X 104 cpm) to 
insulin-[N-acylurea CDI-albumin]. Saturation point was reached 
at an input of 8.0~g conjugate. This is 80 times the amount of 
unconjugated A-COl required for saturation under the same 
conditions. Since l-[A-CDI] is not larger than A-CDI by as 
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much as a factor of 80 (section 2.4), Kobs for the conjugate is 
significantly lower than for both of the unconjugated N-acylurea 
albumins. The lower value is compatible with the fact that the 
components of the conjugate lose some electropositivity during 
the glutaraldehyde coupling procedure such that the final 
product is only moderately basic (Figure 2.3B). Nevertheless 
the capacity of the conjugate to bind DNA is significant. 
The Effect of NaCl Concentration 
The dissociation by Na+ of N-acylurea protein-DNA complexes is 
shown in Figure 3.5. Figure 3.SA illustrates the salt induced 
dissociations of N-acylurea CDI-albumin and N-acylurea 
Me+CDI-albumin from [3H]pBR322 DNA, while Figure 3.SB 
illustrates the comparable dissociation of the conjugated 
binding protein insulin-[N-acylurea CDI-albumin] from [3H]pBR322 
DNA. 
As deduced from the curves, concentrations of NaCl required for 
the half-dissociation of individual N-acylurea protein-DNA 
complexes are: A-CDI, 0.1SM; A-Me+CDI, 0.24M; I-[A-CDI], 0.1M. 
These values confirm previous observations (Figure 3.4) that the 
affinity for DNA (Kobs ) of A-Me+CDI is higher than that of A-CDI, 
and that the affinity of the I-[A-CDI] conjugate for DNA is 
weaker than the DNA binding affinities of either of the 
unconjugated N-acylurea proteins. Moreover these values are 
fully correlative with observed charge properties (Figure 2.3). 
That the sodium ion caused almost complete dissociation of the 
complexes formed between unconjugated N-acylurea albumins and 
DNA (Figure 3.5A) suggests an important role for electrostatic 
interaction in the binding phenomenon. Of considerable interest 
and contrast in this respect is the residual binding displayed 
by I-[A-CDI]-DNA complexes at high concentrations of sodium 
(Figure 3.SB), which possibly indicates the involvement of 
strong additional forces in the binding reaction between 
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Figure 3.5 The effect of NaCl concentration on the 
dissociation of N-acylurea protein-DNA complexes 
0.6 0.8 
DNA binding was assayed by the nitrocellulose filtration method. 
A. Each assay mixture contained 5ng [3H]pBR322 DNA (3.S X 104 
cpm) together with 100ng A-CDI or SOng A-Me+CDI in assay 
buffer 2. Both N-acylurea albumins were prepared at a 
protein to carbodiimide mole ratio of 1 :500. Dissociation 
of pBR322 from A-CDI (.); dissociation of pBR322 from 
A-Me+CDI (0). 
B. Each assay mixture contained 4.5ng [3H]pBR322 DNA (4.1 X 
104 cpm) and 5.5ng unlabelled pBR322 DNA together with 
5.5~g I-[A-CDI] (purified stock solution) in assay buffer 
3 . 
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importance of using a low-salt medium (assay buffers 2 and 3) 
for in vitro binding studies, and emphasise ionic strength as a 
factor for serious consideration in future transfection work 
whether with cells in vitro or whole organisms in vivo. 
The Effect of pH 
Conjugated proteins were used as DNA binding models to study the 
effect of pH on the binding reaction. Figure 3.6 shows the 
amount of [3H]pBR322 DNA bound by 4.0~g insulin-albumin 
(control) and 4.0~g insulin-[N-acylurea CDI-albumin] at pH 
values ranging from 4.0 to 10.0. In order to span this pH 
range, four different types of buffer were necessarily employed 
(section 3.2.2); therefore salts of sodium were selected for use 
in each buffer system and the final sodium concentration 
adjusted to BOmM in every case so as to eliminate variations in 
binding due to the influence of ionic strength and Na+ 
concentration in particular. 
Results showed that 
(i) unmodified I-A bound DNA at low pH (pH 4.0 - 5.0); 
(ii) I-[A-CDI] lost its capacity to bind DNA at high pH 
(pH B.O - 10 . 0), and 
(iii) optimal conditions for controlled nitrocellulose 
filter binding assays existed only close to neutral 
pH (between pH 6.0 and 7.0) . 
These results demonstrate the strong pH dependence of the 
protein-DNA binding reaction as determined by the nitrocellulose 
filter assay. They can be explained strictly in terms of the 
protonation and dissociation of side chain amino and N-acylurea 
groupings, and in this respect they fully support the idea that 
N-acylurea protein-DNA binding is charge dependent and at least 
partially electrostatic in nature. However, it is not known to 
what extent pH differences affect the protein binding properties 
of nitrocellulose. Explanations which account only for charge 
alterations on the proteins are likely, therefore, to be 
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Figure 3.6 pH Dependency of the bindinq of DNA to 
insulin-albumin and insulin-[N-acylurea CDI-albumin] assayed by 
the nitrocellulose filtration technique 
Each assay mixture contained 4.5ng [3H]pBR322 DNA (4.2 X 104 
cpm), 5.5ng unlabelled pBR322 DNA, and 6.0~g purified I-A ( • ) 
or I-[A-CDI] ( 0). Both incubation and washing steps were 
conducted using one of a series of buffers as defined in 
Materials and Methods. 
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simplistic. 
One clearly important result which does emerge is that the 
nitrocellulose fi l ter binding assay must be conducted under 
carefully control l ed conditions of pH close to neutral. This 
conclusion reinforces the importance of having redesigned the 
nitrocellulose filter assay buffering medium for use with 
insulin-albumin conjugates (assay buffer 3); it was changed to 
include a slightly higher concentration of Tris-HCl in order to 
accomodate additions of purified conjugate in low pH acetate 
buffer without the final assay pH going beyond acceptable 
bounds. 
The Effect of Time 
Table 3.1 demonstrates that when N-acylurea protein and DNA are 
brought together in solution, the formation of filter-detectable 
complex is rapid, occurring in less than 30 seconds, the complex 
remaining stable for at least 50 minutes thereafter. 
Table 3.1 Effect of time of incubation on N-acylurea 
protein-DNA binding determined by the nitrocellulose filtration 
assay 
Each assay mixture contained 10ng [3H]calf thymus DNA 
(6.5 X 10 4 cpm) and 1 . 0~g A-CD! (1 :500) in assay buffer 2. 







50.0 (no protein) 










3.3.4 HEPARIN CHALLENGE EXPERIMENTS: THE BINDING PROCESS 
Following initial reaction between N-acylurea proteins and DNA, 
the complexes formed were challenged with heparin at two 
different periods of elapsed time and the residual binding 
measured by nitrocellulose filter assay. Figure 3.7 shows the 
result of heparin competition on the complexes formed between 
N-acylurea CDI-albumin and calf thymus DNA (A), N-acylurea 
CDI-albumin and pBR322 DNA (B), and insulin-[N-acylurea 
CDI-albumin] and pBR322 DNA (C). In their initial state, 30 
seconds after mixing, all complexes formed appeared to be 
susceptible to dissociation when challenged by heparin, 
suggesting a simple, rapidly formed, ion-dependent 
(electrostatic) binding reaction. However, after allowing the 
reaction to proceed for 30 minutes, heparin challenge was 
significantly less effective, indicating the development over 
that period of time of tighter binding involving at least one 
non-electrostatic component. 
3.3.5 FURTHER INVESTIGATIONS INTO THE NATURE OF BINDING 
Minor experiments directed towards obtaining additional 
information on the nature of the binding interactions between 
N-acylurea protein s and DNA were undertaken. Heating N-acylurea 
CDI-albumin-pBR322 complexes to 55°C for 10min had no effect on 
binding. Treating an identical complex with phenol at 20°C did 
not lead to separation of the plasmid into the aqueous phase; 
however, when the phenol contained 0.1%SDS and the extraction 
was at 60°C for 5 min, the plasmid was recovered in the aqueous 
phase and was shown by gel electrophoresis to be mainly in the 
supercoiled form. These results indicate that the complex of 
N-acylurea CDI-albumin and pBR322 DNA is resistant to moderate 
temperatures, is held together by noncovalent bonds, and does 
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Figure 3.7 Time dependency of heparin challenge on N-acylurea 
protein-DNA binding assayed by the nitrocellulose filtration 
method 
Assay mixtures were incubated for either 30sec or 30min prior to 
addition of heparin, then incubation continued for a further 
30sec before filtration. 
A. Heparin challenge to the binding of calf thymus DNA to 
N-acylurea CDI-albumin (1:500). Each assay mixture 
contained 10ng [3H]calf thymus DNA (6.5 X 104 cpm) and 
1 .O~g A-CDI in assay buffer 2. 
B. Heparin challenge to the binding of pBR322 DNA to 
N-acylurea CDI-albumin (1 :500). Each assay mixture 
contained 10ng [3H]pBR322 DNA (7.6 X 104 cpm) and 1 .O~g 
A-CDI in assay buffer 2. 
C. Heparin challenge to the binding of pBR322 DNA to 
insulin-[N-acylurea CDI-albumin]. Each assay mixture 
contained 4.5ng [ 3H]pBR322 DNA (3.2 X 104 cpm), 5.5ng 
unlabelled pBR322 DNA and 6.2~g I-[A-CDI] in assay buffer 
3 . 
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3.4 SUMMARY AND DISCUSSION 
Using both sheared calf thymus DNA (linear, heterogeneous) and 
pBR322 DNA (circular, homogeneous), the DNA binding reactions of 
various N-acylurea albumins and an insulin-conjugated derivative 
have been investigated. Two methods were employed: the agarose 
gel electrophoresis band shift assay, and the nitrocellulose 
filter assay. Bot h of these assays were used at the outset to 
establish the ability of N-acylurea albumins to bind DNA and to 
demonstrate the fundamental dependence of the binding reaction 
on the presence of N-acylurea carbodiimide adducts (Figures 3.1 
and 3.2). In addition, the precision of the nitrocellulose 
filter technique allowed a comparative assessment to be made of 
the binding capacities of the complete series of CDI-treated 
albumins, resultin g in identification of the 1:500 mole ratio 
products as most suitable for conjugation to insulin on grounds 
of significant ability to bind different forms of DNA (Figure 
3.1) . Analysi s of the DNA binding capacity of gel filtration 
fractions of insulin-[N-acylurea CDI-albumin] after post-
conjugation purification was also made possible by the 
nitrocellulose filtration technique (Figure 3.3). 
The nitrocellulose filter method was utilised further to 
investigate various aspects of the DNA binding reaction (Figures 
3.4 - 3.7). For t his purpose, N-acylurea CDl-albumin (1:500) 
and N-acylurea Me+CDl-albumin (1 :500) were chosen as important 
study models, being the modified albumins carrying different 
N-acylurea carbodi imide moieties deemed suitable for conjugation 
to insulin. Insul in-[N-acylurea CDI-albumin] was necessarily 
the conjugated N-acylurea protein selected for study, being the 
only one destined for possible future use in transfection work 
on the basis of solubility (section 2.4). By means of the 
experiments undertaken with these N-acylurea proteins it was 
possible to 
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demonstrate the effect of N-acylurea protein concentration 
on its binding to DNA, and from the binding curves 
determine' the relative affinities for DNA of the different 
N-acylurea proteins; 
show that N-acylurea protein-DNA complexes are sensitive to 
NaCl concentration, and from the dissociation curves 
determine and confirm relative affinities for DNA of the 
different N-acylurea proteins; 
show that the binding reaction is pH dependent; 
show that the binding reaction occurs very rapidly, and 
deduce the existence of more than one mode of interaction 
between N-acylurea proteins and DNA. 
Some of the binding studies using N-acylurea albumin have been 
reported previously in conjunction with supportive observations 
made using N-acylurea transferrins (Huckett et al, 1986). 
A number of factors indicate that there is a strong 
electrostatic component in the binding interaction: 
N-acylurea Me+CDl-albumin, which is more strongly basic 
than the eqivalent N-acylurea CDl-albumin (Figure 2.3A), 




(Figures 3.4A and 3.5A); likewise, the insulin-[N-acylurea 
CDl-albumin] conjugate, which is less basic than either of 
the two N-acylurea albumins (Figure 2.3B), has a 
correspondingly lower Ko~ (Figures 3.4B and 3.5B); 
Kobs for all N-acylurea protein-DNA interactions are 
dependent on monovalent ion concentration ([Na+] in the 
experiments reported here); Ko~ is reduced with increasing 
[Na+] (Figure 3.5), and 
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the polyanion heparin is able to compete with DNA for 
protein binding sites thus reducing Ko~ (Figure 3.7). 
Using thermodynamic analysis as developed by Record et al (1976) 
for the binding of charged ligands to nucleic acids, estimates 
have been made of the number of charge-charge interactions 
occurring in various N-acylurea protein-DNA complexes (Ariatti 
and Hawtrey, 1987); they appear to be of the same order as those 
calculated by Record and colleagues for several naturally 
occurring DNA binding proteins. While the role of electrostatic 
interaction at the binding site is thus strongly supported, and 
might be a dominan t one, additional non-electrostatic forces do 
appear to be operative in the binding reaction as indicated by 
the inability of proteins such as cytochrome C, of similar 
basicity to N-acylurea albumins (Figure 2.3), to bind DNA, 
and 
the existence of at least two modes of binding interaction, 
one of which is not easily disrupted by anionic 
competition, as deduced from heparin challenge experiments 
(Figure 3.7). 
Evidence for non-electrostatic interaction between N-acylurea 
entities and nucleic acid bases, particularly unpaired guanine 
residues, has been provided by H'Nmr spectrometry which 
demonstrates a downfield shift in the signal from the amino 
group of guanosine in solution in DMSO in the presence of 
N-acetylurea (Ariatti and Hawtrey, 1987). The observed shift is 
explicable by hydr ogen bonding; model building was used by the 
same authors to show that three hydrogen bonds are possible with 
guanine whereas a t best only two bonds are possible with A, C, U 
or T. An alternat ive explanation is a glyoxal-type addition 
reaction, also shown to be feasible by modelling. Such 
interactions imply binding within single-stranded regions of 
DNA. The preferential binding of N-acylurea CDl-albumin and its 
conjugate for supercoiled DNA, noted in Figure 3.2 and also 
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reported previously with N-acylurea COl-transferrin (Huckett et 
al, 1986) and N-acylurea Me+CDI-transferrin (Ariatti and 
Hawtrey, 1987), does in fact support this possibility, since DNA 
in the supercoiled form contains more single-stranded regions 
than relaxed closed circular or linearised DNA configurations. 
The heparin challenge experiments (Figure 3.7) indicate the 
existence of two modes of binding interaction which cannot be 
discriminated by nitrocellulose filtration assay (Table 3.1), 
both of which are destroyed by salt (Figure 3.5): (i) 
fast-forming heparin sensitive bonds which are presumably mainly 
electrostatic, and (ii) interactive forces which come into play 
more slowly, resulting in greater binding stability and 
resistance to anionic competition, which probably involve 
non-electrostatic mechanisms. The observed salt sensitivity 
indicates that the latter interaction requires the electrostatic 
component for full stabilisation. In interpreting results of 
heparin challenge on the binding of RNA polymerase to 
restriction fragments of T7D111 DNA, Melancon and coworkers 
(1982) deduced the existence of at least three categories of 
binding interaction, including the two noted here, and showed 
-
that they occurred on certain subsets of fragments and in 
certain positions therein. In the case of the N-acylurea 
protein-DNA interaction, the two modes of binding might be 
interpreted as reflecting either (i) two different categories of 
DNA sequence giving rise to two different types of binding site, 
one of which could be more specific and more stable than the 
other, or (ii) two different types of interaction at each of 
many non-specific binding sites at which DNA sequence is of 
little importance. 
In the light of both the results obtained and known models of 
nucleoprotein complex formation, it is suggested that the 
binding interaction consists of the following: a degree of close 
physical contact occurs between the N-acylurea protein and the 
DNA which is very rapidly stabilised in a non-specific manner by 
electrostatic forces in the form of ion pairing between 
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N-acylurea entities and nucleic acid phosphates. Localised 
unwinding of the DNA double helix might be induced at this stage 
by unknown mechanisms. Thereafter the complex is stabilised 
further in a slower process of accomodation leading to hydrogen 
bonding and possibly other additional interactions. This latter 
process would be somewhat site-dependent, although not 
site-specific, and therefore it is envisaged that accomodation 
might include a degree of movement between the surface of the 
protein and the phosphodiester backbone of the DNA prior to the 
bonding taking place. A precedent exists for this idea: in 
proposing a model for the non-specific binding shown by CAP, 
Weber and Steitz (1984) have suggested that the protein is 
capable of sliding in and out of the major grooves of the DNA to 
sample the sequence until complementarity of structure leading 
to hydrogen bonding is achieved. Those authors conceive that 
electrostatic interaction provides initial long range energy for 
the formation of the complex as well as the orientation of the 
protein and DNA entities in relation to one another, while 
hydrogen and other types of bonds represent short range binding 
energies which come into play secondarily. They base their 
model on thermodynamic calculations which suggest that 
electrostatic stability is maximum at a protein-DNA separation 
distance of 12 A at which hydrogen bonds or other binding 
contacts of a directional nature do not form. Charge-charge 
interactions are clearly not merely binding initiators, however. 
Evidence from Na+ dissociation studies (Figure 3.5; Melancon et 
ai, 1982) indicate that electrostatic interactions continue to 
play an important role in complex stabilisation even after 
secondary bonding has taken place as demonstrated by heparin 
competition (Figure 3.7). 
The residual binding displayed by insulin-[N-acylurea 
CDI-albumin] conjugate at high [Na+] (Figure 3.5B), not seen in 
the dissociation of N-acylurea albumins (Figure 3.5A), is of 
particular interest in view of the possible role of the 
conjugate in gene transfer. In terms of the model described 
above, a residual, Na+-resistant bond would be likely to 
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comprise one of t h e non-electrostatic modes of interaction. One 
possibility is that sufficient hydrogen bonding had taken place 
between the I-"[A-CDI] conjugate and DNA that electrostatic 
interaction was not required to stabilise and maintain overall 
binding free energy, although in view of the salt sensitivity of 
other complexes, including tightly bound examples (Melancon et 
al, 1982), this seems unlikely. Another possibility is that a 
type of bonding such as the formation of glyoxal-type adducts as 
suggested by Ariatti and Hawtrey (1987) had taken place; bonding 
of this type would certainly not be sensitive to ionic 
competition, although it is not known whether it could maintain 
the integrity of the complex without the contribution of charge-
charge interactions. Both of the aforementioned suggestions are 
based on an assumption of complete solubility of binding 
components and bound complex. A further possibility is that a 
proportion of the I-[A-CDI]-DNA assay mixture had coprecipitated 
out of solution in the dissociation experiments. While no 
visual evidence of precipitation was found, this possibility was 
taken seriously because of the insolubility problems encountered 
with insulin-[N-acylurea Me+CDI-albumin]-DNA complexes and the 
vital importance of conjugate-DNA complex solubility to the 
design of future gene transfer experiments. Interestingly, in 
preparing protein-nucleic acid conjugates for use as immunogens, 
Stollar (1980) has noted that in certain circumstances 
carbodiimide-modified proteins may form precipitates with DNA. 
In the present work, therefore, appropriate precautions were 
taken in the transfection protocol to deal with the possibility 
of insoluble complex formation (Chapter 5). 
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CHAPTER FOUR 
BINDING OF INSULIN AND INSULIN CONJUGATES TO HepG2 CELLS 
~ INTRODUCTION 
Techniques designed to measure the binding of a .ligand to its 
receptor are fundamental tools in a number of different research 
disciplines, since effector molecules as diverse as 
neurotransmitters, antibodies, lectins, drugs and hormones all 
act by triggering a cascade of biochemical reactions through the 
initial formation of a complex with the cognate receptor 
situated in the cell surface plasma membrane or in one of the 
organellar membrane systems. In almost all cases, detection and 
measurement of the binding interaction requires a sensitive 
method: most natural ligands occur at extremely low 
physiological concentrations, and their receptors exist in 
femtomole to picomole quantities per milligram of membrane 
protein, which means a receptor concentration of 1 X 10-12 -
1 X 10-~ in a binding assay (Levitzki, 1985). The detection 
methods first devised and still usually employed are forms of 
radioligand assay, in which the ligand is labelled to high 
specific radioactivity using a suitable isotope. The one of 
choice is [125r ], not only because a product of high specific 
radioactivity (150 -1500 kCi/mol) is obtained, but also because 
the half life (t1n = 60.2 days) is moderately long and the 
radioiodination procedure easy to perform in the laboratory 
(Gammeltoft, 1984). Of the various methods available for the 
iodination of peptides and proteins at the time when ligand-
receptor binding studies were being initiated in the late 1960s 
and early 1970s, the one most commonly used was that of Hunter 
and Greenwood (1962) involving chloramine-T oxidation of sodium 
iodide to the cation r+ conducted under buffered aqueous 
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conditions in the presence of the protein substrate. The 1+ 
becomes incorporat ed into the ring structure of the amino acid 
tyrosine directly and rapidly in a single stage reaction at room 
temperature. The iodinated protein may easily then be separated 
from the reactants by gel filtration. 
When insulin is [ ' 251 ]-labelied, the [ ' 251 ] isotope is 
incorporated into tyrosine residues according to their surface 
availability. Tyrosines exist at four positions: A14, A19, B16 
and B26 (Figure 1.2). The resultant labelled insulin 
preparation is highly heterogeneous, consisting mainly of 
monoiodinated and diiodinated isomers, insulin polymers 
(resulting from decay of the latter) and unlabelled native 
insulin (Gammeltoft, 1984). Early endocrinological and 
immunochemical studies had shown that the biological activity of 
such iodinated mixtures in the unfractionated state is low due 
to oxidation damage and multiple iodine substitution (1zzo et 
ai, 1964; Brunfeldt et ai, 1968; Garrat et ai, 1972). Thus, 
even in the preliminary, developmental stages of radioligand 
binding work, a number of laboratories attempted to improve the 
labelling technique by the introduction of milder iodination 
agents such as lactoperoxidase for the suppression of oxidation 
damage (Thorell and Johansson, 1971) and the reduction of 
iodination to minimal levels so that monoiodoinsulin was 
produced (Freychet et ai, 1971); furthermore, over the next few 
years, manipulation of reaction conditions such as pH, mole 
ratio of iodine to insulin, and insulin concentration to achieve 
similar ends became commonplace. Analytical studies of 
protocols such as these, reviewed and summarised by Gammeltoft 
(1984), have shown that under mild conditions the majority of 
iodine becomes incorporated into the A chain, probably because 
the tyrosines therein are more exposed than those in the B chain 
when insulin is dimerised. They have shown also that of the two 
possible A chain-substituted monoiodoinsulin species, the A14 
derivative is fully biologically active while the A19 derivative 
has attenuated activity . These observations are fully 
compatible with structure-function investigations which suggest 
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that TyrA19 but not TyrA14 is part of the receptor-binding region 
of the insulin molecule (Pullen et al, 1976). In recent years, 
, , 'f' d [125I T A14] , I' therefore, pur1f1ed preparat10ns 0 mon010 0 - yr 1nsu 1n 
have been used routinely in insulin-receptor binding assays. 
Separation of one labelled insulin from another may be 
accomplished by gel filtration (Keefer et al, 1981), high 
performance liquid chromatography (HPLC) (Seidah and Chretien, 
1983) or gel electrophoresis (Linde et al, 1983); very commonly, 
however, the approriately labelled insulin, already purified, is 
purchased from a commercial source. For the binding studies 
reported here, a commercially prepared human [125I _TyrA14] insulin 
synthesised by lactoperoxidase iodination and purified by HPLC 
was used. 
In addition to a radiolabelled ligand, any assay of 
ligand-receptor binding requires a population of intact cells, 
purified membranes or solubilised receptors. In the present 
work, cultured HepG2 cells were used as the source of insulin 
receptors and assays were conducted on whole cell populations. 
HepG2 is a human liver cell line isolated by Knowles and 
coworkers (Aden et al, 1979) from a teenage Caucasian male from 
Argentina with primary hepatoblastoma and hepatocellular 
carcinoma. It was initially derived from minces of hepatoma 
biopsy tissue placed on feeder layers of the mouse cell line STO 
(Martin and Evans, 1975), irradiated to the point of 
non-division. Hepatoma sublines were selected after several 
months by feeder-independent in vitro growth in minimal 
essential medium (MEM) supplemented with foetal calf serum. 
After serial passage in MEM more than 50 times, HepG2 cells were 
reported to have recurrent chromosome abnormalities (between 50 
and 56 chromosomes; mean = 55) with a distictive rearrangement 
of chromosome 1; in addition they were shown to retain the 
morphology and many of the biosynthetic capabilities of normal 
liver parenchyma (Knowles et al, 1980). The expression of 
differentiated functions is one of the most interesting and 
useful features of the HepG2 line. An extensive catalogue of 
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liver-specific phenotypic characteristics now known to be 
expressed in HepG2 cells has been tabulated by Darlington 
(1987). Integrated viral DNA is absent from the line, and 
Hepatitis B surface antigen is not synthesised. As a permanent 
cell line having many of the attributes of normal liver cells, 
it is not surprising that HepG2 carries a numerically 
significant population of insulin receptors, and has been chosen 
for a number of studies on these grounds (Ciechanover et al, 
1983; Jacobs and Cuatrecasas, 1986). The HepG2 line was thus a 
strong contender for the insulin binding studies presented in 
this chapter. Use of a permanent cultured human cell line was 
viewed as preferable to the use of isolated hepatocytes 
(Gammeltoft et al, 1978) or adipocytes (Kono, 1975), which can 
vary greatly from one preparation to another, and must for 
convenience be derived from rodent models more distantly related 
to the insulin source species. 
All receptor binding assays require, in addition to 
radioactively labelled ligand and a suitable source of 
receptors, a technique for the separation of bound and free 
ligand to be applied after each binding incubation. Separation 
techniques suitable for use with whole cells are limited; those 
applicable to cells in suspension include filtration (Levitzski, 
1985) and centrifugation (Gammeltoft et al, 1978; Assoian and 
Tager, 1981). In the case of attached cells in culture, 
separation simply necessitates removal of the assay medium 
followed by washing and solubilisation of the cell fraction 
(Ciechanover et al, 1983; Haring et al, 1984). Since HepG2 
cells grow adherent to the substratum, this last method was 
employed in the HepG2 binding assays reported here. 
Insulin binds to its receptor in a reversible bimolecular 
reaction with high rate constants, a proportion of the bound 
ligand dissociating intact from the receptor at the cell 
surface. The insulin-receptor complex is endocytosed in an 
energy-requiring step. This, or one of the subsequent 
intracellular steps, is rate limiting, giving rate constants for 
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overall insulin uptake about one order of magnitude lower than 
those for the ligand-receptor binding reaction on its own 
(Sonne, 1988)." Receptor binding assays designed to investigate 
the nature and kinetics of the bimolecular binding reaction in 
whole cells must, therefore, be conducted under conditions which 
inhibit endocytosis. The most convenient controlling parameter 
is temperature. Adsorptive endocytosis of insulin is known to 
be inhibited by temperatures below 16°C (Marshall, 1985). 
Accordingly, in the present work, prior to all binding 
procedures cells were washed to remove unbound extracellular 
insulin, incubated at 37°C for 1h in serum-free medium in order 
to clear the receptors of bound insulin, then cooled. Binding 
incubations were then set up in serum-free medium at 10°C. 
The joint principles underlying any assay of hormone-receptor 
binding are those of receptor saturability and receptor 
specificity (Roth, 1973; Cuatrecasas et al, 1975). In practice 
this means that the receptor binding of physiological levels of 
[1251 ] -labelled insulin (for example) reaches a point of 
equilibrium with both time and [125I ]insulin concentration, and 
can be inhibited in the presence of an excess of unlabelled 
insulin which has a high affinity for the receptor, but not by 
similar concentrations of other peptide hormones or other 
non-hormone proteins which have low affinities for the receptor. 
It is clear, therefore, that competitive inhibition provides a 
measure of specific receptor binding potential in the competitor 
species. In the work described in this chapter, preliminary 
experiments were carried out to establish the normal equilibrium 
characteristics of the binding of [125I _TyrA14] human insulin to 
HepG2 cells. Subsequently, the capacity of various unlabelled 
substances to compete with free [125 I _TyrA14] human insulin for 
receptor sites on HepG2 cells was investigated in order to (i) 
establish insulin-receptor binding specificity and (ii) measure 
the specific receptor binding capacities of insulin-albumin 
conjugates. 
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4.2 MATERIALS AND METHODS 
4.2. 1 MATERIALS 
HepG2 cells were a gift from Professor Gerry Coetzee, Department 
of Medical Biochemistry, University of Cape Town. Cell culture 
media were obtained from GibCo, Grand Island, New York, U.S.A., 
and sterile plasticware from Sterilin Ltd., Teddington, 
Middlesex, England. Human [125I _TyrA14] insulin (specific 
radioactivity 2000 Ci/mmol) was purchased from Amersham 
International, U.K. All other chemicals were of analytical 
grade. 
4 • 2 • 2 METHODS 
Growth and Maintenance of HepG2 Cells 
HepG2 cells were grown at 37°C in closed gas-tight flasks 
containing Eagle's minimal essential medium supplemented with 
10mM NaHC03 and buffered with 20mM 2-[4-(2-hydroxyethyl)-
1-piperazinyl]-ethanesulphonic acid-NaOH (Na-HEPES), pH 7.3 
(MEM) containing 10%v/v foetal calf serum (MEM+S). Cells at 
semi-confluence (4-7 days' growth) were trypsinised with a 
solution containing 0.25%w/v trypsin, 0.1%w/v EDTA, and the 
suspensions subcultured at 1/6 or 1/3 dilution. 
Protein Determination 
Protein was estimated quantitatively by the method of Lowry 
(1951) as mentioned in section 2.2.2. 
Receptor Binding Studies 
HepG2 cells were' heavily seeded (1/3 splits) into 35mm diameter 
well plates and grown to semi-confluence. Cells were washed 
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twice with MEM (no serum) at 37°C (2ml per well) then incubated 
at 37°C for 1h in the presence of a further 2ml MEM, which was 
subsequently removed. Plates were placed on ice and MEM at 5°C 
added (1ml per well) together with [125I ]insulin and unlabelled 
insulin or insulin conjugate as indicated in the figure legends. 
Additives were thoroughly mixed into the binding medium and 
plates incubated at 10°C. Cells were subsequently washed three 
times with cold phosphate buffered saline (PBS) (4ml per well) 
and drained. After addition of water (1ml per well), cells were 
loosened into suspension with a rubber policeman, 200~1 removed 
for protein determination, and the remainder fully dispersed by 
the addition of 1ml lysis buffer (0.5% SDS, 100mM NaCI, 40mM 
Tris-HCI, 20mM EDTA, pH 7.0) (Shih and Weinberg, 1982). The 
lysates were transferred to tubes for gamma counting. 
4.3 RESULTS 
Characteristics of the binding interaction between human 
[125I - TyrA14]insulin and HepG2 cells are shown in Figure 4.1. 
Figure 4.1A illustrates the time course of binding at 10°C. 
Binding took place rapidly for the first 2h, after which it 
slowed down, reaching a maximum at approximately 16h. Thus, for 
all subsequent binding experiments, incubation was for an 18h 
period at 10°C. The effect of insulin concentration on the 
binding response is presented in Figure 4.1B. The amount of 
insulin bound increased with insulin input, and at an insulin 
concentration of 0.8ng/ml, saturation of the receptor population 
in the system had not yet been reached. 
Results of experiments designed to measure binding competition 
between unlabelled substances and human [125I _TyrA14] insulin are 
shown in Figure 4.2. They demonstrate that porcine insulin and 
insulin-albumin conjugates derived from porcine insulin competed 
effectively with human insulin for receptor sites on HepG2 
cells. Binding resulting from the addition of 0.4ng human 
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Figure 4.1 Binding of human insulin to HepG2 insulin receptors 
Semi-confluent monolayers of HepG2 cells were grown and prepared 
for binding as described in Materials and Methods. 
A. Human[125I - TyrA14]insulin (2}J.I, 0.4ng, 2.36 X 105 cpm) was 
added to each well and the incubation period at 10°C 
varied. 
B. Variable amounts of human [125I _TyrA14] insulin were added to 
the wells and incubation at 10°C allowed to continue for 18 
hours. 
After incubation each well was processed as described in 
Materials and Methods. 
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[125I _TyrA14] insulin alone was reduced to 50% in the presence of 
SOng unlabelled porcine insulin (Figure 4.2A), 300ng unlabelled 
I-A and 200ng unlabelled I-[A-CDI] (Figure 4.2B). By contrast, 
albumin unconjugated to insulin did not compete for binding 
(Figure 4.2B). Furthermore, when I-[A-CDI] was prebound to DNA 
(pBR322), its receptor binding facility was not affected; the 
DNA itself had no affinity for the binding site (Figure 4.2C). 
4.4 SUMMARY AND DISCUSSION 
The binding of human insulin to HepG2 cells has been 
investigated in preliminary experiments (Figure 4.1), the 
results of which demonstrate the typical ligand-receptor binding 
characteristics of time-dependency (Figure 4.1A) and dependence 
upon ligand concentration (Figure 4.1B). Compe~itive 
displacement of human insulin by porcine insulin (Figure 4.2A) 
but not by albumin (Figure 4.2B) indicates that the binding 
reaction shown by insulin occurs specifically in relation 
to the insulin receptor and not at non-specific membrane binding 
sites. In the light of the non-competitive behaviour of 
albumin, the capacity of insulin-albumin conjugates to compete 
with human insulin (Figure 4.2B) demonstrates that the insulin 
constituents of the conjugates are capable of specific receptor 
recognition, and that the presence of N-acylurea substituents on 
the albumin component of I-[A-CDI] does not adversely affect 
conjugate- receptor binding affinity. Moreover, when I-[A-CDI] 
is allowed to form a complex with DNA prior to the cell binding 
incubation its receptor recognition facility is not impaired 
(Figure 4.2C). 
In an investigation into the internalisation and recycling of 
the asialoglycoprotein receptor in relation to the activities of 
the transferrin and insulin receptors in HepG2 cells, Lodish and 
his coworkers (Ciechanover et ai, 1983) have reported 
insulin-receptor binding characteristics which are fully 
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compatible with the results shown in Figure 4.1. The authors 
found that at 4°C binding was time-dependent, saturation of most 
surface sites being reached after 2h, and that binding was 
dependent on ['25I ] insulin concentration, being inhibited by an 
excess of unlabel l ed insulin but not 'bovine serum albumin. 
Their binding curves are of interest in that, using 35mm 
diameter culture dishes and cells grown to semi-confluence as in 
the present work, receptor saturation appears not to have been 
fully reached even at 200nM ['25I ]insulin (1140ng/ml). The 
apparent contrast between those results and the results in 
Figure 4.1 may possibly be explained by the fact that 
Ciechanover and colleagues iodinated their insulin "in house" 
and did not subject the reaction mixture to extensive 
purification. 
For the receptor b inding studies using the HepG2 cell line, 
Lodish's group used porcine insulin, while in the present work a 
combination of human and porcine insulins has been used. The 
structures of human and porcine insulins are almost identical; 
the only variation exists at position B30 which is occupied by 
threonine in the human, and alanine in the pig insulin (Smith, 
1972). As a result of the sequence homology, the two insulins 
show identical binding properties in relation to receptors from 
a particular source (Gammeltoft, 1984). 
The ability of insulin-albumin conjugates to bind insulin 
receptors as shown by competitive displacement of ['25I ]insulin 
(Figure 4.2B) is rather marked. Only 300ng unlabelled I-A or 
200ng unlabelled I-[A-CDIJ is required to bring about the same 
degree of binding inhibition (50%) incurred by SOng unlabelled 
insulin. While t h e molecular weight range of the conjugates is 
not known with any precision, it is certain that it is in the 
region of several hundred thousand (section 2.4), many times the 
molecular weight of monomeric insulin (5700), the reactive form 
of insulin under assay conditions. It would appear, therefore, 
that the affinity of conjugated insulin-albumin for the insulin 
receptor is greater (Kd value lower) than that of insulin itself 
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by an order of magnitude. 
A similar phenomenon has been noted by several laboratories 
concerned with measuring the biological effects of 
macromolecular insulin derivatives. Cuatrecasas (1969) showed 
that when insulin is covalently attached to the insoluble 
polymer Sepharose, its action on isolated fat cells is 
amplified, and Suzuki and colleagues (1972) reported that a 
soluble purified form of insulin-dextran complex is more active 
than insulin itself both in vivo and in vitro. In both those 
investigations, evidence based on polymer size was provided to 
support the idea that the insulin conjugates remained exterior 
to the cell, and it was argued that the binding event at the 
receptor site alone, disassociated from any process of insulin 
translocation across the membrane, provided the stimulus for the 
hormone-induced biochemical responses observed. In a later 
study, Oka and Topper (1974.) coined the epithet "super-active" 
for a soluble form of insulin, released from insulin-Sepharose 
in the presence of bovine serum albumin, which stimulates 
various insulin-induced biochemical processes in murine mammary 
tissue and cells five times more effectively than native 
insulin. The structure of the "super-active" insulin was 
revealed in a later study by the same group (Wilchek et al, 
1975). The insulin-Sepharose had been synthesised by cyanogen 
bromide activation of the Sepharose followed by coupling via an 
amino group on the insulin molecule. On the basis of work with 
model compounds, such conjugates were shown to be 
O-Sepharose-N-substituted isoureas capable of further 
nucleophilic attack by amino groups to give soluble 
N-N'-disubstituted guanidines unattached to the Sepharose. The 
"super-active" insulin was postulated to be a guanidine 
derivative of this kind in which insulin and albumin are the 
substituents: a small conjugate relative to the 
insulin-Sepharose, quite able to enter cells through the 
membrane. The authors point out that their elucidation of the 
chemistry of insulin derivatives of this nature might 
necessitate reexamination of the interpretation previously 
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placed on results obtained with peptide hormone-Sepharose 
conjugates. The conjugates used by Cuatrecasas (1969), for 
example, were "also synthesised by cyanogen bromide activation of 
Sepharose and therefore could have undergone the reactions 
described by Wilchek's group in the presence of cell buffering 
media containing BSA or other proteins. 
Wilchek and coauthors state that the role of the disubstituted 
guanidine residue in conferring super-activity on a hormone such 
as insulin is unknown. The apparent functional similarity 
between their guanidine-linked conjugates and the 
glutaraldehyde-linked conjugates used in the present work 
suggests that the linking structures themselves might be of 
minor significance. It is possible, rather, that some aspect of 
insulin structure altered by the conjugation process is 
responsible for the enhanced activity. 
Certain insulins modified at particular amino acid residues have 
been shown to display increased binding affinities, and the 
results of studies conducted on these compounds allow 
considerable insight into the structure-function relationships 
involved in binding affinity variations. Compared with 
unmodified insulin, monoiodo[TyrB26 ]insulin demonstrates 200% and 
[D-PheB24 ]insulin 180% increased receptor affinity. In the case 
of monoiodo[TyrB26 ]insulin the raised affinity (lowered K
d
) is 
explained by an increase in the rate of association (Sonne et 
al, 1983) while in the case of [D-PheB24 ]insulin a decrease in 
the rate of dissociation occurs (Kobayashi et al, 1982). In a 
manner similar to the latter, chicken insulin shows a decrease 
in the rate of dissociation from human insulin receptors and is 
thus seen to display enhanced binding (Simon et al, 1977). 
Altered binding affinities such as these may have fairly simple 
causes. In the cases of the modified Phe~4 and Tyr~6 residues, 
which are part of the receptor binding region (Figure 1.4), the 
minor changes in structure clearly have direct implications in 
the binding interaction, possibly in the hydrophobic behaviour 
of the cluster of B chain residues involved. In chicken 
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insulin, a histidine is present at the A8 position, just outside 
the receptor binding region, which in bovine and porcine 
insulins is oc·cupied by alanine and in human insulin by 
threonine (Smith, 1972). Histidine, having a larger side group 
than alanine or threonine, may form stabilising interactions 
with amino acid residues in. the receptor or induce minor 
rearrangements of residues in the receptor binding region of the 
ligand (Pullen et ai, 1976), thereby inducing an alteration in 
binding affinity. Like chicken insulin, a number of fish 
insulins are characterised by HisA8 (Gammeltoft, 1984). In 
discussing the biological activity of Atlantic hagfish insulin 
in relation to structure, Cutfield and coworkers (1979) make the 
notable point that a change in Kd by a factor of 2 or 3 
corresponds to only a small difference in standard free energy 
(~GO): of the order of 1 - 2 kcal/mol. A shift of this 
magnitude may be due to a difference of just a few hydrogen 
bonds in the insulin-receptor binding reaction, and could result 
from minor conformational changes. 
It was reasoned previously (section 2.4) that glutaraldehyde 
linkage of insulin to another protein probably occurs through 
the insulin Lys~9 residue, which is not within the deduced 
receptor binding site but is quite close to it (Figure 1.4), and 
it was argued that such a linkage would be unlikely to interfere 
with receptor binding. Results shown in Figure 4.2 support the 
concept of linkage outside the binding site, but do suggest that 
indirect modifications might have been induced at the binding 
site itself. Such rearrangements, if they do exist, might be 
analogous to those thought to be induced by the HisA8 residues 
of chicken and fish insulins, since the B29 and A8 amino acids 
occupy positions similarly close to the periphery of the binding 
site (Figure 1.4). 
The work presented in this chapter is largely concerned with 
establishing the qualitative nature of the binding response 
between insulin-albumin conjugates and HepG2 cells, not wi t h 
precise measurement of binding coefficients. As Sonne (1988) 
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has emphasised, kinetic values obtained from experiments 
performed at low temperature to inhibit endocytosis are valid 
only for that -temperature: binding of insulin to IM-9 
lymphocytes in which receptor-linked endocytosis is absent has 
been shown to be markedly temperature dependent (Waelbroeck et 
al, 1979), and comparable temperature effects have been 
demonstrated in fat cells and liver cells (Gammeltoft, 1984). 
Binding affinity is higher at lower temperatures. It is clear, 
therefore, that conjugate-receptor binding as observed at 10°C 
(Figure 4.2) is not going to be quantitatively the same under 
transfection conditions at 37°C (Chapter 5); there is likely to 
be a shift towards lower affinity (higher Kd values). 
Nevertheless, the assumption is made here that the binding 
responses of insulin and its conjugates to HepG2 cell receptors 
bear similar relationships to one another regardless of 
temperature, and that the general effects illustrated in Figure 
4.2 hold true at 37°C. 
In the experiment designed to investigate binding of the 
I-[A-CDI]-DNA complex to the receptor (results shown in Figure 
4.2C) a situation existed which, it was clear, would be 
encountered again later in transfection work (Chapter 5): that 
of a disparity between optimal conditions for conjugate-DNA 
binding (simple salt buffer; ionic strength, 50mM or less; 
osmolality <100 mmol/kg) and suitably protective conditions for 
conjugate-cell receptor binding (complex cell culture medium; 
osmolality, 298 mmol/kg). The experimental procedure is 
described in the legend to Figure 4.2C. The I-[A-CDI] conjugate 
was prebound to pBR322 DNA under precisely controlled buffer 
conditions designed to give a final concentration of 50mM NaCI 
and a final pH of 6.5. The complex was then added to MEM as 
part of the regular receptor binding protocol. On account of 
its composition, MEM was thought likely to cause an equilibrium 
shift towards dissociation of DNA from the I-[A-CDI] in a manner 
similar to Na+ as illustrated in Figure 3.5, thus reducing the 
proportion of DNA bound to N-acylurea protein at the time of 
receptor binding. Nitrocellulose filter binding assays 
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indicated that this was indeed the case, the amount of DNA bound 
to I-[A-CDIJ in bu ffer being somewhat reduced on MEM addition in 
the appropriat"e proportions (results not shown). However, on 
the basis that the transfection procedure involves the use of 
MEM medium and closely parallels the receptor binding protocol, 
the results presented in Figure 4.2C do validly demonstrate that 
DNA does not interfere with I-[A-CDI]-receptor binding under the 
proposed transfection conditions. 
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CHAPTER FIVE 
INSULIN [N ACYL UREA ALBUMIN) MEDIATED GENE TRANSFER TO HepG2 
CELLS AND SUBSEOUENT EXPRESSION 
~ INTRODUCTION 
The reporter gene chosen for testing the ability of 
insulin-[N-acylurea albumin] to mediate transfection in HepG2 
cells was the stable dominant marker neo (Colbere-Garapin et ai, 
1981), which can be detected by means of the selective growth of 
recipient cells in medium containing G418 at a concentration 
lethal to normal cells (section 1.2.1). 
The compound G418 is one of a large family of aminoglycoside-
aminocyclitol antibiotics characterised by the cyclitol 
2-deoxystreptamine. This group includes the neomycins, in which 
the cyclitol is 4,5-disubstituted, as well as the kanamycins, 
gentamicins and tobramycin, in which the cyclitol is 
4,6-disubstituted. G418 belongs to the latter class, and is 
structurally most closely related to the gentamicins, a large, 
extremely important group of antibiotic compounds produced by 
strains of the actinomycete genus Micromonospora (Hooper, 1982). 
The commercial material termed gentamicin consists primarily of 
gentamicins C" C2 and C'a' products of Micromonospora purpurea, 
first reported by Weinstein et al (1964), the structures of 
which were elucidated later by workers of the Schering 
Corporation (Cooper et ai, 1971). Several naturally occurring 
minor components of the gentamicin complex obtained by the 
fermentation of M. purpurea and other closely related cultures 
have been isolated and characterised, including the gentamicin A 
group (Maehr and Schaffner, 1967), gentamicins Band B" 
gentamicin X2 ' and the antibiotic G418 (Wagman et ai, 1972; 
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Berdy et al, 1977). structural analysis of G418 was 
accomplished by the Scheri ng Corporation research group (Daniels 
et al, 1973) . . The structural characteristics of G418 in 
relation to other important gentamicin-like compounds are 
provided in Figure 5.1. 
All the aminoglycoside antibiotics are active against a range of 
prokaryotic organisms. They interfere with ribosome function, 
and are usually bactericidal, although a few are merely 
bacteriostatic (Tanaka, 1982). In addition to their action on 
bacterial protein synthesis, a small number affect certain 
eukaryotic organisms in a similar manner by interacting with 
mitochondrial ribosomes (Kurtz, 1974), which have architectural 
and functional features in common with the prokaryote ribosome 
(Margulis, 1974). The aminoglycoside antibiotics which promote 
eukaryotic translation errors in this way include paromomycin, 
lividomycin B, hygromycin B, as well as the 2-deoxystreptamine 
antibiotics kanamycins Band C (Wilhelm et al, 1978a,bi Singh et 
al, 1979) and G418 (Jimenez and Davies, 1980). The antibiotic 
G418 has a particularly broad spectrum of activity in both 
prokaryotes and eUkaryotes: it is an extremely potent inhibitor 
of protein synthesis in cell-free extracts of bacterial, fungal, 
algal, plant and animal cells (S. Perzynski, unpublished 
observations, quoted in Jimenez and Davies, 1980). Perzynski's 
results are of especial interest in that they infer the ability 
of G418 to act on cytoplasmic as well as organellar ribosomes. 
The most common form of resistance to aminoglycoside antibiotics 
is provided by plasmid-encoded modifying enzymes which may be 
classified according to mode of action (N-acetylation, 
O-nucleotidylation or O-phosphorylation) and site of action on 
the antibiotic. In this manner twelve major classes of enzyme 
have been recognised. They have been tabulated by Davies and 
Smith (1978) and Umezawa and Kondo (1982), the latter authors 
emphasising the further class subdivisions which have been made 
in some cases to indicate diverse substrate specificity. A 
summary of the basic classification scheme is provided in Table 
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5.1, and the example of class subdivision most relevant to the 
present work shown in Table 5.2. Table 5.1 illustrates that 
deoxystreptamine aminoglycosides are variously subject to 
modification by all three major classes of N-acetyltransferases 
(AAC), two out of four classes of O-nucleotidyltransferases 
(AAD), and two out of five classes of O-phosphotransferases 
(APH). Enzymes of the APH class, the APH(3') group, are the 
ones encoded by neo sequences. The site of phosphorylation of 
this class of enzyme is the 3'-hydroxyl of the 4,-substituent 
amino-hexo- or hepto- pyranose (Table 5.1; Figure 5.1). The 
APH(3') enzymes are therefore capable of transferring phosphate 
groups to kanamycins, neomycins, and other 2-deoxystreptamine 
antibiotics having hydroxyl groups at the 3' position and were 
originally called neomycin-kanamycin phosphotransferases 
(Umezawa, 1974), hence the designation neo for the corresponding 
genes. These same enzymes are now termed aminoglycoside 
3'-phosphotransferases (Umezawa and Kondo, 1982). As shown in 
Figure 5.1, the antibiotic G418 is characterised by a 
3'-hydroxyl group and, as shown in Table 5.2, is susceptible to 
phosphorylation by APH(3') enzymes. 
Aminoglycoside 3'-phosphotransferase enzymes are of three types, 
reflecting minor differences in substrate specificity: APH(3')I, 
APH(3')II and APH(3')III (Table 5.2). Types I and II are both 
capable of phosphorylating the antibiotic G418. APH(3')I is 
found in many different bacterial genera, representing both Gram 
positive and Gram negative types (Davies and Smith, 1978). It 
appears to exist in a number of forms which demonstrate 
variations in molecular weight, pH optimum and K; according to 
source (Matsuhashi et al, 1975). In some organisms the enzyme 
is encoded on a transposable element rather than a plasmid. It 
was APH(3')I from the transposon Tn601(903) (Davies et al, 1977) 
which was used to demonstrate the potential of the neo selection 
system in eukaryotes for the first time: sphaeroplasts of 
Saccharomyces cerevisiae were transformed with a plasmid 
carrying the transposon and screened for the expression of the 
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c=J = variant moieties within related groups 
Figure 5.1 The structure of the antibiotic G418 in relation to 
the gentamicin family of 4,6-disubstituted 2-deoxystreptamine 
aminoglycoside antibiotics (after Okuda and Ito, 1982, and 
Hooper, 1982). 
Trade name of G418: Geneticin 
Full chemical name of G418: 0-2-Amino-2,7-dideoxy-D-glycero-a-D-
glucoheptopyranosyl [1-4] [-O-3-deoxy-4C-methyl-3-[methylamino] -
B-L- arabinopyranosyl]-D-streptamine. 
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Table 5.1 Classes of aminoglycoside-modifying enzymes (after 
Davies and Smith, 1978). 
AS I and II = amino sugars as shown in Figure 5.1 
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SITE OF MODIFICATION 
3-NH2 on deoxystreptamine 
2'-NH2 on AS I of 
deoxystreptamine AGs 
6'-NH2 on AS I of 
deoxystreptamine AGs 
6-0H on streptidine ring 
of streptomycin 
4'-OH on AS I of 
deoxystreptamine AGs 
2"-OH on AS II of 
deoxystreptamine AGs 
3"(9)-O-nucleotidyl- AAD(3")(9) 3"-OH on AS II of streptomycin 





5"-O-phospho- APH (5") 
of spectinomycin 
6-0H on streptidine ring 
of streptomycin 
3'-OH on AS I of 
deoxystreptamine AGs 
2"-OH on AS II of 
deoxystreptamine AGs 
3"-OH on AS II of 
streptomycin 
5"-OH on ribose of 
ribostamycin 
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Table 5.2 Substrate specificities of aminoglycoside 
3'-phosphotransferases (After Umezawa and Kondo, 1982; 
additional information from Colbere-Garapin et al, 1981). 
ENZYME KNOWN SUBSTRATES 
APH(3' )1 KM, KM-B, NM, PM, RM, G418, 
LV( 5"-OH) . 
APH(3' )11 KM, KM-B, NM, PM, RM, G418, 
BT. 
APH(3')III KM, KM-B, RM, BT, LV(5"-OH). 
Abbreviations: KM, kanamycin; NM, neomycin; PM, paromomycin; 
RM, ribostamycin; LV, lividomycin; BT, butirosin. 
Both APH(3')I and II are able to phosphorylate the 3'-OH of 
kanamycin, kanamycin B, neomycin, paromomycin, ribostamycin and 
G418. The contrast in substrate specificity lies in the fact 
that APH(3')I can phosphorylate the 5"-OH group of the 
lividomycins but not the 3'-OH of the butirosins (which have a 
4-amino-2-hydroxybutyryl group as a substituent on the 1-amino), 
while APH(3')II shows the reverse characteristic. No 
information could be found on the susceptibility of gentamicins 
A series, B series and X2 to APH(3') enzymes. 
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(Jimenez and Davies, 1980). In contrast with APH(3')I, 
APH(3')II occurs less widely, but has been detected in at least 
eight bacterial genera and there is evidence to suggest that, 
regardless of source, only one form of the enzyme exists 
(Matsuhashi et al, 1975). It has a molecular weight of 27,000 
(Matsuhashi et al, 1976), a Km for ATP of 24 ± 4~M and a Km for 
neomycin B of 3.9~M (Davies and Smith, 1978). Jorgensen (1979) 
discovered that a neo sequence coding for APH(3')II is carried 
on the transposable element Tn5, and it was the gene from this 
source, in a fragment defined by Rothstein et al (1980), which 
was used by Garapin's group (Colbere-Garapin et al, 1981) in the 
first assay of neo expression in mammalian cells. Garapin and 
coworkers set an important precedent in developing the APH(3')II 
mammalian expression assay, for it constitutes the basis of an 
enormous number of transfection studies undertaken in the past 
eight years, including those reported in this thesis. 
For the gene transfer work described in this chapter, two 
expression vectors were employed, each incorporating neo from 
Tn5. The principles of construction of the two vectors, ptkNEO 
and pAL-8, are outlined in Figures 5.2 and 5.3 respectively. 
Each carries a pBR322 sequence which includes the origin of 
bacterial replication and the ampicillin resistance (ampR) gene 
to facilitate selective growth of plasmid-containing cells 
during preparative plasmid production in a host bacterium 
(section 1.2.1). The essential difference between the two 
vectors lies in the nature of the eukaryotic regulatory 
sequences introduced into the constructs on either side of neo. 
The ptkNEO vector contains control regions taken from the herpes 
simplex virus Type 1 (HSV1) thymidine kinase (tk) gene (Wagner 
et al, 1981), while pAL-8 incorporates control sequences from 
simian virus 40 (SV40) (Reddy et al, 1978; Laimins et al, 1982). 
An additional difference between the two vectors, which makes a 
considerable distinction in terms of size, but little functional 
difference in the context of the experiments conducted here, is 
that the vector pAL-8 carries a further insert, a 6.6kb sequence 











CATATTAA ('TATA ' box) 
pBR322 ampR and ori sequence 
NEO from Tn5 
HSV 1 thymidine kinase 
regulatory regions 
Figure 5.2 Construction of the e xpression vector ptkNEO 
(Barbara Wold) 
The ful l sequence is provided in Appendix I. 
sequence base position size 
PvuII*-BamHI pBR322 ampR and ori 1-2653 (2653bp) 
BamHI-BgllI HSV1 tk 5' proximal to neo 2654-3117 (464bp) 
BglII-SalI Tn5 neo 3118-4287 (1170bp) 
SmaI*-PvuII HSV1 tk 3' proximal to neo 4288-4913 (626bp) 











pBR322 ampR and ori sequence 
NEO from Tn5 
SV40 early promoter regions 
6.6 kb pT24-C3 insert (ras) 
Figure 5.3 Construction of the expression vector pAL- 8 
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The HSV1 tk gene regulatory regions employed in the ptkNEO 
vector (Figure 5.2) are utilised in much the same fashion as in 
the naturally occurring tk gene itself, as elucidated by Wagner 
and coworkers (1981) in a major analysis of the tk nucleotide 
sequence. In a position 5' proximal to neD is inserted a 463bp 
BamHI/BgIII fragment from upstream of the tk open reading frame 
(ORF) which includes a Goldberg-Hogness-like "TATA" box 
(CATATTAA), the first base pair of which determines the 
beginning of mRNA production 31 nucleotides further along the 
sequence. In addition, 44 nucleotides prior to the "TATA" box 
(85 nucleotides prior to the start of the mRNA) , is a sequence 
(GGCGAATTC) of probable regulatory significance, similar to one 
noted by Benoist et al (1980) to be conserved in many eukaryotic 
genes. While the mRNA start position lies within the tk insert, 
the first ATG indicating the mRNA AUG codon for the initiation 
of translation is within the neD sequence itself. At the other 
end of neD (3' proximal) is inserted a 620bp SalI/PvuII sequence 
from downstream Df the tk ORF. This includes, close to the 
beginning, thus almost immediately following the neD sequence, 
the translation termination codon TGA (mRNA, UGA) , followed by 
two identical short sequences (AATAAA), 48 and 61 nucleotides 
beyond the TGA respectively. These hexanucleotide regions 
constitute examples of the polyadenylation signal common to all 
polyadenylated mRNAs, occurring 1-4-30 nucleotides prior to the 
beginning of the poly(A) tail (Proudfoot and Brownlee, 1976). 
The SV40 regulatory sequences employed in the construction of 
pAL-8 (Figure 5.3) appear to be much the same as those used in 
the classical pSV2 vectors (Gorman, 1985) (section 1.2.1). 
Upstream of neD is the 323bp PvuII/HindIII fragment of the SV40 
early region promoter which includes a 72bp repeated enhancer 
(Gruss et al, 1981; Laimins et al, 1982), a"TATA" box (Ghosh et 
al, 1981), the SV40 origin of replication and the site for the 
start of transcription (Laimins et al, 1982). Downstream of neD 
is a larger fragment of the SV40 genome which terminates at a 
BamHI site and thus very probably parallels the sequence 
utilised in a similar position in pSV2 constructs. This 
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incorporates a splice donor-acceptor sequence in the form of the 
small t-antigen intron, followed by polyadenylation signals 
(Gorman, 1985)". A more precise analysis of the region 
downstream from neo is not possible at the present time as a 
detailed map of the pAL-8 construct has not been made available 
from source. Information concerning the SV40 region inserted 
between the pBR322 sequence and ras is sparse for the same 
reason. 
Prior to their use in transfection of HepG2 cells, it was 
necessary that both ptkNEO and pAL-8 be replicated in and 
harvested from a suitable host bacterium. The host chosen for 
this purpose was Escherichia coli strain HB101, a hybrid 
resulting from a cross between E. coli K-12 and E. coli B, 
commonly used as a plasmid recipient via transformation and 
regarded as a favourable host for large-scale plasmid production 
(Bolivar and Backman, 1979). Its genotype is ~, leu-, thi-, 
hsdS20 (rB-, mB-), recA13, ara-14, proA2, lacY1, galK2, rpsL20 
(Smr ), xyl-5, mtl-1, supE44, A- (Bolivar and Backman, 1979; 
Maniatis, 1982). 
The effective transfer of a ptkNEO or pAL-8 vector during the 
transfection procedure and subsequent stable expression of the 
neo gene in recipient HepG2 cells was seen to be observable in 
two ways. Firstly, and primarily, by long term phenotypic 
selection leading to the demonstration of cell survival during a 
period of G418 treatment shown to be inimical and ultimately 
lethal to the untransfected cell line. Secondly, genotypically, 
by the identification of the neo gene sequence in DNA extracted 
from stably G418-resistant cell populations derived from 
transfected cell cultures. Clearly, the second of these 
approaches requires a positive result in the first, and is 
therefore by its very nature corroborative. In the event of 
positive selection of G418 resistance, it was planned to follow 
this second approach by employing the Southern blotting 
technique (Southern, 1975), in which electrophoretically 
size-fractionated DNA is transferred from an agarose gel matrix 
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to a solid membrane support, and subsequently hybridised to a 
labelled DNA probe comprising the sequence of interest. The 
Southern blotting and hybridisation method, capable of the 
identification of single copy gene insertions, has been 
described as "one of the most powerful tools of molecular 
biology" (Wahl et al, 1987). Its extreme sensitivity and 
specificity at the DNA sequence level was regarded as 
particularly significant in the context of using the neo-G418 
system to detect transfection: positive results would provide 
definitive, molecular proof of gene transfer events otherwise 
only phenotypically inferred. 
5.2 MATERIALS AND METHODS 
5.2.1 MATERIALS 
The expression vector ptkNEO, constructed by Dr Barbara Wold of 
the Biology Division, California Institute of Technology, was 
supplied by Dr Shirley Taylor of the same institution. The 
expression vector pAL-8 was a gift from Professor Peter Jones, 
Comprehensive Cancer Center, University of Southern California 
School of Medicine. Escherichia coli strain HB101 was supplied 
by Professor Dave Woods, Microbial Genetics Research Unit, 
Department of Microbiology, University of Cape Town. 
Bacteriological culture media and ingredients were purchased 
from Difco Laboratories, Detroit, Michigan, U.S.A., cell culture 
media from GibCo, Grand Island, New York, U.S.A., and sterile 
plasticware from Sterilin Ltd., Teddington, Middlesex, England. 
Filter sterilisation units were from Millipore Corporation, 
Bedford, Mass, U.S.A. DNA polymerase I (EC 2.7.7.7) Klenow 
fragment, restriction endonucleases, A DNA and plasmid pBR322 
were obtained from Boehringer Mannheim GmbH, Penzberg, Western 
Germany. Lysozyme (EC 3.2.1.17) (Product Code No. L-6876), 
ethidium bromide (Product Code No. E-8751), ampicillin (Product 
Code No. A-9518), chloramphenicol (Product Code No. C-0378), 
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Geneticin (G418) (Product Code No. G-5013), polyvinylpyrrolidone 
(average mol.wt. 360000) (Product Code No. P-5288), dextran 
sulphate (average mol.wt. 500000) (Product Code No. 0-8906) and 
ficoll (average mol.wt. 400000) (Product Code No. F-4375) were 
from the Sigma Chemical Co., st. Louis, Mo. U.S.A. Thymidine 
5'_[a_32p] triphosphate (specific radioactivity 3000 Ci/mmol), 
Hybond C-extra nitrocellulose blotting membrane and Hyper-film 
MP X-ray film were obtained from Amersham International, U.K. 
X-ray film developer (G150c) and rapid X-ray film fixer (G334c) 
were purchased from Agfa-Gevaert, Durban, R.S.A. Proteinase K 
(Code 24568) and caesium chloride (Code 2039) were obtained from 
Merck, Darmstadt, Federal Republic of Germany. Agarose (ultra 
pure grade and low melting temperature grade) was obtained from 
BioRad Laboratories, Richmond, Ca, U.S.A. Sephadex G-50 was 
from Pharmacia Fine Chemicals, Uppsala, Sweden. All other 
reagents were of analytical grade. 
5 • 2 • 2 METHODS 
Maintenance of HepG2 Cells 
HepG2 cells were grown and maintained as described in section 
4.2.2. 
Generation of Expres'sion vectors 
The expression vector plasmids ptkNEO and pAL-8 were each 
propagated in Escherichia coli strain HB101. Initial 
transformation was achieved using a simple calcium method 
(Harley et ai, 1982) (section 1.1.2) and stocks of the 
respectively transformed host strain kept on ampicillin media as 
both anaerobic stab cultures and frozen glycerol-broth cultures. 
Large scale plasmid production followed conventional protocols 
(Maniatis et ai, 1982) involving growth of the host to the late 
logarithmic phase in 650-1000ml volumes of aerated broth 
containing ampicillin (50~g/ml), followed by amplification of 
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the plasmid under the influence of chloramphenicol (170~g/ml) 
over a period of 1 6-18h, and subsequent harvesting of cells by 
refrigerated centr ifugation at 4000Xg for 10min. Extraction of 
plasmids was by the boiling method of Holmes and Quigley (1981) 
or the cleared lysate method of Katz et al (1973), and 
purification was by centrifugation in caesium chloride-ethidium 
bromide (CsCl-EB) density gradients (Radloff et al, 1967). The 
CsCl-EB-ONA solutions (refractive index, ~ = 1.3860) were set up 
in open-topped ni t rocellulose tubes, sealed with liquid 
paraffin, and cent rifuged in a SW50 rotor at 40,000rpm for 40h 
at 20°C in a Beckman L5-65 ultracentrifuge. Plasmid bands were 
removed manually under UV illumination using drawn out pasteur 
pipettes inserted from the top of the tube. Removal of EB from 
the plasmid fractions was accomplished by several extractions 
with water-saturat ed redistilled n-butanol; final traces of 
butanol were removed by an ether extraction. The plasmid 
solutions were subsequently dialysed exhaustively at 4°C against 
TE buffer (10mM Tris-HC1, 1mM EOTA, pH 7.5). The final 
preparations were stored over chloroform (5%v/v) at -15°C. 
00260/00280 values: 1.68 - 1.82. Yields: 900 - 950~g per 1000ml 
original culture. 
Analysis and Quantification of DNA 
Spectral analysis of ONA was accomplished using either a Beckman 
24 or a Philips PU8700 series spectrophotometer in the UV range 
220-320nm. Estimations of purity were made by comparing 
00260/00280 ratios to the protein-free ideal (1.8), and 
concentrations calculated by applying the relationship: 00 of 
1.0 = 50~g double-stranded ONA/ml (Maniatis et al, 1982). 
Agarose Gel Electrophoresis of Plasmid vectors 
Plasmids and restr iction digests of plasmids were analysed by 
separation in 1.2%w/v agarose gels at neutral pH. A BioRad Mini 
Sub ONA cell system was used: gel dimensions 100 X 65 X 3mm. 
Gels were made and run in buffer containing 36mM Tris-HC1, 30mM 
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sodium phosphate and 10mM EDTA (final pH 7.5). Each well sample 
contained 0.4-0.6~g (2-7~1) DNA. Prior to gel application, 
samples consisting of linear restriction fragments were heated 
to 65°C for 10min , cooled on ice, then mixed with 1/3 the sample 
volume of loading buffer (50%w/v sucrose, 4M urea, 0.1%w/v 
bromophenol blue, 50mM EDTA, pH 7.5). Unrestricted plasmid 
I 
samples were mixed with loading buffer without prior heat 
treatment. Electrophoresis was at 40-50V for 2-3h. Preparative 
electrophoresis for the separation and excision of restriction 
fragments for subsequent labelling as probes was performed in a 
similar manner on gels of low melting temperature agarose. 
Visualisation of DNA Gels 
Immediately following electrophoresis, DNA gels were stained in 
a dilute solution of ethidium bromide (0.5~g/ml; 15min), 
destained briefly in running water (±2 min), then viewed by 
transmitted UV light at 300nm wavelength. Ultraviolet 
illuminated gels were photographed using Kodak Tri-X Pan black 
and white film (ASA 400) in a single lens reflex camera fitted 
with a 55mm close-up lens and a red filter (exposure: f11, 20 -
35sec). 
Labelling of neo Probe 
A 923bp PstI fragment of ptkNEO representing the majority of the 
neo gene sequence and no extraneous sequences (Figure 5.5) was 
labelled with thymidjne 5'-[a-~P] triphosphate by the method of 
Feinberg and Vogelstein (1983) in which the denatured DNA is 
allowed to anneal in the presence of random hexanucleotide 
primers and polymerise under the influence of the DNA polymerase 
I (Klenow) enzyme. The desired plasmid sequence was excised 
from an EB-stained electrophoretic gel of low melting 
temperature agarose, water added (3~1/mg gel), and the sample 
boiled for 7 minutes immediately prior to use in the labelling 
reaction (Feinberg and Vogelstein, 1984). The reaction product 
was subjected to spun column purification using Sephadex G-50 
159 
(Maniatis et ai, 1982) then stored at -1SoC. Specific activity 
was 6.0 X 108 - 2.2 X 109 cpm/~g TCA-precipitated DNA. 
Transfection Procedure 
HepG2 cells were heavily seeded (1/3 splits) in 2Scm2 flasks and 
grown to semi-confluence. Cells were washed three times with 
4ml MEM (no serum), then incubated at 37°C for 1h in the 
presence of a further 4ml MEM, which was subsequently removed. 
Flasks were placed on ice and 2ml MEM at SoC added together with 
I-[A-CDI] or control protein as indicated in the legend to 
Figure S.7. After overnight incubation at 10°C, flasks were 
again placed on ice, the medium removed, and 1ml MEM at SoC 
added together with expression vector as indicated. Flasks were 
transferred from ice to incubation at 10°C (30min), 20°C 
(30min), then 37°C (S.Oh). At this stage 3ml MEM+S (plus serum) 
was added and incubation continued for 24h. Flasks were 
trypsinised and duplicate subcultures established containing 106 
cells per flask. Growth was continued for a further 24h before 
the first addition of G418. 
stable HepG2 Expression of neo: G418 Selection 
Following the trypsinisation of post-transfection cells, G418 
stock solution (24mg total antibiotic/ml H20 adjusted to pH 7.4 
with NaOH and filter sterilised) was added to the medium to give 
a final concentration of 1200~g/ml (active drug content = 
approximately SO% of this) and incubation continued for S days, 
after which the medium was changed and fresh G418 added at a 
final concentration of 600~g/ml. Medium changes were effected 
at approximately S day intervals thereafter, the G418 level 
being lowered further to and maintained at SOO~g/ml. Following 
the unambiguous appearance of resistant clones (14-21 days) and 
the death of most non-resistant cells (21-28 days), one set of 
flasks was stained for the recording of clone distribution. 
Surviving cells in the other set were trypsinised for subculture 
and propagation in a G418 maintenance regime and ultimately 
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subjected to DNA extraction. 
Photomicrography of Cells and Clones 
HepG2 cells were photographed in situ using Ilford FP4 black and 
white film (ASA 125) in a Nikon F301 single lens reflex camera 
body attached to a Nikon TMS inverted microscope. Cells were 
photographed under phase contrast illumination in the presence 
of a green filter using a X10 objective. At maximum light 
intensity under these conditions an exposure of 1 or 2 seconds 
was required. 
Macroscopic Visualisation of Clones 
Flasks containing clones to be stained were treated as follows: 
medium was removed, cells rinsed twice with PBS (5ml), fixed 
with redistilled methanol (5ml, 2min), stained with a 1/10 
aqueous dilution of standard Giemsa (5ml, 2-5min), then rinsed 
generously with water several times. Flasks were drained and 
air-dried. Stained flasks were photographed in a conventional 
manner under a combination of incident and transmitted white 
light using high contrast black and white film, usually Kodak 
technical pan 2415. 
Extraction of Genomic DNA from HepG2 Cells 
DNA extraction was by a modification of the method of Shih and 
Weinberg (1982). Duplicate 75cm2 flasks of cells were used for 
each DNA preparation. Each culture flask was decanted, washed 
twice with 15ml cold PBS, drained, and then gently agitated for 
10min in the presence of 3ml lysis buffer (0.5% SDS, 100mM NaCl, 
40mM Tris-HC1, 20mM EDTA, pH 7.0). Proteinase K (O.Sml, 2mg/ml, 
freshly prepared) was added to the total pooled lysate (6ml) to 
give a final enzyme concentration of 15S~g/ml, and the digestion 
mixture incubated at 37°C for 3.Sh. The DNA solution was then 
deproteinised by means of one 90% (aqueous) phenol extraction 
followed by two chloroform: isoamylalcohol (24:1v/v) 
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extractions. DNA was subsequently ethanol precipitated, spooled 
out on a glass rod, and dissolved overnight in 1ml 0.1SSC at 
5°C. Final DNA solutions were dialysed exhaustively against 
0.1SSC at 5°C then stored at -15°C. OD260/0D280 ratios: 1.73 -
1.93. Yields: 113 - 544~g per extraction (150cm2 area of almost 
confluent cells). 
Detection of the Stabilised neo Sequence in Transfected HepG2 
Genomic DNA 
This was carried out by blotting and hybridisation essentially 
according to Southern (1975). Genomic DNA samples as indicated 
in the legend to Figure 5.8 were separated in 0.9 - 1.2% agarose 
gels at neutral pH using either a BioRad Mini Sub DNA cell 
system (gel size 100 X 65 X 3mm; electrophoresis at 40-50V for 
2-3h) or a water-cooled FMC Resolute chamber (gel size 200 X 150 
X 6mm; electrophoresis at 40V for 10h). Loading and running 
buffers were used as described earlier in this section for 
plasmid gels. Immediately following electrophoresis, gels were 
denatured without prior depurination (1.5M NaCl, 0.5M NaOH) , 
neutralised (1.5M NaCl, 0.5M Tris-HCl, 1mM EDTA, pH 8.0), then 
set up for capillary blotting on to nitrocellulose (Amersham 
Hybond C-extra) using 10 X SSC (1 .5M NaCl, 0.15M Na
3 
citrate) as 
blotting medium. Blotting was continued f or 12 - 16h. The 
blotted nitrocellulose membrane was washed (6 X SSC, 5min), 
drained, and allowed to air dry, after which it was fixed by 
heat treatment at 80°C (no vacuum) overnight. The fixed blot 
was stored desiccated at 20°C until use in hybridisation, when 
it was prewetted with 2 X SSC. The prehybridisation and 
hybridisation procedures were each conducted in the presence of 
50%v/v formamide at 42°C in heat-sealed, heavy-duty polyethylene 
pockets. Prehybridisation time, 3h; hybridisation time, 20h. 
Prehybridisation solution: 5 X Denhardt's solution; 5 X SSC; 
50mM sodium phosphate buffer, pH 7.0; 1%w/v glycine; 0.1%w/v 
SDS; 50%v/v deionised formamide; 500~g/ml freshly boiled carrier 
DNA. Volume per small gel blot, 10ml; per large gel blot, 20ml. 
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Hybridisation solution: 1 X Denhardt's solution; 5 X SSC; 20mM 
sodium phosphate buffer, pH 7.0; 10%w/v dextran sulphate 
(mol.wt. 500000); 0.1%w/v SDS; 50%v/v formamide; 500~g/ml 
freshly boiled carrier DNA; 10 - 20ng/ml freshly boiled 
[32p ]-labelled neo probe. Volume per small gel blot, 5ml; per 
large gel blot, 7.5 - 10ml. 
Denhardt's solution (X 100): 2%w/v polyvinylpyrrolidone (mol.wt. 
360000); 2%w/v ficoll (mol.wt. 400000); 2%w/v BSA. 
The hybridised blot was washed under conditions of high 
stringency as follows and then air dried: 
Wash 1 - 2 X SSC, 0.5%w/v SDS, 20°C, 5min; 
Wash 2 - 2 X ssc, 0~1%w/v SDS, 20°C, 15min; 
Wash 3 - 0.1 X SSC, 0.5%w/v SDS, 68°C, 40min; 
Wash 4 - 2 X SSC, no SDS, 20°C, 5 min; 
Wash 5 - as wash 4. 
Autoradiographic visualisation of the probed blot was achieved 
by exposing it to X-ray film (Amersham Hyper-film MP) sandwiched 
between intensifying screens at 20°C. Exposure varied from 10h 
to several days according to the specific activity of the probe 
at the time of use. For X-ray film processing, Agfa-Gevaert 
G150c developer and G334c rapid fixer were employed. For 
subsequent conventional photography of the autoradiograph, a 
high contrast black and white film was used, usually Kodak 
technical pan 2415. 
5.3 RESULTS 
Physical state of the neo Expression Vectors 
Caesium chloride-ethidium bromide density gradient purification 
of each plasmid vector gave rise to two distinct bands; a less 
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dense upper band representing the nicked circular form, which 
allows extensive EB intercalation, and a denser lower band 
representing the supercoiled form which places considerable 
constraint upon EB intercalation (Radloff et al, 1967) (Figure 
5.4A). After withdrawal of the bands followed by removal of the 
ethidium bromide content by organic extraction and final 
exhaustive dialysis (section 5.2.2), analysis of the plasmid 
fractions by agarose gel electrophoresis showed that while the 
upper band consisted entirely of the nicked circular form, the 
lower band usually contained plasmid in both the nicked circular 
and supercoiled configurations (Figure 5.4B). This could have 
been the result of either inter-band contamination during 
removal from the gradient, or the nicking of a proportion of the 
supercoiled population during the subsequent purification steps. 
The former idea was never supported by observations of 
reciprocal contamination: the upper band material appeared 
always to be 'clean'; thus it seemed most likely that 
post-gradient nicking was indeed taking place, despite routine 
pretreatment of dialysis tubing (section 2.2.2) and 
sterilisation of vessels. Furthermore, in the case of pAL-8, 
the lower band material also contained linearised plasmid 
(Figure 5.4C), which if present during CsCI separation would 
have appeared in the upper band. This observation suggests that 
the treatments following density gradient separation exerted 
considerable shear forces which, for a large plasmid like pAL-8, 
were sufficient to physically fragment the DNA double helix. 
The step during which this shearing might have taken place is 
that 'of butanol extraction. In the case of both ptkNEO and 
pAL-8, the lower band material containing approximately 50% 
supercoiled plasmid was the fraction used for transfection work. 
In confirmation of the known sizes of the two expression 
vectors, ptkNEO (4913bp) ran rather more slowly than pBR322 
(4363bp) during agarose gel . electrophoresis, while pAL-8 
(>11000bp) ran very much more slowly than either pBR322 or 
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Figure 5.4 Physical state of purified expression vectors 
A. Typical condition of vector after CsCl-EB density gradient 
purification. 
Upper band: relaxed (nicked) circular configuration . 
Lower band: supercoiled configuration. 
B. Content of p t kNEO CsCl-EB gradient bands, after EB removal 
and dialysis , as shown by agarose gel electrophoresis. 
1, pBR322 mar ker; 2, ptkNEO, lower band material; 3, 
ptkNEO, upper band material; 4, ptkNEO, crude extract prior 
to CsCl-EB purification. 
C. Relative vector size, as shown by agarose gel 
electrophoresis. 
1, pBR322 (4363bp); 2, ptkNEO (4913bp); 3, pBR322 (4363bp); 
4, pAL-8 (>1 1 000bp) . . 
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Figure 5.5 Scission of ptkNEO by the restriction endonuclease 
PstI 
A. Cleavage map showing the 5 expected fragments, including a 
923bp sequence cut within the neo gene. 
B. Agarose gel electrophoresis of PstI-restricted ptkNEO. 
1, A-EcoRI-HindIII molecular weight markers; 2-4, PstI 
digests of 3 independent ptkNEO preparations. 
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The ptkNEO PstI Fragment Representing the neo Seguence 
The restriction endonuclease PstI, which cleaves DNA at the 
sequence CTGCA/G, cuts the expression vector ptkNEO in five 
places, thereby giving rise to five fragments of the following 
sizes: 2184, 1317, 923, 252 and 237bp. A ptkNEO-PstI cleavage 
map, based on the complete ptkNEO sequence, is shown in Figure 
5.5A, and the fragments, separated on an agarose gel, are 
depicted in Figure 5.5B. The 923bp fragment, highlighted in 
Figure 5.5B, consists of the majority of the neo sequence, cut 
within the gene on both sides, thus excluding the flanking HSV1 
tk sequences altogether. Preparative gels of low melting 
temperature agarose, in which several identical ptkNEO-PstI 
digests were run in adjacent wells, were used for the separation 
and excision of this fragment prior to [32p ]-labelling and 
subsequent use as a probe in Southern hybridisation as described 
in section 5.2.2. 
Detection of the G418 Resistant Phenotype in HepG2 Cells 
The course of action of the antibiotic G418 on HepG2 cells is 
shown in Figure 5.6. The decline and death of the normal, 
untransfected, G418-sensitive HepG2 cell line over a period of 
21 days is depicted in Figure 5.6A. The development, over the 
same period, of isolated clones of surviving, G418-resistant 
cells within a neo-transfected population is shown in Figure 
5.6B . Semiconfluent islands of G418-resistant cells, derived 
from clone populations by trypsinisation and subculture in G418 
medium through several passages, representing a total of over 40 
days of G418 treatment, are illustrated in Figure 5.6C. 
Figure 5.7 illustrates the final result of a transfection 
experiment in which clonal colonies have arisen over a period of 
28 days in the presence of G418, indicating reception of the neo 
gene and its stable expression. The presence of numerous clones 
in the experimental flasks E1 - E4 together with the absence of 
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Figure 5.6 Typically observed microscopic effect of the 
antibiotic G418 on HepG2 survival 
Cells were subjected to transfection and/or G418 treatment and 
photomicrography as described in section 5.2.2. 
A. Decline and death of a normal, untransfected cell 
population. 
B. Development of surviving clonal colonies of G418-resistant 
cells in a pAL-8 transfected cell population. 
C. Appearance of a G418-resistant culture after trypsinisation 
of clonal colony cells from B. and continued growth through 
several passages in G418 maintenance medium. 
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Figure 5.7 Macroscopic appearance of clones resistant to G418 
following insulin-[N-acylurea albumin] mediated transfer of the 
expression vectors ptkNEO and pAL-8 to HepG2 cells 
Cells were subjected to transfection and G418 selection as 
described in section 5.2.2. After 28 days of G418 treatment, 
one complete experimental set of flasks was stained for the 
visualisation of clones as described in section 5~ 2.2. 
TRANSFECTION FLASKS: E1 and E2, I-[A-CDI] (40~g) plus ptkNEO 
(4~g); E3 and E4, I-[A-CDI] (40~g) plus pAL-8 (4~g). 
TRANSFECTION CONTROL FLASKS: Qi, no protein, no vector; C2, no 
protein, pAL-8 (4~g); C3, unconjugated I (18.25~g) and A 
(21.75~g) plus pAL-8 (4~g); C4, unconjugated I (18.25~g) and 
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Figure 5.8 Genomic Southern hybridisation: detection of the 
neo seQuence in stably G418 resistant HepG2 cells following 
insulin-[N-acylurea albumin] mediated transfection 
Cells were subjected to transfection and G418 selection as 
described in section 5.2.2. After 28 days of G418 treatment, 
one complete experimental set of flasks was stained for the 
visualisation of clones (Figure 5.7). Flasks of the duplicate 
set containing surviving cells (E1 - E4) were trypsinised and 
each of the cell populations propagated on a G418 maintenance 
regime, through several passages, for a further 16 days (Figure 
5.6C) until there were sufficient cells for DNA extraction. DNA 
was analysed for the neo sequence using as probe a 923bp PstI 
fragment of ptkNEO within the neo gene (Figure 5.5). 
A. MINI GEL BLOT: 1, PstI digested ptkNEO (2ng) plus salmon 
sperm carrier DNA (3~g); 3, neo fragment (923bp) from PstI 
digested ptkNEO (2ng) plus carrier DNA (3~g); 5, PstI digested 
HepG2 cell line DNA (12~g); 6, PstI digested HeLa cell line DNA 
( 12~g) . 
B. LARGE GEL BLOT : 1, undigested ptkNEO (4913bp) (1ng) plus 
carrier DNA (7~g) ; 3, undigested pAL-8 (>11000bp) (1ng) plus 
carrier DNA (7~g) ; 5, neo fragment excised from PstI digested 
ptkNEO (923bp) (1ng) plus carrier DNA (7~g); 7-10, PstI digested 
DNAs from G418 resistant HepG2 cell populations E1 - E4 
respectively (28~g per well). 
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evidence that DNA transfer takes place only by means of 
I-[A-CDI] and not as a result of any effects of I-A or 
unconjugated protein constituents. Frequencies of stable 
transfection resulting from ptkNEO transfer (mean = 2.0 X 10-5 ) 
are lower than for pAL-8 (mean = 5.5 X 10-5 ). The relationship 
of these frequencies to the frequencies of stable transfection 
resulting from other methods of gene transfer is shown in Table 
5 . 3 . 
Detection of the Stabilised neD Sequence in Transfected HepG2 
Genomic DNA 
Genotypic evidence for neD transfer and its subsequent 
stabilisation as a replicative entity is provided in Figure 5.8, 
which shows the results of Southern hybridisation of genomic DNA 
samples extracted from the HepG2 cell line and from transfected 
populations derived from it. Figure 5.8A illustrates the 
absence of neD in the DNA of two mammalian cell lines including 
HepG2. In the case of the HepG2 cells, the DNA required was 
necessarily extracted prior to transfection experiments, since 
control cell populations within the experiments themselves 
ultimately died as a result of G418 treatment (Figure 5.7). 
Figure 5.8B shows the presence of the neD sequence in the 
transfected HepG2 populations E1 - E4, grown on G418 for a total 
of 44 days, through several passages, from duplicate flasks of 
those shown in Figure 5.7. 
5.4 SUMMARY AND DISCUSSION 
The capacity of insulin-[N-acylurea albumin] to carry DNA into 
mammalian cells bearing insulin receptors has been investigated 
using expression vectors incorporating the reporter gene neD 
under the control of eukaryotic regulatory elements. The 
presence of neD in recipient cells was detected by means of 
their survival in the presence of a lethal dose of the 
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antibiotic G418. Since this system of detection involves long 
term selection, it provides an indication of not only gene 
transfer but also replicative maintenance of the gene through 
many cell divisions and its stable expression. A clear 
demonstration of t he stable expression of the neo gene following 
ptkNEO and pAL-8 t ransfer to HepG2 cells is provided by (i) the 
appearance of dis t inct clones among I-[A-CDI]-vector treated 
cells grown for 2 - 4 weeks on a G418 regime lethal to untreated 
cells (Figures 5.6B and 5.7), and (ii) identification of the 
exogenous neo sequence in DNA extracted after clone populations 
produced in parallel to those shown in Figure 5.7 had been grown 
for 44 days on the antibiotic (Figures 5.6C and 5.8). Complete 
lack of survivors in control flasks in which cells were provided 
with vector in the presence of no protein, I + A, I + A-CDI and 
I-A respectively (Figure 5.7) constitutes evidence that the gene 
transfer events depended on an agent capable of binding to both 
DNA and insulin receptor. Furthermore, free A-CDI, present at a 
concentration equivalent to that in the I-[A-CDI] conjugate, 
does not bring about transformation, indicating that 
non-specific cation-induced uptake is not involved. These 
results suggest t hat gene transfer has taken place under the 
direction of insulin via the endocytotic pathway. 
Observations made previously in relation to the solubility 
properties of the insulin-[N-acylurea albumin]-DNA complex had 
suggested that a degree of insolubility might be encountered 
under transfection conditions (section 3.4). In the 
transfection protocol, therefore, care was taken to avoid ' the 
possibility of insoluble material being precipitated in the 
medium. This was achieved by establishing conjugate-receptor 
binding during a pre-incubation period, following this with 
removal of unbound conjugate, and only then adding expression 
vector DNA for at t achment to the receptor-bound carrier. 
Receptor cycling was inhibited by temperature control until the 
DNA binding step was complete. In addition to circumventing any 
insolubility problems, this approach to binding allowed the 
addition of excess amounts of conjugate and DNA at each step, 
172 
maximised binding and possibly increased transfection 
efficiency. The alternative would have been to ensure removal 
of particulate material by membrane filtration of the complex 
before addition to cells. This might prove to be a suitable 
approach for future in vivo gene transfer studies, but further 
investigation into the interactions of soluble I-[A-DI]-DNA 
complex and components of the medium would be a desirable 
prerequisite. 
During the period of initiation and development of the 
transfection and selection protocol, no precedent could be found 
in the literature for the use of the neo-G418 system in HepG2 
cells. Suitable concentrations of G418 for the killing of 
untransfected cells had to be determined empirically, therefore, 
using regimes applicable to other cell lines as guides. Gorman 
(1985) has pointed out the importance of this determination, 
commenting that cells may escape the lethal effect if the dose 
of antibiotic is too low, and suggesting that initial trials 
should employ G418 concentrations ranging from 200 - 1000~g/ml. 
Examples of concentrations found suitable for use with mammalian 
cell lines include 250~g/ml (active drug) for murine 
teratocarcinoma cell lines (Jakob and Nicolas, 1987), 300~g/ml 
(active drug) for transformed monkey cell lines (Gerard and 
Gluzman, 1985), 500~g/ml (whole drug) for a wide variety of 
mammalian cell lines (Flyer et al, 1983), 625~g/ml (whole drug) 
for NIH 3T3 cells (Anklesaria et al, 1987), and 1000~g/ml (whole 
drug) for NIH 3T3 cells (Cepko et al, 1984). The active drug 
component of most commercial preparations of G418 is in the 
region of 40 - 60%. In the G418 used for the work described 
here it ranged from 48.6 - 53.0% according to production lot, 
and was regarded as 50% for convenience. The antibiotic regimen 
eventually found suitable for HepG2 cells consisted of an 
initial G418 treatment at 600~g/ml (active drug) for 5 days, a 
further treatment at 300~g/ml (active drug) for 5 days, followed 
by maintenance treatment at 250~g/ml (active drug), medium being 
changed at 5 day intervals until the selection process was 
complete. The G418 sensitivity of HepG2 cells thus appears to 
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be intermediate in the range shown by other cell lines. 
However, it was notable that while the G418-induced death of 
normal HepG2 cell populations was fairly advanced after 10 days 
or so, it was not fully complete until 3 - 4 weeks after the 
start of treatment. Increasing the dosage in the maintenance 
medium made little significant difference to the temporal 
factor. The kill i ng period quoted for other cell lines is 
generally shorter : 1 - 2 weeks (Gorman, 1985; Flyer et al, 
1983). It is int~resting to consider the possibility that a 
highly differentiated liver cell line such as HepG2 might retain 
the normal hepatic ability to detoxify drugs, including 
compounds such as the gentamicins. If so, the process of neo 
selection would probably be retarded, even at high 
concentrations of G418. In normal liver tissue in vivo, 
aminoglycoside antibiotics may be inactivated in the microsomal 
apparatus by conversion to N-glucuronides (A. Papaphilippou, 
personal communication). 
An important factor in interpreting the growth of G418-resistant 
clonal colonies is that it can be assumed that the medium in 
which the clones develop maintains a high concentration of 
unchanged antibiot ic. In the majority of cases of naturally 
occurring resistance studied in prokaryotic systems, 
aminoglycoside antibiotics are not inactivated or detoxified in 
the culture medium (Davies and Smith, 1978). It is thought that 
the mechanism of resistance depends, rather, on intracellular 
enzymatic modification interfering with or blocking the 
transport of the drug into and within the cell interior, 
possibly by direct interaction of the modified antibiotic with a 
carrier molecule. Little is known about the uptake of 
aminoglycoside compounds by sensitive cells, however, so the 
means by which such uptake processes may be inhibited in 
resistant types remain speculative (Davies and Smith, 1978). 
The significance to the present work of what is known of the 
mechanism of resistance is that there is little chance of 
artefactual clones having arisen as a result of extracellular 
G418 degradation. 
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Expression of the neo gene following insulin-[N-acylurea 
albumin] transfection has been shown to be extremely stable. 
The clones which arose in duplicate transfection flasks over 4 
weeks were either fixed and stained (Figure 5.7) or trypsinised 
and grown to high cell numbers through several subsequent 
subculture passages in G418 medium (Figure 5.6C) for the 
eventual extraction of genomic DNA. This DNA, utilised in 
Southern blotting for the detection of the neo gene (Figure 
5.8), was thus derived from cells which had experienced 44 days 
of continuous G418 treatment and many cell divisions. In 
parallel experiments, cells were sometimes maintained in G418 
medium for even longer periods: up to 78 days. Recent 
observations during further transfection experiments, incomplete 
at the present time, suggest that G418-resistant cells do not 
lose the neo gene even when grown through numerous passages in 
medium free of the antibiotic, that is, in the absence of 
selection. 
The size of the G418-resistant clones developed (Figure 5.7) 
varied greatly within each treated population regardless of 
vector. This phenomenon has measurable parallels in plant 
genetics: individual neo-positive plantlets grown up from Ti 
plasmid-transformed tissue show wide quantitative difference in 
resistance to kanamycin; this is generally thought to indicate 
that expression of inserted genes is enhanced or suppressed 
according to genomic position, which varies as a result of 
random integration (Rogers et ai, 1986). The wide variations in 
insertional pos i tion which appear to be indicated by differences 
in clonal size do emphasise the point that populations of clones 
are themselves unlikely to be clonal in the strict sense, but 
rather genetical ly heterogeneous, although in a manner 
, 
undetectable by the methodologies used in the work presented 
here. 
In enumerating clones, those which were particularly small were 
ignored; transformation frequencies were estimated 
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neo SV40 (early) 
neo HSV1 tk 
neo SV40 (early) 
neo M-MSV 
neo SV40 (early) 
RSV 
src (whole genome) 
neo SV40 (early) 
various various 
FREQUENCY OF 
STABLE TRANSFORMATION REFERENCE 
(per 1 06 cells) 
1 Darlington (1987) 
1 - 10 Tsao et al (1987) 
20 section 5.3 
55 section 5.3 
100 Flyer et al (1983) 
186 Fechheimer et al (1987) 
up to 800 Kawai and Nishizawa (1984) 
1000 Stopper etal (1987) 
1000 or more Graessmannn and Graessmann 
(1983); Celis (1984) 
Table 5.3 Stable transformation of mammalian cell lines: efficiency of the insulin-[N-acylurea 




induced stable gene transfer to be approximately 20 times 
(ptkNEO) and 55 times (pAL-8) more efficient than typical stable 
transformation of HepG2 cells brought about by the calcium 
phosphate procedure (Darlington, 1987), although only 0.2 
(ptkNEO) and 0.5 (pAL-8) the efficiency of neo transfer to 
mammalian cells effected via retroviral constructs (Flyer et ai, 
1983). 
The notable difference in frequency between ptkNEO- and 
pAL-8-induced expression of neo might indicate that SV40 
promoter sequences signal transcription in HepG2 cells more 
effectively than do the HSV1 tk control regions. The inclusion 
of the tandem 72bp repeat enhancer in the SV40 early promoter 
region upstream of neo in pAL-8 constitutes one possible 
explanation for the observed difference. The dramatic effect of 
this enhancer both in SV40 and in other chimaeric recombinants, 
independent of position and orientation, has been well 
documented (Moreau et .al, 1981; Laimins et ai, 1982). 
Furthermore, Capecchi (1980) has shown specifically that its 
presence increases the transformation efficiency of the HSV1 tk 
gene. 
An additional or alternative explanation may lie in the fact 
that pAL-8 contains the origin of replication of SV40, which 
signifies the possibility of the transfected vector existing 
episomally in the cytoplasm in a stable manner, transmissible to 
daughter cells during division. For this type of replication to 
take place, only one virally encoded protein is required: the T 
antigen (Ishimi et ai, 1988). In transfection studies with 
transformed monkey cells, Gerard and Gluzman (1985) showed that 
certain recombinant vectors carrying the neo sequence and the 
SV40 origin of replication, specifically designed for 
cytoplasmic autonomy, were maintained in an episomal form in 
recipient cells , persisting even in the absence of biochemical 
selection. In their work, evidence for episomal copies of neo 
was provided by Southern hybridisation of low molecular weight 
DNA extracted by the Hirt procedure (Hirt, 1967); chromosomal 
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DNA extracts were not tested. However, in a rigorous 
investigation involving the introduction of various conventional 
pSVneo plasmid vectors (including pSV2neo) into mammalian cells, 
Southern and Berg (1982) showed clearly that during the course 
of G418 selection the neo gene became exclusively associated 
with high molecular weight (genomic) DNA, autonomously 
replicating forms being absent as indicated by complete lack of 
the neo sequence in the Hirt fraction. At the present time it 
is not known whether the T antigen gene is incorporated into the 
SV40 regions of the pAL-8 construct, so the possibility of 
episomal replication of neo cannot be excluded. However, it is 
probable, as discussed in section 5.1, that the pAL-8 SV40 
components are closely related to those in the pSV2 vectors, and 
that the stable expression of neo observed is solely the result 
of genomic integration. That chromosomal integration events 
have occurred is supported by the fact that neo is identifiable 
in transfected genomic DNA (Figure 5.8B) and by the 
demonstration of stable expression following transfection with 
ptkNEO, which carries no eukaryotic origin of replication. 
The design of the insulin-[N-acylurea albumin] gene carrier is 
such that its most important role is played out at the plasma 
membrane in effecting transportation of extracellular DNA to the 
cell interior. The ligand-directed passage of DNA across the 
membrane is likely to be highly efficient. During subsequent 
intracellular processing, however, the route of DNA is less 
controlled, and numerous hazards in the form of enzymatic or 
membrane barriers must be encountered. Ultimate delivery to the 
nucleus would seem to be a rare event. The use of insulin as 
ligand might offer an advantage in this respect. In contrast 
with some ligand proteins which are delivered via membrane-bound 
vesicles to lysosomes, it is increasingly evident that insulin 
degradation inside the cell takes place in endosomal rather than 
lysosomal compartments (Sonne, 1988). Thus DNA still associated 
with the I-[A-CDI] complex after entry may not be directed 
actively towards lysosomal nucleases. It is tempting to 
speculate further upon the possibility of insulin-[N-acylurea 
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albumin] directing passage of vector DNA into the nucleus via 
the insulin receptors situated in the nuclear membrane (Vigneri 
et al, 1978). Attractive as this idea is, DNA binding studies 
have shown that in the ionic environment of the cytoplasm the 
I-[A-CDI]-DNA complex is likely to be at least partially 
dissociated (Figure 3.5B). A proportion of vectors reaching the 
cytoplasm are probably, therefore, free. The reversibility of 
binding is a desirable feature in general, since the DNA 
released is completely unmodified. However, if a soluble 
insulin carrier with a higher affinity for DNA could be devised, 
the advantage o f dissociability would not be lost, and the 
postulation of insulin-directed endosomal transport and nuclear 




~ THE WORK IN PERSPECTIVE 
The carbodiimide modification of proteins to produce N-acylurea 
derivatives with DNA-binding properties and their potential in 
gene transfer has been reported previously (Huckett et al, 1986; 
Ariatti and Hawt rey, 1987). In this thesis it has been 
demonstrated that cross-linking insulin to carbodiimide-modified 
albumin produces a soluble macromolecule capable of both 
specific recognition of the insulin receptor and DNA transport, 
thereby affording a means of targeted transfection from solution 
without the involvement of particulate intermediates, excessive 
foreign chemicals, cell disruption or infective agents. 
Evidence is provided which suggests that by means of this DNA 
carrier system, in a manner consistent with the proposed model 
(Figure 1.1), the exogenous gene neo from the bacterial 
transposon Tn5 has been inserted through the insulin receptor 
endocytotic pathway into the HepG2 hepatoma cell line, 
integrated into the genome, and stably expressed. 
Exploitation of the efficiency and specificity of cell entry 
afforded by receptor-mediated endocytosis had been suggested in 
various ways prior to this work being undertaken. The targeting 
of drugs, enzymes and genetic material had been considered by 
various research groups in this context, as discussed briefly in 
section 1.3.5. For example, Poznansky and coworkers achieved 
delivery of a-1 , 4-glucosidase to muscle cells and hepatocytes 
using a covalent ly conjugated enzyme-albumin-insulin complex 
(Poznansky et al, 1984», and Pastan's group (Cheng et al, 1983) 
devised a mechanism of covalent attachment between nucleic acid 
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and protein with the purpose in view of genetic correction via 
endocytosis. More recently, an alternative methodology for the 
preparation of oligonucleotide-peptide hybrids has been reported 
with the stated aim of targeting anti-sense oligonucleotides 
into cells via endocytosis for the therapeutic inhibition of 
gene expression (Haralambidis et ai, 1989). In contrast with 
applications of endocytotic transport such as these, the method 
of gene transfer expounded in the present work combines the 
elegance of ligand-directed carrier insertion with non-covalent 
reversible binding of the DNA to the carrier, a possible 
advantage in the cell interior. Work by Wu and Wu published 
during the course of this investigation illustrates use of a 
parallel approach: by employing as carrier a conjugate of 
asialoorosomucoid and high molecular weight cationic 
poly-L-lysine, which binds DNA electrostatically in much the 
same manner as N-acylurea protein, those workers have 
demonstrated transient expression of the bacterial cat gene in 
HepG2 hepatoma cells in culture (Wu and Wu, 1987; Wu and Wu, 
1988a) and in rat liver in vivo (Wu and Wu, 1988b). The work 
described in thi s thesis adds, therefore, to a growing body of 
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evidence that receptor mediated endocytosis provides an 
effective pathway by which exogenous molecules may be directed 
into the interior of target cells, and in particular shows that 
highly efficient stable genetic transformation may result from 
the use of this facility. 
The fact that the work undertaken in the present investigation 
is so closely allied to the work reported by Wu and Wu (1987, 
1988a) gives the latter an important status in relation to the 
thesis: comparisons are especially pertinent. For example, the 
poly-L-lysine used by Wu and Wu is of the same molecular size 
(mean Mr = 69000) as the N-acylurea albumin used here (m wt = 
68000 for the monomer). However, conjugation of the 
poly-L-lysine to the ligand asialoorosomucoid (ASOR) was in a 
1:5 mole ratio and employed N-succinimidyl 3-(2-pyridyldithio) 
propionate as coupling agent, compared to conjugation of 
N-acylurea albumin to insulin in a 1:10 ratio by means of 
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glutaraldehyde as in the present work. A more relevant 
difference is that Wu and Wu devised a simple but effective 
method for determining the proportion of ASOR-poly-L-lysine 
conjugate that should be mixed with plasmid DNA in order to 
optimise the DNA content of a soluble complex. Thus mixtures of 
[125 I ]-labelled conjugate and DNA in 2M NaCl were set up in which 
the concentrations of conjugate varied (0 - 160nM) but the 
concentration of DNA remained constant (87nM). Mixtures were 
incubated for 1h at 25°C, then dialysed against 0.15M NaCl for 
24h using low molecular weight cut-off dialysis tubing. Samples 
were subsequently filtered through membranes with a pore size of 
O.2~M to ensure that the complexes did not contain precipitates. 
Fluorometric measurements of DNA in the filtrates showed that 
there was no significant loss of DNA due to the filtration step. 
The samples were then electrophoresed in an agarose gel, after 
which the DNA was visualised by ethidium bromide staining and 
the conjugate located by autoradiography. The results of this 
procedure enabled the authors to identify the 2:1 mole ratio of 
conjugate to DNA as the one optimising complex formation. This 
ratio was used, therefore, in all subsequent transfection work; 
moreover, the complexes were always subjected to a precautionary 
prefiltration step. In further contrast to the present work, 
ASOR-poly-L-lys i ne transfection was carried out in the presence 
of foetal calf serum and a Ca++ supplement (5mM), pSV
2
CAT was 
employed as expression vector, and the SK-Hep 1 line (ASOR 
receptor-negative) used as a cellular control. Receptor-
positive HepG2 cells used as recipients demonstrated transient 
expression of the cat gene at twice the efficiency of the 
calcium phosphate method in the authors' hands. 
While the particular strength of the present work compared to 
that of Wu and Wu lies in its clear demonstration of stable 
expression following endocytotic gene transfer (Figures 5.7 and 
5.8), there are several aspects of the approach taken by those 
authors, mentioned above, which could be gainfully introduced 
into the insulin-[N-acylurea albumin] methodology as reported to 
date. The most important is the measurement and optimisation of 
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soluble conjugate-DNA complex. Of lesser importance, but of 
considerable val ue in confirming the mechanism of gene transfer, 
is the use of an endocytosis-negative cell line as control. Of 
some further interest would be an investigation into the effect 
of Ca- on endocytotic transfection. 
6.2 PROSPECTS FOR DEVELOPMENT OF THE WORK 
Various extensions to the studies contributing to this thesis 
have suggested t hemselves during the course of the work. 
Together with t h e modifications suggested by the approach used 
by Wu and Wu, t hey fall into six categories as follows: 
Mechanism of Conjugate-DNA Binding 
The manner in wh ich insulin-[N-acylurea albumin] conjugate binds 
DNA non-specifically is presented and discussed in chapter 3. 
The residual DNA binding shown by the conjugate at high ionic 
strength (Figure 3.SB) is intriguing, and deserves some further 
attention. In particular, two of the possible explanations 
offered in section 3.4 could be investigated. Firstly, 
non-electrostatic interaction in the form of hydrogen bonding, 
suggested by Ariatti and Hawtrey (1987) to have particular 
potential in relation to guanine residues in single-stranded 
regions of DNA, could be studied by examining the binding of 
I-[A-CDI] to single-stranded DNAs such as M13 DNA and 
single-stranded poly-G, or by employing oligo-G fragments as 
competitors of double-stranded DNA binding. Secondly, the 
possibility that the residual binding 'is artefactual due to 
partial precipitation of the I-[A-CDI]-DNA complex could be 
examined by introducing a prefiltration step into the procedure. 
This latter poin t of investigation would be covered should the 
conjugate-DNA complex optimisation protocol of Wu and Wu (1987; 
1988a), described above, be adopted. 
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Specificity of Coniugate-Receptor Binding in Transfection 
The binding reaction between I-[A-CDI] and HepG2 cells is 
described and discussed in chapter 4. On the basis that the 
binding kinetics (Figure 4.2) indicate clearly that the 
conjugate interacts specifically with the insulin receptor and 
not with non-specific sites on the cell surface, the 
transfection work which follows, presented in chapter 5, is 
assumed to depend upon receptor-determined endocytotic uptake. 
Further evidence that the uptake is indeed a receptor specified 
process is provi ded by the apparent inability of A-CDI to 
mediate gene transfer (Figure 5.7). However, as discussed above 
in relation to the work of Wu and Wu (1987;1988a), additional 
support for the specificity of the process could be provided by 
the use in transfection of control cells lacking the appropriate 
receptor. Few cells, if any, demonstrate complete absence of 
the insulin receptor (Rosen, 1987). Convenient controls would 
best be selected, therefore, from mutant cell lines in which 
insulin receptor function is seriously impaired; alternatively, 
IM-9 lymphocytes, which carry insulin receptors but do not 
exhibit endocytosis, could possibly be used for this purpose. 
Parameters of Transfection 
A substantial and meaningful extension to the work would be to 
characterise the important parameters of transfection using the 
insulin receptor pathway, and to establish optimal conditions 
for both gene t r ansfer and subsequent expression. For a study 
of this nature, it would be prudent to use, in the initial 
stages, a transient expression assay to provide a rapid and 
quantitative indication of transfection and cytoplasmic 
expression. A well tested transient expression vector such as 
pSV2CAT would be convenient for this purpose, although it would 
also be possible to continue using ptkNEO and pAL-8 and to assay 
for the transient expression of neo using techniques for the 
identification and quantification of APH{3')II enzyme, 
electrophoretically separated from a crude cell extract, such as 
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the method of Reiss et al (1984) or a Western blotting 
technique. The importance to expression of such factors as time 
after transfection, culture medium composition (including Ca++ 
concentration), state of the recipient cells, the optimal 
concentrations of carrier and donor DNA, and the physical state 
of the DNA could then be investigated with relative ease. It 
has been noted by a number of workers that the expression of 
transfected DNA depends upon its topology, although the 
character of the dependency varies from system to system. In 
CV-1 and L cells, supercoiled DNAs yield markedly higher levels 
of expression than their linerarised equivalents (Weintraub et 
ai, 1986); in p l ant protoplasts, however, linear forms of 
plasmid DNA have been observed to be superior to supercoiled 
structures as active templates for gene expression (Ballas et 
ai, 1988). Further investigations, possibly using a wider range 
of expression vectors, could lead to reliable and reproducible 
mean values for the frequencies of transient and stable 
expression, thereby establishing the relationship between the 
two. In the case of vectors based on SV40 regulatory sequences 
it would be important to extend the studies of stable expression 
to include Southern blotting of both a Hirt DNA fraction (Hirt, 
1967) and a genomic DNA extract in order to establish the 
replicative mode of the inserted plasmid and thus the occurrence 
of chromosomal versus episomal maintenance of the reporter gene 
(section 5.4). Establishment of transfection frequencies using 
the classical calcium phosphate technique with the same range of 
vectors would provide a valuable general comparat i ve measure of 
the efficiency of the transfection system in HepG2 cells. 
Sophistication of the Method 
Methodological i mprovement is seen to be a logical and desirable 
direct development of the present work, which suffers from the 
interrelated limitations of poor conjugate solubility, poor 
conjugate-DNA complex solubility, and only moderate 
conjugate-DNA affinity under physiological conditions. Some of 
these problems are due to the limited solubility of insulin 
185 
itself at neutral pH, and might be overcome only by turning to a 
more soluble alternative ligand. It has already been 
established by other members of the research group that when 
readily soluble ligand proteins such as transferrin and 
asialoorosomucoid (0, acid-glycoprotein) are modified with 
carbodiimides containing a quaternary nitrogen function, thus 
eliciting a stronger electrostatic interaction with DNA than in 
the case of tert iary carbodiimide modification (Figure 3.5A), 
the complexes so formed demonstrate greater flexibility in 
solution than the equivalently modified insulin-albumin 
conjugate (Huckett et ai, 1986; N. Moodley, unpublished 
results). However, alternative ways of modifying insulin could 
possibly be found; it is also possible that establishment of 
optimal conditions for transfection using the tertiary 
derivative I-[A-CDI], as mentioned in the previous subsection, 
might in itself resolve sufficient of the difficulties to 
achieve a desirable degree of technical amendment. 
Intracellular Fate of Transfected DNA 
A completely separate area of investigation, one which might 
constitute a project in its own right, is that of following the 
transport route and survival of donor DNA within the cell 
interior following transfection. The interaction, if any, of 
the DNA with lysosomes, endosomal elements and the nuclear 
membrane would be among the primary objectives. This type of 
study would necessitate employing the kinds of techniques used 
to follow the fate of ligands themselves: radio- or 
immunolabelling of the DNA, and its subsequent intracellular 
visualisation or observed association with subcellular fractions 
at various times after transfection, combined with the use of a 
variety of inhibitors. Work of this nature is fairly difficult, 
and interpretations even more so. However, any data concerning 
localisation of the transfected DNA in the various cytoplasmic 
pathways and its possible occurrence in the nucleus would be 
intrinsically interesting, and would hav~ additional value in 
relation to ongoing work concerning the relative frequencies of 
186 
transient and s t able expression. 
Application of the Method in vivo 
Ultimately, it would be challenging to undertake the 
receptor-mediated delivery of a foreign gene to animal tissue in 
vivo; in fact, there are arguments for moving in this direction 
without delay (section 6 . 3). The most recently published work 
of Wu and Wu (1988b) models this approach using the pSV2CAT 
system in rats. A similarly simple transient expression vector 
would be the most reasonable and practical one to use with the 
N-acylurea protein method in the first place, and would lend 
itself to investigating the organ targeting potential of a 
specific ligand. Insulin might prove a poor choice of ligand 
for targeted gene delivery, since its cognate receptor exists in 
almost every type of cell (Rosen, 1987); however, it is found in 
greatest concentrations in liver and fat, and it would be of 
value to determine whether those tissues would constitute prime 
areas of transfection activity in vivo. Since the present work 
has shown that long term expression of neo is possible using an 
N-acylurea protein carrier in vitro, it would be particularly 
interesting to proceed eventually to the use of a suitable 
stable expression system in a whole animal model. 
6.3 SPECULATIONS 
The possible avenues of further investigation briefly outlined 
in section 6.2 are necessarily seen in the context of the 
current status of molecular biology in general and foreign gene 
expression in particular. Should it be possible for some of 
these lines of study to be undertaken in the future, it is clear 
that their emphasis would be modified in accordance with 
contemporary fi ndings in the field. While the findings 
themselves are not predictable, it is possible to speculatively 
suggest the areas in which the greatest progressive shifts might 
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occur. 
At the present time, gene transfer research appears to be most 
active in the following four areas: 
The production of commercially important transgenic animals and 
plants. Recent reviews of the genetic engineering of livestock 
(Pursel et al, 1989) and crop plants (Gasser and Fraley, 1989) 
indicate that dramatic progress is being made in these fields. 
The expansion of gene transfer practice within the agricultural 
industry is such that regulatory approval and patent protection 
are key issues; these in turn are determining, at the highest 
levels of government, the nature and degree of further 
investment in the relevant technology. 
Therapeutic gene replacement in vivo. Increasingly numerous and 
sophisticated reports of gene therapy in whole animal models are 
appearing in the literature. In general, the momentum within 
this area of endeavour is being generated by the success of the 
approach involving transplantation of recombinant cells. For 
example, transformed endothelial cells introduced into denuded 
iliofemoral arteries of swine have been shown to become 
implanted into the vessel wall and to express the recombinant 
gene there 2 - 4 weeks later (Nabel et al, 1989) . In a study of 
related significance reported by Mulligan's group, prosthetic 
vascular grafts seeded with genetically modified endothelial 
cells have been implanted successfully into dogs, survival of 
the recombinant cells being demonstrated after 5 weeks (Wilson 
et al, 1989). As a measure of the medical relevance and urgency 
of this type of work, Friedmannn (1989) has reviewed current 
progress towards gene therapy in humans, closely following a 
number of previous reviews (section 1.2.3). 
Mammalian gene targeting by homologous recombination. The 
current status of intrachromosomal gene targeting has been 
reviewed by one of the major research workers in this area 
(Capecchi, 1989). Significant accomplishments have been made in 
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the last two years, especially in terms of the development of 
methods for the identification in embryonic stem cells of a 
desired recombinational event. These advances, added to the 
importance in human gene therapy in particular of correct gene 
placement, augur well for the future growth of this aspect of 
genetic transfer. 
Gene delivery to specific organelles. A number of recent 
studies have emphasised an interest in gene transfer to those 
organelles which contain non-nuclear DNA: mitochondria and 
chloroplasts. Since a number of crucially important enzymes are 
encoded in these organellar genomes, gene transfer which is 
specifically directed to them provides a tool with which 
fundamental organelle controlled processes may be altered and 
thereby studied. Using the microprojectile method, for 
instance, Chlamydomonas chloroplast genome modification (Boynton 
et ai, 1988) and Saccharomyces mitochondrial transformation 
(Johnston et ai, 1988) have been achieved, and by means of 
conjugating a short piece of DNA (24bp) to a mitochondrial 
precursor protein, Vestweber and Schatz (1989) have demonstrated 
mitochondrial DNA uptake in yeast. Related to this type of 
approach is the possibility of introducing DNA into the nucleus 
in a directed manner via nuclear proteins or nuclear membrane 
receptors. Kaneda et al (1989), for example, have shown that a 
fivefold increase in expression is observed when DNA is 
cointroduced with nuclear protein into rat liver. 
While the first of the above areas of research activity is 
unlikely to have serious impact on the future prospects of 
receptor-mediated gene transfer (and vice-versa), the last three 
mentioned might have some bearing on its development and 
application. An effective method of soluble DNA transfer with 
the potential for targeting to cells or tissues, as modelled in 
this study and concomitantly by Wu and Wu (1987; 1988a), does 
fill a gap in the range of available methodologies (Table 1.1), 
and the evidence that it is applicable in vivo (Wu and Wu, 
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1988b) makes the possibility of its therapeutic application 
realistic and exciting. In the current research climate, 
therefore, the t ransition of the receptor-mediated approach 
towards whole a n imal work and its refinement in terms of 
intracellular targeting would seem to be important. In 
addition, the e ndocytotic method of molecular transfer appears 
to show promise in relation to organellar gene delivery, 
especially perhaps in the case of insulin-based carriers. The 
fact that a proportion of endocytosed insulin receptors normally 
remains undegraded in the cell and that receptors are detectable 
at sites on the nuclear membrane has been noted in section 
1.3.4, and its implications for transport of DNA into the 
nucleus discussed in section 5.4. For this reason, and 
especially in the light of the apparent growth of interest in 
subcellular gene targeting mechanisms, further development of 
insulin-directed gene transfer in particular would seem to have 
a modest degree of profitable potential, worthy of pursuit. 
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NUCLEOTIDE SEQUENCE OF THE EXPRESSION VECTOR ptkNEO 
The vector ptkNEO was previously called pNE03. 
The sequence was compiled from known details of Barbara Wold's 
original construction provided by Dr Shirley Taylor and Nevis 
Fregien, in conjunction with the respective published sequences 
of pBR322 (Sutcliffe, 1979), the Herpes Simplex Virus Type 1 tk 
gene (Wagner et al, 1981) and the Tn5 neo gene (in Gorman, 
1985). 
pBR322 ampR and ori 





HSV1 tk 5' proximal to neo 




4288-4913 (626bp) HSV1 tk 3' proximal to neo 
* Some bases have been removed in the vicinity of ligation 
sites: PvuII and SmaI sites destroyed. 
*tk/PBR322 ligation site 
PvuII (17bp of the pBR322 sequence removed) 
10 20 30 40 50 
GTGATGACGG TGAAAACCTC TGACACATGC AGCTCCCGGA GACGGTCACA 
60 70 80 90 100 
GCTTGTCTGT AAGCGGATGC CGGGAGCAGA CAAGCCCGTC AGGGCGCGTC 
110 120 130 140 150 
AGCGGGTGTT GGCGGGTGTC GGGGCGCAGC CATGACCCAG TCACGTAGCG 
160 170 180 190 200 
ATAGCGGAGT GTATACTGGC TTAACTATGC GGCATCAGAG CAGATTGTAC 
210 220 230 240 250 
TGAGAGTGCA CCATATGCGG TGTGAAATAC CGCACAGATG CGTAAGGAGA 
260 270 280 290 300 
AAATACCGCA TCAGGCGCTC TTCCGCTTCC TCGCTCACTG ACTCGCTGCG 
225 
310 320 330 340 350 
CTCGGTCGTT CGGCTGCGGC GAGCGGTATC AGCTCACTCA AAGGCGGTAA 
360 370 380 390 400 
TACGGTTATC CACAGAATCA GGGGATAACG CAGGAAAGAA CATGTGAGCA 
410 420 430 440 450 
AAAGGCCAGC AAAAGGCCAG GAACCGTAAA AAGGCCGCGT TGCTGGCGTT 
460 470 480 490 500 
TTTCCATAGG CTCCGCCCCC CTGACGAGCA TCACAAAAAT CGACGCTCAA 
510 520 530 540 550 
GTCAGAGGTG GCGAAACCCG ACAGGACTAT AAAGATACCA GGCGTTTCCC 
560 570 580 590 600 
CCTGGAAGCT CCCTCGTGCG CTCTCCTGTT CCGACCCTGC CGCTTACCGG 
610 620 630 640 650 
ATACCTGTCC GCCTTTCTCC CTTCGGGAAG CGTGGCGCTT TCTCAATGCT 
<: ori::::> 
660 670 680 6·90 700 
CACGCTGTAG GTATCTCAGT TCGGTGTAGG TCGTTCGCTC CAAGCTGGGC 
710 720 730 740 750 
TGTGTGCACG AACCCCCCGT TCAGCCCGAC CGCTGCGCCT TATCCGGTAA 
760 770 780 790 800 
CTATCGTCTT GAGTCCAACC CGGTAAGACA CGACTTATCG CCACTGGCAG 
810 820 830 840 850 
CAGCCACTGG TAACAGGATT AGCAGAGCGA GGTATGTAGG CGGTGCTACA 
860 870 880 890 900 
GAGTTCTTGA AGTGGTGGCC TAACTACGGC TACACTAGAA GGACAGTATT 
910 920 930 940 950 
TGGTATCTGC GCTCTGCTGA AGCCAGTTAC CTTCGGAAAA AGAGTTGGTA 
960 970 980 990 1000 
GCTCTTGATC CGGCAAACAA ACCACCGCTG GTAGCGGTGG TTTTTTTGTT 
226 
1010 1020 1030 1040 1050 
TGCAAGCAGC AGATTACGCG CAGAAAAAAA GGATCTCAAG AAGATCCTTT 
1060 1070 1080 1090 1100 
GATCTTTTCT ACGGGGTCTG ACGCTCAGTG GAACGAAAAC TCACGTTAAG 
1110 1120 1130 1140 1150 
GGATTTTGGT CATGAGATTA TCAAAAAGGA TCTTCACCTA GATCCTTTTA 
end ampR.-
1160 1170 1180 1190 1200 
AATTAAAAAT GAAGTTTTAA ATCAATCTAA AGTATATATG AGTAAACTTG 
1210 1220 1230 1240 1250 
GTCTGACAGT TACCAATGCT TAATCAGTGA GGCACCTATC TCAGCGATCT 
1260 1270 1280 1290 1300 
GTCTATTTCG TTCATCCATA GTTGCCTGAC TCCCCGTCGT GTAGATAACT 
1310 1320 1330 1340 1350 
ACGATACGGG AGGGCTTACC ATCTGGCCCC AGTGCTGCAA TGATACCGCG 
1360 1370 1380 1390 1400 
AGACCCACGC TCACCGGCTC CAGATTTATC AGCAATAAAC CAGCCAGCCG 
1410 1420 1430 1440 1450 
GAAGGGCCGA GCGCAGAAGT GGTCCTGCAA CTTTATCCGC CTCCATCCAG 
1460 1470 1480 1490 1500 
TCTATTAATT GTTGCCGGGA AGCTAGAGTA AGTAGTTCGC CAGTTAATAG 
1510 1520 1530 1540 1550 
TTTGCGCAAC GTTGTTGCCA TTGCTGCAGG CATCGTGGTG TCACGCTCGT , 
PstI 
1560 1570 1580 1590 1600 
CGTTTGGTAT GGCTTCATTC AGCTCCGGTT CCCAACGATC AAGGCGAGTT 
1610 1620 1630 1640 1650 
ACATGATCCC CCATGTTGTG CAAAAAAGCG GTTAGCTCCT TCGGTCCTCC 
1660 1670 1680 1690 1700 
GATCGTTGTC AGAAGTAAGT TGGCCGCAGT GTTATCACTC ATGGTTATGG 
227 
1710 1720 1730 1740 1750 
CAGCACTGCA TAATTCTCTT ACTGTCATGC CATCCGTAAG ATGCTTTTCT 
1760 1770 1780 1790 1800 
GTGACTGGTG AGTACTCAAC CAAGTCATTC TGAGAATAGT GTATGCGGCG 
1810 1820 1830 1840 1850 
ACCGAGTTGC TCTTGCCCGG CGTCAACACG GGATAATACC GCGCCACATA 
1860 1870 1880 1890 1900 
GCAGAACTTT AAAAGTGCTC ATCATTGGAA AACGTTCTTC GGGGCGAAAA 
1910 1920 1930 1940 1950 
CTCTCAAGGA TCTTACCGCT GTTGAGATCC AGTTCGATGT AACCCACTCG 
1960 1970 1980 1990 2000 
TGCACCCAAC TGATCTTCAG CATCTTTTAC TTTCACCAGC GTTTCTTGGGT 
2010 2020 2030 2040 2050 
GAGCAAAAAC AGGAAGGCAA AATGCCGCAA AAAAGGGAAT AAGGGCGACA 
...- start ampR 
2060 2070 2080 2090 2100 
CGGAAATGTT GAATACTCAT ACTCTTCCTT TTTCAATATT ATTGAAGCAT 
2110 2120 2130 2140 2150 
TTATCAGGGT TATTGTCTCA TGAGCGGATA CATATTTGAA TGTATTTAGA 
2160 2170 2180 2190 2200 
AAAATAAACA AATAGGGGTT CCGCGCACAT TTCCCCGAAA AGTGCCACCT 
2210 2220 2230 2240 2250 
GACGTCTAAG AAACCATTAT TATCATGACA TTAACCTATA AAAATAGGCG 
2260 2270 2280 2290 2300 
TATCACGAGG CCCTTTCGTC TTCAAGAATT CTCATGTTTG ACAGCTTATC 
2310 2320 2330 2340 2350 
ATCGATAAGC TTTAATGCGG TAGTTTATCA CAGTTAAATT GCTAACGCAG 
2360 2370 2380 2390 2400 
TCAGGCACCG TGTATGAAAT CTAACAATGC GCTCATCGTC ATCCTCGGCA 
228 
2410 2420 2430 2440 2450 
CCGTCACCCT GGATGCTGTA GGCATAGGCT TGGTTATGCC GGTACTGCCG 
2460 2470 2480 2490 2500 
GGCCTCTTGC GGGATATCGT CCATTCCGAC AGCATCGCCA GTCACTATGG 
2510 2520 2530 2540 2550 
CGTGCTGCTA GCGCTATATG CGTTGATGCA ATTTCTATGC GCACCCGTTC 
2560 2570 2580 2590 2600 
TCGGAGCACT GTCCGACCGC TTTGGCCGCC GCCCAGTCCT GCTCGCTTCG 
2610 2620 2630 2640 2650 
CTACTTGGAG CCACTATCGA CTACGCGATC ATGGCGACCA CACCCGTCCT 
2660 2670 2680 2690 2700 
GTGGATCCGG GTCCTAGGCT CCATGGGGAC CGTATACGTG GACAGGCTCT , pBR322/tk ligation site 
BamHI 
2710 2720 2730 2740 2750 
GGAGCATCGC ACGACTGCGT GATATTACCG GAGACCTTCT GCGGGACGAG 
2760 2770 2780 2790 2800 
CCGGGTCACG CGGCTGACGG AGCGTCCGTT GGGCGACAAA CACCAGGACG 
2810 2820 2830 2840 2850 
GGGCACAGGT ACACTATCTT GTCACCCGGA GCGCGAGGGA CTGCAGGAGC , 
PstI 
2860 2870 2880 2890 2900 
TTCAGGGAGT GGCGCAGCTG CTTCATCCCC GTGGCCCGTT GCTCGCGTTT 
2910 2920 2930 2940 2950 
GCTGGCGGTG TCCCCGGAAG AAATATATTT GCATGTCTTT AGTTCTATGA 
2960 2970 2980 2990 3000 
TGACACAAAC CCCGCCCAGC GTCTTGTCAT TGGCGAATTC GAACACGCAG 
possible control sequence 
(Benoist et al, 1980) 
3010 3020 3030 3040 3050 
ATGCAGTCGG GGCGGCGCGG TCCCAGGTCC ACTTCGCATA TTAAGGTGAC 
Goldberg-Hogness 'TATA' box 
3060 3070 3080 3090 3100 
GCGTGTGGCC TCGAACACCG AGCGACCCTG CAGCGACCCG CTTAACAGCG , 
PstI 
229 
3110 3120 3130 3140 3150 
TCAACAGCGT GCCGCAAGAT CTGATCAAGA GACAGGATGA GGATCGTTTC , tk/neo ligation site 
BglII 
3160 3170 3180 3190 3200 
GCATGATTGA ACAAGATGGA TTGCACGCAG GTTCTCCGGC CGCTTGGGTG 
3210 3220 3230 3240 3250 
GAGAGGCTAT TCGGCTATGA CTGGGCACAA CAGACAATCG GCTGCTCTGA 
3260 3270 3280 3290 3300 
TGCCGCCGTG TTCCGGCTGT CAGCGCAGGG GCGCCCGGTT CTTTTTGTCA 
3310 3320 3330 3340 3350 
AGACCGACCT GTCCGGTGCC CTGAATGAAC TGCAGGACGA GGCAGCGCGG , 
PstI 
3360 3370 3380 3390 3400 
CTATCGTGGC TGGCCACGAC GGGCGTTCCT TGCGCAGCTG TGCTCGACGT 
3410 3420 3430 3440 3450 
TGTCACTGAA GCGGGAAGGG ACTGGCTGCT ATTGGGCGAA GTGCCGGGGC 
3460 3470 3480 3490 3500 
AGGATCTCCT GTCATCTCAC CTTGCTCCTG CCGAGAAAGT ATCCATCATG 
3510 3520 3530 3540 3550 
GCTGATGCAA TGCGGCGGCT GCATACGCTT GATCCGGCTA CCTGCCCATT 
3560 3570 3580 3590 3600 
CGACCACCAA GCGAAACATC GCATCGAGCG AGCACGTACT CGGATGGAAG 
3610 3620 3630 3640 3650 
CCGGTCTTGT CGATCAGGAT GATCTGGACG AAGAGCATCA GGGGCTCGCG 
3660 3670 3680 3690 3700 
CCAGCCGAAC TGTTCGCCAG GCTCAAGGCG CGCATGCCCG ACGGCGAGGA 
3710 3720 3730 3740 3750 
TCTCGTCGTG ACCCATGGCG ATGCCTGCTT GCCGAATATC ATGGTGGAAA 
3760 3770 3780 3790 3800 
ATGGCCGCTT TTCTGGATTC ATCGACTGTG GCCGGCTGGG TGTGGCGGAC 
230 
3810 3820 3830 3840 3850 
CGCTATCAGG ACATAGCGTT GGCTACCCGT GATATTGCTG AAGAGCTTGG 
3860 3870 3880 3890 3900 
CGGCGAATGG GCTGACCGCT TCCTCGTGCT TTACGGTATC GCCGCTCCCG 
3910 3920 3930 3940 3950 
ATTCGCAGCG CATCGCCTTC TATCGCCTTC TTGACGAGTT CTTCTGAGCG 
3960 3970 3980 3990 4000 
GGACTCTGGG GTTCGAAATG ACCGACCAAG CGACGCCCAA CCTGCCATCA 
4010 4020 4030 4040 4050 
CGAGATTTCG ATTCCACCGC CGCCTTCTAT GAAAGGTTGG GCTTCGGAAT 
4060 4070 4080 4090 4100 
CGTTTTCCGG GACGCCGGCT GGATGATCCT CCAGCGCGGG GATCTCATGC 
4110 4120 4130 4140 4150 
TGGAGTTCTT CGCCCACCCC GGGCTCGATC CCCTCGCGAG TTGGTTCAGC 
4160 4170 4180 4190 4200 
TGCTGCCTGA GGCTGGACGA CCTCGCGGAG TTCTACCGGC AGTGCAAATC 
4210 4220 4230 4240 4250 
CGTCGGCATC CAGGAAACCA GCAGCGGCTA TCCGCGCATC CATGCCCCCG 
4260 4270 4280 4290 4300 
AACTGCAGGA GTGGGGAGGC ACGATGGCCG CTTTGGCGGG AGATGGGGGA , neo/tk ligation site ,-
Pst! (some bases removed) Sma! 
4310 4320 4330 4340 4350 
GGCTAACTGA AACACGGAAG GAGACAATAC CGGAAGGAAC CCGCGCTATG 
4360 4370 4380 4390 4400 
ACGGCAATAA AAAGACAGAA TAAAACGCAC GGGTGTTGGG TCGTTTGTTC 
polyadenylation signals 
4410 4420 4430 4440 4450 
ATAAACGCGG GGTTCGGTCC CAGGGCTGGC ACTCTGTCGA TACCCCACCG 
4460 4470 4480 4490 4500 
AGACCCCATT GGGGCCAATA CGCCCGCGTT TCTTCCTTTT CCCCACCCCA 
231 
4510 4520 4530 4540 4550 
ACCCCCAAGT TCGGGTGAAG GCCCAGGGCT CGCAGCCAAC GTCGGGGCGG 
4560 4570 4580 4590 4600 
CAAGCCCGCC ATAGCCACGG GCCCCGTGGG TTAGGGACGG GGTCCCCCAT 
4610 4620 4630 4640 4650 
GGGGAATGGT TTATGGTTCG TGGGGGTTAT TCTTTTGGGC GTTGCGTGGG 
4660 4670 4680 4690 4700 
GTCAGGTCCA CGACTGGACT GAGCAGACAG ACCCATGGTT TTTGGATGGC 
4710 4720 4730 4740 4750 
CTGGGCATGG ACCGCATGTA CTGGCGCGAC ACGAACACCG GGCGTCTGTG 
4760 4770 4780 4790 4800 
GCTGCCAAAC ACCCCCGACC CCCAAAAACC ACCGCGCGGA TTTCTGGCGC 
4810 4820 4830 4840 4850 
CGCCGGACGA ACTAAACCTG ACTACGGCAT CTCTGCCCCT TCTTCGCTGG 
4860 4870 4880 4890 4900 
TACGAGGAGC GCTTTTGTTT TGTATTGGTC ACCACGGCCG AGTTTCCGCG 
4910 4920 
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BINDING OF DNA TO ALBUMIN AND TRANSFERRIN 
MODIFIED BY TREATMENT WITH WATER-SOLUBLE 
CARBODIIMIDES 
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Abstract-N-Acylurea derivatives of albumin and transferrin prepared with the water-soluble carbo-
diimides N-ethyl-N' -(3-dimethylaminopropyl)carbodiimide and N-ethyl-N' -(3-trimethylpropylammo-
nium)carbodiimide iodide have been found to bind different types of DNA. The two proteins were 
reacted with varying amounts of carbodiimide in water at pH 5.5 for 3(H)0 hr at 20°, and then purified. 
In the case of iron-loaded transferrin, reactions with carbodiimides were in phosphate-buffered saline 
(pH7.5) to prevent loss of iron from the protein. [lH]N-Ethyl-N'-(3-trimethylpropylammon-
ium)carbodiimide iodide was used for the determination of covalently attached N-acylurea groups in 
the modified proteins, and gel electrophoresis for changes in charge and possible aggregation through 
cross-linking. Binding of DNA to N-acylurea proteins was studied by means of agarose gel electrophoresis 
and nitrocellulose filter binding. N-Acylurea albumin and N-acylurea transferrin at low concentrations 
retarded the migration of A-Pstl restriction fragments , pBR322 plasmid and M13 mp8 single-standed 
DNA on agarose gels, while at higher concentrations of modified protein the N-acylurea protein-DNA 
complexes were unable to enter the gel. Nitrocellulose filter assays showed that binding of pBR322 
DNA and calf thymus DNA to N-acylurea proteins is rapid and dependent on protein concentration 
and the ionic strength of the medium. N-Acylurea albumins prepared with each of the two carbodiimides 
gave comparable plots for DNA bound versus protein concentration. On the other hand, binding of 
DNA by N-acylurea transferrins differed according to the carbodiimide used in the synthesis. N-Acylurea 
CDI-transferrin (prepared with tertiary carbodiimide) was less effective than either of the two N-
acylurea albumins in binding DNA. In contrast with these results, N-acylurea Me+CDI-transferrin 
(prepared with quaternary carbodiimide) was far more effective in binding DNA and in this respect 
was similar to the N-acylurea albumins. On the basis of experiments in which N-acylurea protein-DNA 
complexes were treated with heparin, two types of binding could be distinguished . These were (i) a 
weak binding occurring in the initial stages of interaction and (ii) a tight binding which developed on 
further incubation of the complexes. These studies show that binding of DNA by N-acylurea proteins 
is a reversible process dependent on ionic strength; interaction appears to be electrostatic in nature, 
although other forms of binding might be involved. The possible use of N-acylurea proteins for DNA 
transfer into cell systems is discussed. 
A well established procedure for raising antibodies 
to drugs such as 9-/3-D-arabinofuranosylcytosine 
(ara-C) for the purpose of radioimmunoassay is to 
use as the immunogen ara-C covalently conjugated 
to a protein such as albumin. In order to obtain 
specificity for the arabinose moiety of the ara-C, the 
5'-O-succinyl derivative of the nucleoside is coupled 
to lysine side chains of the albumin by means of the 
water-soluble carbodiimide N-ethyl-N' -(3-dimethyl-
aminopropyl)carbodiimide (CDI)t [1,2]. Carbo-
diimide-mediated coupling is a general procedure for 
linking many different types of hapten to carrier 
proteins [3] and is popular because of its simplicity 
of operation and efficiency under mild conditions. 
During experiments concerned with the prep-
aration of nucleoside-albumin conjugates using CDI 
as the coupling agent , we also reacted the protein 
with the carbodiimide in the absence of nucleoside 
* To whom correspondence should be addressed . 
t Abbreviations: CDr, N-ethyl-N'-(3-dimethylamino-
propyl) carbodiimide; Me+CDI, N-ethyl-N' -(3-trimethyl-
propylammonium) carbodiimide iodide; PBS , phosphate-
buffered saline; SSC, saline sodium citrate. 
to obtain the N-acylurea substituted protein [4-6]. 
This was used for certain studies during the course 
of which we observed that the N-acylurea protein 
was able to bind different types of DNA. This obser-
vation is interesting and has led us to investigate the 
mechanism of the interaction between carbodiimide-
modified proteins and DNA and also to enquire 
whether we could modify proteins such as trans-
ferrin , asialo ll'racid glycoprotein and others to bind 
DNA without altering their interaction with specific 
cell surface receptors. Receptor-mediated endo-
cytosis of the protein (ligand)-DNA complexes 
might be possible , thus allowing selective transfer of 
DNA into cells [7,8] . 
This work describes (i) initial experiments on the 
modification of bovine serum albumin and human 
serum transferrin by the water-soluble carbodi-
i~id~s N-ethyl-N' -(3-dimethylaminopropyl)carbo-
dllmlde HCl (CDI) and N-ethyl-N' -(3-trimethyl-
propylamI?0n,ium)carbodiimide iodide (Me+CDI), 
a CDI denva~lve which contains a positively charged 
9uatern~ry mtrogen (Fig. 2), and (ii) a study of the 
mteractIOn of these modified proteins with different 
classes of DNA. 
1249 
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MATERIALS AND METHODS these conditions in contrast with the unmodified 
proteins. 
Materials. Bovine serum albumin, human serum N-Acylurea Me+CDI-(Fe3+)transferrin. Transfer-
transferrin , heparin , calf thymus DNA and DNase 1 rin (4 mg, 0.04 ,umol) saturated with Fe3+ ion [13] in 
(EC 3.1.21.1) were obtained from the Sigma Chemi- 0.6 ml of phosphate-buffered saline (PBS) (pH 7.5) 
cal Co. , St Louis, MO. Restriction enzyme Pst! (EC was added to N-ethyl-N'-(3-trimethylpropylammon-
3.1.23.31), pBR322 DNA, A DNA and DNA poly- ium)carbodiimide iodide (7.35 mg, 24.7,umol) dis-
me rase 1 (EC 2.7.7.7) were from Boehringer- solved in 0.8 ml water. The reaction mixture (pH 
Mannheim. [3H]Methyl iodide (specific radioactiv- 7.5) was incubated at 20° for 36 hr in the dark . It was 
ity , 85 Ci/mmol), [3H]dTTP (specific radioactivity , then dialysed exhaustively against 0.1 M NaCI at SO 
97 Ci/ mmol) and M13 mp8 single-stranded DNA and stored at -15°. 
were from Amersham, U.K. N-Ethyl-N'-(3- In an alternative procedure, iron-free transferrin 
dimethylaminopropyl)carbodiimide HCl (CDI) was was reacted with N-ethyl-N'-(3-trimethylpropylam-
from Merck. Agarose (ultra pure grade) , acrylamide monium)carbodiimide iodide in PBS (pH 7.5) under 
and bis-acrylamide were obtained from BioRad. identical conditions to those described above for the 
DEAE Sephacel and Sephadex G-50 were from iron-saturated protein. It was dialysed against 0.1 M 
Pharmacia. All other reagents were of Analar grade. NaCl and then treated with ferric citrate before 
Sheared calf thymus DNA . Calf thymus DNA storage. In each of these alternative procedures the 
(approximately 12 kb in size) was prepared by pass- reaction mixtures represent a carbodiimide to pro-
ing a solution of DNA (0.1 mg/ ml) in 0.1 SSC (SSC, tein mole ratio of 500: 1. 
0.15 M NaCl , 0.015 M trisodium citrate) through a Analysis for iron was by the a-dipyridyl method 
25G-Yale syringe needle six times. [14] and spectra (,l'max at 465 nm). 
[3H]calf thymus and pBR322 DNA . These were Number ofN-acylurea groups attached to proteins. 
labelled by the nick translation procedure [9] and For this determination , transferrin or albumin was 
the DNA purified by the spun-column method [10] reacted with [3H]N-ethyl-N' -(3-trimethylpropylam-
using Sephadex G-50. monium)carbodiimide iodide exactly as described 
[3H]calf thymus DNA, 6.5 x 106 c.p.m./ ,ug. [3H]_ above for the various N-acylurea protein prep-
pBR322 DNA, 7.6 x 106 c.p.m./,ug. arations. Reaction was either in water at pH 5.5 or 
Protein determination. Protein was determined by PBS at pH 7.5 . For radioactive counting, aliquots of 
the method of Lowry [11] using either bovine serum · the modified transferrins were ,Precipitated with an 
albumin or human serum transferrin as standard. equal volume of cold 10% (w/v) TCA, filtered on 
[3H]N - Ethyl- N' - (3- trimethylpropylammonium)- Whatman GF / C filters, washed with 25 ml of cold 
carbodiimide iodide. The quaternary carbodiimide 5% (w/ v) TCA, dried and counted in scintillation 
was prepared essentially according to the method of fluid (Beckman HP/ b). In the case of the modified 
Kopczynski and Babior [12], with minor changes, albumin preparations, precipitation was with cold 
from the hydrochloride salt of cm (500 mg, 2.62 60% (w/ v) TCA and subsequent washing with cold 
mmol) and methyl iodide (0.71 g, 5 mmol) containing 30% (w/v) TCA; all other aspects of treatment were 
250,uCi [3H]methyl iodide. The hygroscopic product the same as for the transferrins . 
(520 m~ , 1.76 mmol) with a specific radioactivity of Agarose gel electrophoresis ofN-acylurea protein-
44,uCi/ mmol was stored in the dark over P20 S at DNA complexes. N-Acylurea proteins were incu-
-15°. bated for 20 min at 18-20° with one of the following: 
Modification of proteins with carbodiimides. Albu- A-Pst! restriction fragments , pBR322 DNA or M13 
min and transferrin respectively were treated with mp8 DNA. Each reaction mixture contained in a 
either CDI or Me+CDI at various carbodiimide to final volume of 10 /-Ll: A-Pst! (0.48/-Lg DNA) or 
protein mole ratios which ranged from 10: 1 to pBR322 (0.33 ,ug DNA) or M13 mp8 (0.28,ug DNA), 
2000: 1. A similar reaction procedure was followed a variable concentration of N-acylurea protein , 
in each case. The following procedure is for a typical 6.6 mM Tris-HCl (pH 7.0) , 3 mM sodium 
reaction of CDI with transferrin at a mole ratio of phosphate, 100 mM NaCl , 2 mM MgCl2 and 0.1 mM 
500 : 1. EDT A. The incubated samples (N-acylurea protein-
N - Ethyl- N'- (3 - dimethylaminopropyl)carbodi- DNA complexes), as well as DNA controls, were 
imide HCl (15 mg, 80/-Lmol) in 1.5 ml of water was mixed with a stop solution containing sucrose, urea, 
added to an aqueous solution (1.3 ml) of transferrin bromophenol blue and EDTA , then run in 1.2% 
(12 mg, 0.16/-Lmol) and the clear reaction mixture agarose gels with a buffer containing 36 mM Tris-
carefully adjusted to pH 5.5 by the addition of dilute HCl, 30 mM sodium phosphate and 10 mM EDTA 
HC!. The mixture was allowed to stand at room (final pH 7.5) . Gels were stained with ethidium 
temperature (18-20°) for 48-60 hr in the dark and bromide (1.5 ,ug/ ml). 
then dialysed exhaustively against 0.05 M NaCl con- Agarose gel electrophoresis of proteins . Proteins 
taining 0.3 mM EDTA (pH 7.0) at 5°. Aliquots of and N-acylurea proteins were mixed with stop solu-
the dialysed product , N-acylurea CD I-transferrin, tion and run in 1.2% agarose gels as described above. 
were stored at -15°. Gels were stained with Coomassie Brilliant Blue in 
Purification of the N-acylurea protein conjugates methanol-acetic acid-water (5 : 1: 5, v/v/ v) . 
can be achieved by chromatography on small SDS-polyacrylamide gel electrophoresis . Proteins 
columns of DEAE-cellulose (Sephacel) of dimen- and N-acylurea proteins were analysed by SDS-
sions 1.4 x 12 cm using 0.05 M NaCl containing polyacrylamide gel electrophoresis according to 
0.01 M Tris-HCI (pH 7.0) as the eluent. N-Acylurea Laemmli [15]. 
proteins are not retained on the column under Nitrocellulose filter binding assay. Binding assays 
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Fig. 1. Agarose gel electrophoresis of proteins and proteins modified with N-ethyl-N' -(3-dimethyl-
aminopropyl)carbodiimide . Protein load, 10-15 p,g per well. (A) N-Acylurea proteins prepared at a 
carbodiimide to protein mole ratio of 500: 1. 1, albumin; 2, N-acylurea CDI-albumin; 3, cytochrome C; 
4, transferrin; 5 and 6, different amounts of N-acylurea CDI-transferrin and 7, RNase A. (B) N-Acylurea 
albumins prepared at a range of carbodiimide to protein mole ratios. 1, albumin; 2-6, N-acylurea 
albumins prepared at ratios of 10: 1, 50 : 1, 100: 1, 250: 1 and 500: 1 respectively; 7, albumin. 
were carried out in the following manner: Each 
reaction mixture contained the following in a final 
volume of 200 .ul: r3H~calf thymus DNA (0.01 .ug , 
6.5 x 104 c.p.m.) or [H]pBR322 DNA (O.Ol.ug , 
7.6 x 104 c.p .m.), 10 mMTris-HCl (pH7.5) , 0.05 M 
NaCl, 5 mM EDTA and protein as indicated in the 
figures. Reaction mixtures were incubated at 18-20° 
for 30 min, then carefully filtered through presoaked 
nitrocellulose filters (Millipore Type HA, 0.45.um) 
and washed with 2.0 ml of buffer containing 10 mM 
Tris:"HCl (pH 7.5) , 0.05 M NaCI and 5 mM EDTA. 
Filters were dried , then counted in scintillation fluid. 
In certain binding experiments incubations were 
carried out in a buffer of higher ionic strength: 10-
50 mM Tris-HCI, 0.05-1.0 M NaCI and 5 mM 
EDT A. Washing of the nitrocellulose filters was then 
executed with the buffer used for the incubation. 
RESULTS 
N-Acylurea proteins prepared with N-ethyl-N' -(3-
dimethylaminopropyl)carbodiimide 
Albumin and transferrin were treated with the 
water-soluble carbodiimide N-ethyl-N'-(3-dimethyl-
aminopropyl)carbodiimide HCl at a carbodiimide to 
protein mole ratio of 500 : 1 under dilute reaction 
conditions at pH 5.5. These conditions are similar to 
those used for the coupling of small ligands to albu-
Table 1. Reaction of [3H)N-ethyl-N'-(3-trimethylpropylammonium)carbodiimide iodide with albumin and transferrin 
Carbodiimide (mole) 
Moles N-acylurea Moles (side chain 
ratio pH of attached per mole carboxyl groups) 
Protein Protein (mole) reaction protein per mole protein 
Albumin 500 :1 5.5 27 97 
Albumin 150:1 5.5 13 97 
Transferrin 500 :1 5.5 20 85 
Transferrin 150 : 1 5.5 4 85 
(Fe3+)Transferrin • 500 : 1 7.5 17 85 
(Fel+)Transferrint 500 :1 7.5 23 85 
• Transferrin was saturated with iron before carbodiimide treatment. 
t Transferrin was first modified by the carbodiimide at pH 7.5 and then iron-loaded. 
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min for the preparation of antigens [1] . Agarose gel 
electrophoresis of the carbodiimide-modified pro-
teins at pH 7.5 showed that they had undergone 
changes as regards electrophoretic mobility , becom-
ing more basic (Fig. 1A). For studies on the inter-
action of DNA with N-acylurea proteins it was con-
sidered important to have a series of N-acylurea 
proteins synthesized at varying mole ratios of car-
bodiimide to protein. A range of N-acylurea albu-
mins was prepared, therefore , which varied in the 
initial carbodiimide to protein mole ratio from 10 : 1 
to 2000 : 1. The result of agarose gel electrophoresis 
at pH 7.5 of certain of these preparations is shown 
in Fig. lB. It is seen that as the carbodiimide to 
protein ratio increases there is a progressive decrease 
in the mobility of the modified proteins to the positive 
pole of the gel, representing a decrease in electro-
negativity of the proteins. 
Sodium dodecyl sulphate (SDS)-polyacrylamide 
gel electrophoresis indicated very little carbodiimide-
induced polymerization of either albumin or trans-
ferrin under the reaction conditions described, even 
at high carbodiimide to protein ratios (results not 
shown) . 
N-Acylurea proteins prepared with N-ethyl-N'-(3-tri-
methylpropylammonium )carbodiimide iodide 
Proteins were also treated with [3H]N-ethyl-N' -(3-
trimethylpropylammonium)carbodiimide iodide for 
the purpose of (i) introducing into the protein con-
cerned the N-acylurea grouping containing a posi-
tively charged quaternary nitrogen function (Fig. 2) 
and (ii) allowing determination of the number of N-
acylurea groups covalently attached to the protein 
after carbodiimide modification [16, 17]. Table 1 
shows the number of N-acylurea groups covalently 
attached to albumin and transferrin respectively fol-
lowing reaction with the [3H]-labelled quaternary 
carbodiimide at two different initial carbodiimide to 
protein mole ratios, 150: 1 and 500 : 1. The values for 
both albumin and transferrin show that the higher 
the carbodiimide to protein ratio during reaction, the 
greater the number of N-acylurea groups attached 
to the protein product. In the case of iron-loaded 
transferrin treated with the carbodiimide at a 500: 1 
ratio (pH7.5), the number of N-acylurea groups 
which become covalently attached is slightly different 
according to whether the transferrin was iron-loaded 
before or after carbodiimide modification. Analysis 
had shown that the transferrin pre-loaded with iron 
suffered no loss of Fe3+ ion on carbodiimide mod-
ification, and that the iron-free transferrin treated 
with Fe3+ ion after carbodiimide modification was 
able to bind the ion successfully. 
Agarose gel electrophoresis of N-acylurea protein-
DNA complexes 
Results presented in Fig. 3A show the interaction 
and retardation of migration of A-Pst! DNA frag-
ments by N-acylurea CDI-transferrin. Results pre-
sented in Fig. 3B show that N-acylurea CDI-deriva-
tives of transferrin and albumin also interact with 
and retard the migration of pBR322 DNA. At higher 
concentrations of modified protein the N-acylurea 
protein-DNA complexes are unable to enter the gel. 
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Fig. 2. Chemical structures of carbodiimide (i), protein (ii) , 
O-acylurea protein (iii) and N-acylurea protein (iv) . The 
quaternary carbodiirnide is shown by (v) . R , --C2H s. 
Albumin, transferrin and the basic protein cyto-
chrome C are without effect on DNA migration. 
When N-acylurea proteins were run in gels with 
M13 mp8 single-stranded DNA, similar positive 
interactions were observed (results not shown) . 
Binding of DNA to N-acylurea proteins using the 
nitrocellulose filtration method of assay 
The binding of DNA to N-acylurea proteins was 
also investigated by filtration of protein-DNA com-
plexes through nitrocellulose filters [18--22] . The 
ionic strength of the incubation and washing solution 
was carefully controlled as the salt concentration was 
found to be important in the binding reactions. In 
these experiments we used a buffer containing 
0.01 M Tris-HCI (pH 7.5) , 0.05 M NaCl and 5 mM 
EDTA. 
Figure 4 shows the binding of pBR322 DNA and 
calf thymus DNA to N-acylurea CDI-albumin at 
varying concentrations of protein. The two different 
types of DNA show similar binding characteristics 
up to a value of 0.05 I-tg protein. Thereafter , the level 
of calf thymus DNA binding remains constant with 
increasing protein concentration. Maximum binding 
of pBR322 DNA occurs at a value of 0.1 I-tg protein. 
Figure 4 also shows the binding of both types of 
DNA to N-acylurea Me+CDI-albumin. Both 
pBR322 DNA and calf thymus DNA exhibit maxi-
mum binding with this N-acylurea protein at 0.02-
0.05 I-tg protein. 
Experiments on the binding of DNA by different 
N-acylurea transferrins was also carried out, and the 
results are shown in Fig. 5. In contrast with the 
binding of DNA by N-acylurea CDI-albumin (Fig. 
4) , N-acylurea CD I-transferrin was less efficient 
requiring approximately ten times more protei~ 
(1 I-tg) for maximal binding. On the other hand , N-
acylurea Me+CDI-transferrin was able to bind both 
pBR322 DNA and calf thymus DNA maximally in 
the range 0.02-0.05 I-tg protein , and is therefore con-
siderably more effective than N-acylurea CDI-trans-
ferrin in binding DNA. It is of interest to note 
that N-acylurea Me+CDI-(Fe3+)transferrin showed 
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Fig. 3. Agarose gel electrophoresis of N-acylurea protein-DNA complexes. (N-Acylurea proteins 
prepared at a carbodiimide to protein mole ratio of 500 : 1.) (A) Interaction .of N-acylurea CDI-
transferrin with J..-Pstl DNA restriction fragments . 1, J..-Pstl DNA plus transfernn (4 Ilg) ; 2-4, J..-Pstl 
DNA plus N-acylurea COl-transferrin (2, 4 and 8 Ilg respectively); 5 and 6, J..-Pstl DNA plus cytochrome 
C (4 and 8 Ilg respectively). J..-Pstl DNA, 0.48 Ilg per well. (B) Interaction of N-acylurea COl-proteins 
with pBR322 DNA. 1, pBR322 marker; 2, pBR322 plus albumin (4 Ilg); 3 and 4, pBR322 plus N-
acylurea COl-albumin (4 and 8 Ilg respectively); 5, pBR322 plus transferrin (4 Ilg); 6 and 7, pBR322 
plus N-acylurea COl-transferrin (4 and 8 Ilg respectively) ; 8, pBR322 plus cytochrome C (4 Ilg) . pBR322 
DNA, 0.33 Ilg per well . 
similar binding characteristics to iron-free N-acyl-
urea Me+CDI-transferrin (Fig. 5). 
Studies on the rate of binding of DNA to N-
acylurea proteins was carried out at 5° and 20° using 
the nitrocellulose filter method of assay. At both 
temperatures the reaction was very fast, with binding 
occurring in less than 1 sec (results not given). How-
ever, as is shown later, this initial rapid binding 
appears to be weak, changing to a tight or more 
stable form of binding with time. 
N-Acylurea proteins used.in the binding experi-
ments described above were all prepared at a 
carbodiimide to protein mole ratio of 500: 1. A series 
of N-acylurea CD I-albumins varying in the carbo-
diimide to protein mole ratio employed during syn-
thesis from 10: 1 to 2000: 1 was evaluated for binding 
ability by nitrocellulose filter assay. The binding of 
pBR322 DNA and calf thymus DNA by the various 
N-acylurea CD I-albumins is shown in Fig. 6. It 
should be noted that these particular binding assays 
were carried out in a buffer of higher ionic strength 
than that quoted previously; the buffer contained 
0.05 M Tris-HCI (pH 7.5) , 0.1 M NaCI and 5 mM 
EDT A. Results demonstrate that N-acylurea albu-
mins prepared at CDI to protein mole ratios of 250: 1 
and greater are able to bind DNA. 
The effect of NaCl concentration on the binding of 
N-acylurea proteins to DNA 
A strong salt dependency of the binding between 
different types of protein and DNA has been 
observed [18, 23-26] and is indicative of electrostatic 
interaction between basic amino acids of the protein 
and phosphate groups of the nucleic acid. Struc-
turally , the N-acylurea proteins (Fig. 2) are modified 
proteins with positively charged tertiary amino or 
quaternary ammonium groups attached via a spacer 
to glutamic and aspartic acid side chains of the 
protein. Electrostatic interaction between these 
groupings and DNA phosphates appeared likely and 
for this reason studies were carried out on the effect 
of salt concentration on DNA binding. 
N-Acylurea proteins and DNA were incubated 
at 20° in a buffer consisting of 0.01 M Tris-HCl 
(pH 7.5) , 0.05 M NaCI and 5 mM EDTA for 30 min; 
the solutions were then brought to the desired NaCl 
concentration, left for 5 min and finally filtered 
through nitrocellulose filters . Results of the salt-
induced dissociations are shown in Fig. 7. Con-
centrations of NaCI required for the half-dissociation 
of individual N-acylurea protein-DNA complexes as 
deduced from the curves shown are: N-acylurea CD 1-
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N-Acylurea albumin (~g) 
Fig. 4. Binding of DNA to N-acylurea albumins at varying 
protein concentration assayed by the nitrocellulose fil-
tration method. DNA per reaction mixture, 0.01 p.g . Mod-
ification of albumin was at a carbodiimide to protein mole 
ratio of 500 : 1. N-Acylurea CDI-albumin with PH)pBR322 
DNA (e) and with [3H)calf thymus DNA (0); N-acylurea 
Me+CDI-albumin with [3H)pBR322 DNA (_) and with 
[3H)calf thymus DNA (0); albumin control with either 
DNA (L) . 
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N-Acylurea transferrin (~g ) 
Fig. 5. Binding of DNA to N-acylurea transferrins at vary-
ing protein concentration assayed by the nitrocellulose 
filtration method. DNA per reaction mixture, 0.01 p.g. 
Modification of the transferrin was at a carbodiimide to 
protein mole ratio of 500 : 1. N-Acylurea CDr-transferrin 
with [3H)pBR322 DNA (e) and with [3H)calf thymus DNA 
(0 ) ; N-acylurea Me+CDI-transferrin with [3H)pBR322 
DNA (_) and with pH)calf thymus DNA (0) ; N-acylurea 
Me+CDI-(Fe3+)transferrin with [3H)pBR322 DNA (CD) and 
with [3H)calf thymus DNA (CD); transferrin control with 
either DNA (L ). The N-acylurea Me+CDI-
(Fe3+)transferrin used in these experiments was iron-loaded 
prior to carbodiimide modification . 
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COl-TREATED ALBUMIN SAMPLES 
Fig. 6 . . ~I?dmg of DN~ to N-acylur~a albumm~ prepa~ed with N-ethyl-N'-(3-dimethylaminopropyl)-
carbodllmlde at carbodmrude to protem mole ratIOs varymg from 10: 1 to 2000 : 1. All reaction mixtures 
con tamed 0.01 p.g D~~A and ~. 8 p.g protein. (A) [ ~H)calf thymus DNA with the complete range of N-
acylurea CDr-albumms. (B) [ H)pBR322 DNA With the complete range of N-acylurea CDr-albumins . 
Fig. 7. The effect of NaCl concentration on the dissociation of N-acylurea protein-DNA complexes. N-
Acylurea proteins were all prepared at a carbodiimide to protein mole ratio of 500: 1. Protein per 
reaction mixture: N-Acylurea CDI-albumin, 0.10 /lg ; N-acylurea Me· CDI-albumin, 0.08 /lg; N-acylurea 
CDI-transferrin , 2.0 /lg ; N-acylurea Me+CDI-transferrin, 0.20 /lg. DNA per reaction mixture, 0.005 /lg . 
(A) Dissociation of [3H]pBR322 DNA from N-acylurea CDI-albumin (e) and N-acylurea Me+CDI-
albumin (0 ). (B) Dissociation of [3H]pBR322 DNA from N-acylurea CDI-transferrin (e) and N-
acylurea Me+CDI-transferrin (0 ). 
albumin , 0.15 M; N-acylurea Me+CDI-albumin, 
0.24 M ; N-acylurea CDI-transferrin , 0.18 M and N-
acylurea Me+ -CD I-transferrin , 0.26 M. 
Heparin challenge experiments 
Nitrocellulose filter retainable complexes are 
formed rapidly between N-acylurea proteins and 
DNA at both 5° and 20°. These initial complexes 
appear to be bound weakly , as they are dissociated 
if challenged by the polyanion heparin within 30 sec 
of formation (Fig. 8). However, formation of tightly 
bound complexes occurs if the binding reaction is 
allowed to proceed for 30 min at 20° or 37°. A heparin 
challenge at this time is significantly less effective in 
causing dissociation of the complex (Fig. 8) . 
Further investigations into the nature of binding 
Further experiments aimed at obtaining infor-
mation on the nature of the binding interactions 
between N-acylurea proteins and DNA were under-
taken. Heating of N-acylurea CD I-albumin and N-
acylurea CDI-transferrin at 55° for 10 min had no 
effect on their interaction with DNA. We were not 
able to extract pBR322 DNA from its complex with 
N-acylurea CDI-albumin by use of phenol in the 
absence of SDS. However , in the presence of 0.1 % 
SDS at 60° for 5 min , pBR322 DNA was extracted 
into the aqueous phase during treatment with 
phenol , and recovered mainly in the supercoiled 
form (as shown by agarose gel electrophoresis). The 
results suggest that this particular N-acylurea pro-
tein-DNA complex is not held together by covalent 
bonds and that interaction does not involve the intro-
duction of nicks into the DNA. 
Competition experiments with various synthetic 
RNA polynucieotides produced inhibition of binding 
of pBR322 DNA to N-acylurea CDI-transferrin to 
differing degrees. Poly(G) produced the strongest 
inhibition, followed by poly(A) , poly(U) and 
poly(C) . Poly(m7G) and poly(I) also inhibited bind-
ing but to a lesser degree than poly(G) . The mono-
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Heparin ( fig ) 
Fig. 8. The effect of heparin on the binding of DNA to N-
acylurea transferrin . [3H]pBR322 DNA (0.01 /lg) and N-
acylurea CDI-transferrin (500: 1 mole ratio preparation; 
4.0 /lg) were mcubated together for different times at either 
20° or 37°. Each sample was then challenged with heparin 
for 30 sec and immediately processed by nitrocellulose fil-
tration. Incubation for 0.5 min at 20° (e) ; incubation for 
30 min at 20° (D) ; incubation for 30 min at 37° (0 ). 
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DISCUSSION 
The work presented in this paper describes the 
modification of albumin and transferrin with water-
soluble carbodiimides to give N-acylurea proteins 
which are able to bind various types of DNA, includ-
ing A-Pstl restriction fragments , pBR322 plasmid, 
calf thymus DNA and single-stranded M13 mp8 
DNA. 
Binding reactions were investigated by two 
methods. Initial experiments made use of agarose 
gel electrophoresis to show that DNA migration was 
retarded in the presence of N-acylurea pro,teins , and 
that at higher concentrations of modified protein, N-
acylurea protein-DNA complexes were not able to 
enter the gel. Further experimental work was based 
on the binding of N-acylurea protein-DNA com-
plexes to nitrocellulose membrane filters. Using this 
type of assay we were (i) able to study the effect of 
N-acylurea protein concentration on its binding to 
calf thymus and pBR322 DNA, (ii) measure the rate 
of formation of complexes, which is rapid , (iii) show 
that N-acylurea protein-DNA interactions are sen-
sitive to salt concentration , and (iv) distinguish two 
modes of interaction between N-acylurea proteins 
and DNA. 
Additional experiments involving phenol extrac-
tion of N-acylurea protein-DNA complexes in the 
presence of SDS showed that pBR322 could be 
recovered in an intact supercoiled form . This infor-
mation, together with the results of salt dissociations 
and heparin competition experiments, suggests that 
binding is electrostatic in nature , although other 
forms of binding might also be involved. 
Results presented in Fig. 7 highlight the depen-
dence of the apparent association constant (Kobs) 
for the N-acylurea albumin-pBR322 and N-acylurea 
transferrin-pBR322 interactions on monovalent ion 
concentration [M+]. The reduction of Kobs with 
increasing [M+] suggests a strong electrostatic com-
ponent in the free energy of the binding interaction. 
Assuming B-conformation of DNA in solution 
[25], the geometry of known DNA binding proteins 
allows for considerable contact with the duplex as 
determined by model building, revealing a large non-
electrostatic component in the DNA complex. Thus 
Cro, lambda repressor and CAP are believed to 
interact with DNA of standard B-geometry through 
hydrogen bonding of base pairs in the major groove 
with specific side chains in a-helical regions located 
therein [26] . Van der Waals interactions as well as 
the expected electrostatic attractions are apparent 
[26]. The non-electrostatic component of the ligand-
nucleic acid complexes formed between carbodi-
imide-modified albumin or transferrin and DNA is 
believed to be minor , since the lack of detectable 
complex formation between unmodified albumin and 
transferrin with either pBR322 or calf thymus DNA 
indicates poor molecular contact. The con,cept of 
relative surface exposure of nucleic acids , which has 
not been developed as extensively as with proteins, 
has been investigated by Alden and Kim [27] to 
identify the most accessible atoms or regions of 
nucleic acids available for intermolecular inter-
actions. These studies reveal that the accessible area 
in B-DNA is rather polar, with phosphate oxygens 
accounting for 45 % of this surface. Their peripheral 
location further supports the notion that the charge-
charge interactions observed in our studies between 
carbodiimide-modified proteins and DNA are 
accounted for in large measure by ion pairs formed 
between DNA phosphate and the nitro gens of the 
N-acylurea groups attached to the proteins. This may 
not be the case with single-stranded M13 mp8 since 
the accessible surface of single-stranded DNA is 
known to be larger and considerably more hydro-
phobic due to greater base exposure [27] . Indeed, 
model building suggests that ion pairs of the type 
mentioned may be stabilized by specific hydrogen 
bonding between N-acylureas and the bases. 
Melancon and co-workers [23] have carried out 
detailed studies on the binding of Escherichia coli 
RNA polymerase to restriction enzyme digests of 
TIDll1 DNA. In addition to normal promoter com-
plexes, these authors observed both fast-forming 
heparin-sensitive complexes and polymerase-DNA 
complexes insensitive to challenge with heparin but 
formed at a slower rate. It is of interest to note that 
in this respect our synthetic N-acylurea proteins form 
complexes with DNA which have similarities to the 
non-promoter complexes found in the bacterial sys-
tem (Fig. 8). 
The preparation of nucleic acid-protein con-
jugates for use as immunogens has been outlined 
by Stollar [28] . In one method, methylated serum 
albumin which is positively charged is used to prepare 
insoluble complexes with DNA. In an alternative 
method, a nucleotide or oligonucleotide is reacted 
with a water-soluble carbodiimide and then added 
to a protein for coupling; the nucleotide or oligo-
nucleotide appears to become linked to the protein 
through a covalent phosphoramidate bond. Inter-
estingly, Stollar notes that in certain cases an excess 
of carbodiimide modifies the protein carboxyl groups 
such that the resultant protein forms a precipitate 
with DNA. 
Cheng et ai. [7] have recently suggested that the ' 
introduction of DNA into cells with genetic defects 
may be achieved by linking the DNA to a protein 
which can be bound by specific cell surface receptors. 
Internalization via receptor-mediated endocytosis 
might thus allow entry of the DNA into a specific 
cell type. These workers have devised a method 
which involves chemical modification of both protein 
and DNA components , followed by the covalent 
linking of the two moieties through disulphide 
exchange reactions. The finding that N-acylurea 
albumin was able to bind DNA non-covalently and 
reversibly suggested that carbodiimide-modification 
of transferrin and other polypeptides which react 
with cell surface receptors might give N-acylurea 
substituted molecules that are able to bind DNA and 
still interact successfully with their receptors , thereby 
affording an alternative approach to this possible 
method of DNA (gene) transfer [7,8]. Reaction of 
iron-free and iron-loaded transferrin with carbo-
diimides was therefore undertaken. It is notable that 
the resultant N-acylurea transferrins, both iron-free 
and iron-loaded, bind DNA to a similar degree (Fig. 
5). 
Work on the interaction of N-acylurea protein-
DNA complexes with cells is in progress. 
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Evidence is presented for targeted gene delivery to HepG2 cells 
via the endocytotic pathway under the direction of insulin. 
Serum albumin was treated with the water-soluble carbodiimide 
N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide hydrochloride 
and the resultant positively charged N-acylurea albumin 
'covalently conjugated to insulin by glutaraldehyde 
cross-linkage. The conjugated protein is shown by 
nitrocellulose filter binding and gel band shift assays to bind 
DNA, and by competitive displacement of [ ' 25 I ]insulin to bind to 
the insulin receptor . When the expression vectors ptkNEO and 
pAL-8 which incorporate the neo gene were complexed to the 
conjugate in an in vitro system of transfection, G418 resistant 
clones developed at frequencies of 2.0 - 5.5 X 10-5 • 
Subsequently, a 923bp PstI fragment within the neo sequence was 
identified by Southern transfer in genomic DNA from transfected 
cell populations which had been maintained on a G418 regime for 
44 days. 
Abbreviations: BSA, bovine serum albumin; CDI, N-ethyl-N'-(3-
dimethylaminopropyl)-carbodiimide; DMSO, dimethyl sulphoxide; 
HEPES, 2-[4-(2-hydroxyethyl)-1-piperazinyl]-ethanesulphonic 
acid; SSC, 0.15M NaCI, 0.015M trisodium citrate. 
INTRODUCTION 
The deliberate i nsertion and integration of functionally active 
genes into mammalian cells is now a commonplace procedure which 
has manifold application in molecular biology and medicine. The 
transfer of specific genes permits: study of the functional 
domains of proteins [1], fine dissection of the mechanisms by 
which gene expression is regulated [2], elucidation of cellular 
differentiation hierarchies by the introduction of clonal 
markers into embryonic cells or primitive stem cells [3], 
analysis of oncogene and putative oncogene function in 
carcinogenesis [ 4], the production of transgenic animals [5] and 
the correction of genetic disorders [6]. 
A variety of me t hodologies exist for the necessary transfer of 
exogenous DNA to the cell interior. The most straightforward 
and commonly used ,are chemical methods such as those involving 
treatment with calcium phosphate [7] or a cationic facilitator 
[8] which induce indiscriminate DNA attachment to the membrane 
and thereby give rise to endocytotic uptake. It has been shown 
recently, however, that the calcium phosphate transfection 
protocol has been implicated in perturbations of gene expression 
[9, 10]. Other popular methods of gene transfer involve active 
injection of DNA during physical puncture [11] or passive uptake 
during poration or abrasion of the membrane in the presence of 
DNA [12, 13] but , while moderately efficient, these are open to 
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some criticism on the grounds that they are intrinsically 
aggressive. Also, as with the chemical techniques, they are 
applicable only to in vitro cell systems. A further category of 
techniques relies upon the mediation of DNA transfer via 
membrane-bound vesicles such as intact protoplasts [14], 
erythrocyte ghosts [15], reconstituted viral envelopes [16] and 
liposomes [17], the last of these having the design capacity to 
be adapted for targeting to specific cell types both in vitro 
and in vivo [18]. In a class of their own are viral vectors: 
reconstructed viruses, especially retroviruses, disarmed and 
expropriated for the carriage, insertion and precisely 
controlled genomic integration of DNA sequences [19]. Such 
vectors constitute the most efficient means of gene transfer 
known at the present time, but the technicalities are too 
intricate for many straightforward applications and there are 
numerous difficulties still existing which must be resolved 
before this approach can be widely advocated [20]. 
In this communication we present a procedure for gene transfer 
which exploits the efficiency and specificity of internalisation 
afforded by the process of receptor-mediated endocytosis [21]. 
DNA in the naked state is carried into the cell reversibly bound 
to a soluble protein ligand recognisable by its cognate receptor 
at the plasma membrane surface. The non-covalent complexing of 
DNA to ligand is achieved by modifying the protein with a 
water-soluble carbodiimide, N-ethyl-N'-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (CDI) under controlled conditions 
which allow the formation of basic N-acylurea moieties at the 
carboxyl groups of available aspartate and glutamate residues 
[22]. The resultant electropositive N-acylurea protein readily 
interacts with ionised phosphodiester backbone regions of DNA 
and tenaceous salt bridges are formed [23]. In the case of 
small polypeptide ligands, modification of the ligand itself is 
minimised by covalently attaching it in the unmodified state to 
N-acylurea serum albumin, thereby creating a conjugate which 
relegates the receptor binding and DNA binding functions to 
separate protein surfaces on one macromolecule (Figure 1). 
Since the modified ligands are extensively purified prior to use 
in transfection, and are applied together with unmodified DNA to 
recipient cells at low concentration in medium which requires no 
special adjuvants, they mimic the behaviour of their native 
counterparts and undergo natural endocytotic uptake in a highly 
directed and non-inimical manner. Prudent choice of ligand 
could possibly make this method of gene transfer applicable to a 
variety of cell lines in culture. Furthermore, the potential 
exists to develop the concept for targeting genes to specific 
tissue types in whole animal investigations. 
In this study we have modelled the approach using insulin as the 
ligand of choice. We describe the preparation of 
insulin-[N-acylurea albumin] conjugates, their binding to 
insulin receptors on cultured HepG2 cells, and their application 
in the uptake into and expression in HepG2 cells of the neo gene 
from the bacterial transposon Tn5 incorporated into the 
expression vectors ptkNEO and pAL-8. 
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MATERIALS AND METHODS 
Materials. Bacteriological culture media and ingredients were 
obtained from Difco Labs, cell culture media from GibCo, and 
sterile plasticware from CelCult. Filter sterilisation units 
and nitrocellulose discs were from Millipore. Monocomponent 
porcine insulin was purchased from Novo Biolabs; bovine serum 
albumin (fraction V), DNA polymerase I (EC 2.7 . 7.7), DNA 
polymerase I Klenow fragment, restriction endonucleases and 
plasmid pBR322 from Boehringer-Mannheim; DNase I (EC 3.1.21.1), 
lysozyme (EC 3 . 2 . 1.17), ethidium bromide, ampicillin, 
chloramphenicol and Geneticin (G418) from the Sigma Chemical Co. 
[Methyl,1' ,2,_3H] thymidine S'-triphosphate (specific 
radioactivity 93 Ci/mmol), thymidine S'_[a_32p] triphosphate 
(specific radioactivity 3000 Ci/mmol), ['25I-tyrosine A14] human 
insulin (specific radioactivity 2000 Ci/mmol), Hybond C-extra 
and Hyper-film MP were obtained from Amersham, U.K. 
Anti-porcine insulin was purchased from Bio-Yeda. 
N-Ethyl-N'-(3-dimethylaminopropyl) carbodiimide hydrochloride 
and caesium chloride were from Merck. Agarose (ultra pure grade 
and low melting temperature grade), acrylamide, bis-acrylamide, 
nitrocellulose sheets and Immun-Blot kit were obtained from 
BioRad. Sephadex G-SO and G-100 were from Pharmacia. All other 
reagents were of analytical grade. 
Maintenance of HepG2 cells. HepG2 cells [24] were grown at 37°C 
in flasks containing Eagle's minimal essential medium 
supplemented with 10mM NaHC03 and buffered with 20mM Na-HEPES, 
pH 7.3 (MEM) containing 10%v7v foetal calf serum (MEM+S). Cells 
at semi-confluence (4-7 days' growth) were trypsinised with a 
solution containing O.2S%w/v trypsin, O.1%w/v EDTA, and the 
suspensions subcultured at 1/6 or 1/3 dilutions. 
Generation of expression vectors. The expression vector 
plasmids ptkNEO and pAL-8 were each propagated in Escherichia 
coli strain HB101. Initial transformation was achieved using a 
simple calcium method [2S] and stocks of the respectively 
transformed host strain kept on ampicillin media as both 
anaerobic stab cultures and frozen glycerol-broth cultures. 
Large scale plasmid production followed conventional protocols 
[26], extraction of plasmids was by the boiling method [26] or 
the lysozyme-Triton X-100 method of Katz et al [27] and 
purification was by centrifugation in caesium chloride-ethidium 
bromide (CsCI-EB) density gradients [28]. After EB removal from 
the plasmid fractions and subsequent dialysis against TE buffer 
(10mM Tris-HCI, 1mM EDTA, pH 7.S) the final preparations were 
stored over chloroform (S%v/v) at -1SoC. 
Quantification of DNA. DNA was estimated spectrophotometrically 
by UV absorption. 
Agarose gel electrophoresis. Plasmids and restriction digests 
of plasmids were analysed on 1.2% agarose gels run at pH 7.S and 
stained with EB using conventional methodology [26]. 
Preparative electrophoresis for the separation and excision of 
restriction fragments for subsequent labelling as probes was 
237 
performed in a similar manner on gels of low melting temperature 
agarose. For the analysis of DNA-protein binding by band shift 
assay, plasmids were bound to proteins prior to electrophoresis 
as described in the legend to Figure S. For the analysis of the 
charge properties of proteins, protein samples were 
electrophoresed as above but subsequently fixed in 10%w/v TCA, 
stained with 0.02S%w/v aqueous Coomassie Brilliant Blue in 
10%w/v TCA, and destained in 10%w/v TCA, S%v/v acetic acid. 
Labelling of pBR322. The plasmid pBR322 was labelled by the 
nick translation protocol [29] i n the presence of [methyl, 
l' ,2,_3H] thymidine S'-triphosphate and subsequently purified by 
the spun column method using Sephadex G-SO [26]. The product 
was stored at - 1 SoC. Specific activity was 6.0 - 8.S X 106 
cpm/~g TCA-prec i pitated DNA. 
Labelling of neo probe. A 923bp PstI fragment of ptkNEO 
representing the majority of the neo gene sequence and no 
extraneous sequences was labelled with thymidine S'_[a_32p] 
triphosphate by the method of Feinberg and Vogelstein [30]. The 
desired fragmen t was excised from an electrophoretic gel of low 
melting temperat ure agarose, water added (3~l/mg gel), and the 
sample boiled for 7 minutes immediately prior to use in the 
labelling reaction. The reaction product was subjected to spun 
column purificat ion using Sephadex G-SO (2S) then stored at 
-15°C. Specific activity was 6.0 X 108 - 2.2 X 109 cpm/~g 
TCA-precipitated DNA. 
Preparation of N-acylurea albumins. The N-acylurea derivative 
of bovine serum albumin (BSA) was prepared as previously 
described [23] b y reaction of the protein with N-ethyl-N'-
(3-dimethylaminopropyl) carbodiimide HCl (CDI), at a 1:S00 mole 
ratio. The product was dialysed exhaustively against saline-
EDTA (SOmM NaCl, 0.3mM EDTA, pH 7.0) at SoC and aliquots stored 
at -1SoC. 
Conjugation of insulin to albumins. Insulin was cross-linked to 
BSA at a 10:1 mole ratio by a development of the method of 
Poznansky et al [31]. Insulin (4.2mg, 7.37 X 10-7 moles, 
dissolved in 600~l DMSO at 37°C) was mixed with unmodified BSA 
or its N-acylurea derivative (Smg, 7.3S X 10-8 moles, in 1ml 
saline-EDTA) at 20°C then diluted with 4.0ml SOmM acetate 
buffer, pH 3.6, and the solution cooled to SoC. Glutaraldehyde 
(90~1, 2S%) was added and the reaction mixture maintained in the 
cold overnight. Thereafter, crystall~ne glycine (7Smg) was 
added, dissolved, and allowed to react with excess 
glutaraldehyde for 2.Sh at 20°C . The reaction mixture was then 
dialysed exhaustively against 10mM acetate buffer, pH 4.0, 
containing S%v/v DMSO at SoC. The resultant clear, pale 
straw-coloured solutions were stored in aliquots at -1SoC. 
Fractionation of conjugates. Conjugates were purified by gel 
filtration through Sephadex G-100. Fractions (1ml) were stored 
at -1SoC for up to 8 weeks. Conjugates for use in transfection 
experiments were fractionated under sterile conditions. 
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Quantification of protein. Protein was estimated by the method 
of Lowry et al [32] using BSAas standard. 
Identification of insulin in the conjugates. Insulin was 
detected semi-quantitatively in the conjugate fractions by 
immuno-dot-blotting. Each fraction tested was diluted in 
elution buffer to a concentration of 66ng protein/~l. These 
starting solutions, together with a range of double dilutions 
derived from them, were applied in 1~1 aliquots to 
nitrocellulose and processed according to the BioRad Immun-Blot 
procedure using anti-insulin (1/333) as first binding agent, 
protein A-horseradish peroxidase (1/2500) as second binding 
agent, and a mixture of 4-chloro-1-naphthol (dissolved in 
methanol) and hydrogen peroxide (aqueous) as colour reagent. 
Molecular size determination. Protein conjugates were analysed 
by SDS-polyacrylamide gel electrophoresis according to the 
method of Laemmli [33]. 
DNA binding assay. The binding of DNA to protein conjugate 
fractions was estimated by filtration through nitrocellulose in 
a variation of the method previously described [23]. Mixtures 
containing SOmM NaCI, 20mM Tris-HCI (pH 7.0), 1mM EDTA, 
[3H]pBR322 (4.Sng, 3.3 X 104 cpm), unlabelled pBR322 (S.Sng) and 
protein as indicated in the figure legends in a final volume of 
200~1 were incubated at 20°C for 30min, then filtered through 
nitrocellulose discs (Millipore Type HA, 2Smm diameter, 0.4S~ 
pore size) and rinsed with 2.0ml of buffer consisting of SOmM 
NaCI, 20mM Tris-HCI (pH 7.0), 1mM EDTA. The nitrocellulose 
filters were wetted in rinse buffer prior to use. Finally, 
filters were air-dried and counted for radioactivity in 
scintillation fluid. 
Receptor binding studies. HepG2 cells were heavily seeded (1/3 
splits) into 3Smm diameter well plates and grown to 
semi-confluence. Cells were washed twice with MEM (no serum) at 
37°C (2ml per well) then incubated at 37°C for 1h in the 
presence of a further 2ml MEM, which was subsequently removed. 
Plates were placed on ice and MEM at 5°C added (1ml per well) 
together with [ ' 25I ]insulin and unlabelled insulin or insulin 
conjugate as indicated in the figure legends. Additives were 
thoroughly mixed into the binding medium and plates incubated at 
10°C. Cells were subsequently washed three times with cold 
phosphate buffered saline (PBS) (4ml per well) and drained. 
After addition of water (1ml per well); cells were loosened into 
suspension with a rubber policeman, 200~1 removed for protein 
determination, and the remainder fully dispersed by the addi t ion 
of 1ml lysis buffer (0.5% SDS, 100mM NaCI, 40mM Tris-HCI, 20mM 
EDTA, pH 7.0) [34] . The lysates were transferred to tubes for 
gamma counting. 
Transfection procedure. HepG2 cells were heavily seeded (1/3 
splits) in 2Scm2 flasks and grown to semi-confluence . Cells 
were washed three times with 4ml MEM (no· serum), then incubated 
at 37°C for 1h in the presence of a further 4ml MEM, which was 
subsequently removed. Flasks were placed on ice and 2ml MEM at 
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5°C added together with I-[A-CDI] or control protein as 
indicated in the legend to Figure 8. After overnight incubation 
at 10°C, flasks were again placed on ice, the medium removed, 
and 1ml MEM at 5°C added together with expression vector as 
indicated. The vector samples used comprised superhelical and 
nicked circular forms of plasmid DNA in approximately equal 
proportions. Fl asks were transferred from ice to incubation at 
10°C (30min), 20°C (30min), then 37°C (S.Oh). At this stage 3ml 
MEM+S (plus serum) was added and incubation continued for 24h. 
Flasks were trypsinised and duplicate subcultures established 
containing 106 cells per flask. Growth was continued for a 
further 24h before the first addition of G418. 
stable expression of NEG: G418 selection. Following the 
trypsinisation of post-transfection cells, G418 stock solution 
(24mg total antibiotic/ml H~O adjusted to pH 7.4 with NaOH and 
filter sterilised) was added to the medium to give a final 
concentration of 1200~g/ml (biological activity = 50% of this) 
and incubation continued for 5 days, after which the medium was 
changed and fresh G418 added at a final concentration of 
600~g/ml. Medium changes were effected at approximately 5 day 
intervals thereafter, the G418 level being lowered further to 
and maintained at SOO~g/ml. Following the unambiguous 
appearance of resistant clones (14-21 days) and the death of 
most non-resistant cells (21-28 days), one set of flasks was 
stained for the recording of clone distribution. Surviving 
cells in the other set were trypsinised for subculture and 
propagation in a G418 maintenance regime and ultimately 
subjected to genomic 
DNA extraction. 
Extraction of genomic DNA from HepG2 cells. Duplicate 7Scm2 
flasks of cells were used for each DNA preparation. Extraction 
was according to the method . of Shih and Weinberg [34]. Final 
DNA solutions were dialysed exhaustively against 0.1SSC at 5°C 
then stored at -15°C. 
Detection of the integrated neo sequence in transfected HepG2 
DNA. This was carried out by Southern hybridisation [35]. 
Blots were probed with a 923bp neo fragment and washed under 
conditions of high stringenCy. Bands were visualised by 
autoradiography. 
RESULTS 
Preparation of N-acylurea albumin 
N-Acylurea albumin (A-CDI) was prepared by treating BSA with the 
water-soluble carbodiimide N-ethyl-N'-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (CDI), under conditions previously 
described, in which 27 out of a total of 97 side chain carboxyl 
groups per BSA molecule become substituted by N-acylurea 
moieties leading to significantly increased electropositivity as 
shown by agarose gel electrophoresis at pH 7.5 [23]. During the 
reaction the carbodiimide induces a degree of polymerization of 
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albumin as shown by the behaviour of A-CDI on gel filtration 
(Figure 2.). 
Preparation of insulin-albumin conjugates 
Monocomponent porcine insulin (I) was covalently cross-linked to 
BSA (A) and N-acylurea BSA (A-CDI) by reaction with 
glutaraldehyde to give rise to the conjugates I-A and I-[A-CDI] 
respectively (Figure 1.). In order to ensure the attachment of 
several molecules of insulin (mol wt 5700) to each molecule of 
albumin (mol wt 68000) reaction mixtures contained an insulin to 
BSA mole ratio of 10:1 (mole calculations based on unmodified 
BSA input in both cases). Reaction and subsequent purification 
was conducted at low pH (3.6-4.0) in the presence of DMSO 
(5-10%v/v) in order to maintain insulin solubility at the 
required protein concentration. Gel filtration of the dialysed 
reaction mixtures through Sephadex G-100 showed the two reaction 
products to have identical profiles representing a series of 
high molecular weight complexes with only insignificant amounts 
of protein evident at the position of unconjugated insulin 
elution (Figure 2.). The incorporation of insulin into the 
conjugate fraction was confirmed by SDS polyacrylamide gel 
electrophoresis (results not shown). Furthermore, presence of 
insulin in the high molecular weight product was demonstrated 
unambiguously by immuno-dot-blot analysis, with the highest 
ratios of insulin to total protein being apparent in fractions 
18 to 24 (Figure 2.). Results (not shown) of agarose gel 
electrophoresis at pH 7.5 of the conjugate fractions bore out 
the anticipated charge differences between I-A and I-[A-CDI], 
the latter showing considerably increased electropositivity due 
to the presence of basic N-acylurea moieties attached to surface 
aspartate and glutamate residues. 
Binding of DNA to insulin-albumin conjugates 
Purified conjugates obtained by gel filtration through Sephadex 
G-100 were assayed for DNA binding activity by the 
nitrocellulose filtration technique. The binding of DNA to 
N-acylurea proteins has been shown to be salt concentration 
dependent [23]; consequently the ionic strength of the 
incubation and washing medium must be carefully controlled. In 
addition, both protein-DNA binding and protein-nitrocellulose 
binding are pH dependent, and it was found to be important to 
conduct these assays between pH 6.0 and pH 7.5 (results not 
shown). Accordingly, for these experiments, an assay buffer was 
devised which maintained suitable ionic strength and pH despite 
the addition of variable volumes of conjugate dissolved in 10mM 
acetate buffer, pH 4.0. The assay buffer used was 50mM NaCI, 
20mM Tris-HCI (pH 7.0), 1mMEDTA. 
Figure 3. illustrates typical binding interactions of pBR322 DNA 
with the various size species of I-A and I-[A-CDI] obtained by 
gel filtration. Each assay mixture contained 1.5~g conjugate. 
At this level of protein the DNA present " in the assay mixture 
(lOng) is not limiting (refer to Figure 4.). The capacity to 
bind DNA is demonstrated by I-[A-CDI] but not I-A. While all 
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fractions of I-[A-CDI] undergo significant binding, binding is 
lowest f o r the very large polymers and there is a reproducible 
trend for the binding capacity of the larger species of 
conjugate to be inversely proportional to molecular size 
(fraction s 15 - 20). This is likely to be a reflection of the 
reduction in the ratio of surface area to weight that 
accompani es polymerization. Maximal binding is achieved and 
maintaine d over a range of the more moderately sized species 
(fraction s 21 - 24). 
On the b a sis of (i) DNA binding capacity, (ii) insulin content, 
and (iii ) concentration, I-[A-CDI] fractions 19 to 23 inclusive 
were pool ed to provide an I-[A-CDI] stock solution for use in 
all subse quent experiments. Fractions of I-A were pooled in an 
equivalen t manner. stock solution concentrations ranged from 
0.38 to 0. 42~g protein/~l. 
The inter action of pBR322 DNA with insulin-albumin conjugates at 
varying c oncentrations of protein is shown in Figure 4. Results 
confirm t hat onl y I-[A-CDI] undergoes binding. Total DNA per 
reaction mixture is 10ng. The amount of DNA bound is seen to 
increase linearl y as the input of I-[A-CDI] rises to 6~g; 
maximum b inding is reached at 8~g I-[A-CDI]. 
DNA bindi ng by I -[A-CDI] is illustrated by alternative means in 
Figure 5 . which shows the result of DNA gel electrophoresis 
following incubation of pBR322 samples (0.45~g) with varying 
amounts o f insul in-albumin conjugates. Retardation of migration 
resulting from t he complexing of DNA to protein starts to become 
visible a t 1.0~g I-[A-CDI], particularly in relation to the 
supercoi l band, and at 1.66~g I-[A-CDI] significant retardation 
of both s upercoi l and nicked circular forms is seen as 
continuou s smudging of the DNA. At higher levels of I-[A-CDI] a 
proportio n of the complex is virtually unable to enter the gel. 
In contra st, I-A is shown to bring about no significant 
retardat i on of migration. Unmodified albumin and the basic 
protein c ytochrome C are without effect on pBR322 migration 
under the same electrophoretic conditions [23]. Insulin is 
similarly without effect (result not shown). 
Binding o f insulin and insulin-albumin conjugates to the insulin 
receptor 
Since laboratory iodination of insulin with [1251 ] incurs 
oxidation damage and brings about indiscriminate labelling of 
tyrosine residues leading to decreased biological activity 
including aberrant receptor binding [36], commercially produced 
human ins ulin [ 125I ]-labelled only at the A14 tyrosine was 
employed in these investigations. Monoiodo[TyrA14 ]insulin is 
fully ac t ive in receptor binding assays [36]. The binding to 
insulin r eceptor s of unlabelled porcine insulin and 
insulin-a lbumin conjugate derivatives was studied by determining 
their abi lity to compete with free radioactively labelled human 
insulin f or receptor sites on HepG2 cells. Preliminary 
e~pe~iments were ~ar~ied out{ therefore, to establish the normal 
b1nd1ng c haracter1st1cs of [ 25I_Tyr~4] human insulin to HepG2 
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cells. 
Prior to all binding procedures cells were washed to remove 
extracellular ligand, incubated at 37°C for 1h in serum-free 
medium i n order to clear the receptors of bound ligand, then 
cooled. Temperatures below 16°C are known to inhibit 
absorptiv e endocytosis of insulin [37]. Accordingly, binding 
incubations were set up in serum-free medium at 10°C. 
Figure 6A. presents the time course of binding of human insulin 
to HepG2 cells at 10°C. Binding takes place rapidly for the 
first 2h , after which it slows down, reaching a maximum at 
approxima tely 16h. For all subsequent binding experiments 
incubatio n was for an 18h period at 10°C. The effect of ligand 
concentra tion on the binding of human insulin to HepG2 cells is 
shown in Figure 6B. Binding increases with insulin input, and 
at an ins ulin concentration of 0.8ng/ml, saturation of the 
receptor population in the system is not yet reached. 
Porcine i nsulin as well as insulin-albumin conjugates derived 
from porc ine insulin compete effectively with human insulin for 
specific receptor sites on HepG2 cells ~Figure 7.). Binding 
resulting from the addition of 0.4ng [12 I _TyrA14] human insulin 
alone is reduced to 50% in the presence of 50ng porcine insulin 
(Figure 7A.), 300ng I-A and 200ng I-[A-CDI] (Figure 7B.). By 
contrast , albumin unconjugated to insulin does not compete for 
binding. Furthermore, Figure 7C. shows that when I-[A-CDI] is 
prebound to DNA its receptor binding facility is not affected. 
DNA itsel f has no affinity for the binding site. 
Insulin- {N-acvl urea albumin] mediated transfection 
DNA trans fer to HepG2 cells was tested using the expression 
vectors p tkNEO and pAL-8, both of which carry the bacterial 
sequence neo from transposon Tn5 which encodes aminoglycoside 
3'-phosphotransferase II. This gene is normally absent in 
mammalian cells but if inserted and expressed confers upon them 
resistanc e to t h e lethal effects of the 2-deoxystreptamine 
antibiot i c G418 (Geneticin), thus acting as a dominant selective 
marker [ 38]. Viral promoter sequences allow expression of neo 
on trans f er: in ptkNEO the gene is linked on either side to HSV 
thymidine kinase regulatory sequences; in pAL-8 the flanking 
transcrip tional control regions are derived from SV40. 
Figure 8 . illustrates clonal colonies which have arisen over a 
period of 28 days in the presence of G418, indicating reception 
of the n e o gene and its stable expression. The presence of 
numerous clones in flasks E1 - E4 together with the absence of 
surviving cells in control flasks C1 - C5 provides phenotypic 
evidence that DNA transfer takes place only by means of 
I-[A-CDI] and not as a result of any effects of I-A or 
unconjuga ted protein constituents. Frequencies of stable 
transfec t ion resulting from ptkNEO transfer (mean = 2.0 X 10-5 ) 
are lower than for pAL- 8 (mean = 5.5 X 10-5 ). 
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Genotypic evidence for neo transfer is provided in Figure 9., 
which shows the results of Southern hybridisation of genomic DNA 
samples extracted from the HepG2 cell line and from transfected 
populations derived from it. Figure 9A. illustrates the absence 
of neo i n two mammalian cell lines including HepG2. Figure 9B. 
shows pre sence of the neo sequence in the transfected HepG2 
populations E1 - E4, grown on G418 to high cell number through 
several passages, over a total period of 44 days, from duplicate 
flasks o f those shown in Figure 8. 
DISCUSSION 
The carbodiimide modification of proteins to produce N-acylurea 
derivativ es with DNA-binding properties and their potential in 
gene transfer has been reported previously [23, 39]. Here, we 
demonstra te that cross-linking insulin to carbodiimide-modified 
albumin p roduces a soluble macromolecule capable of both 
specific recogni tion of the insulin receptor and DNA transport, 
thereby a ffording a possible means of targeted transfection from 
solution without the involvement of particulate intermediates, 
excessive foreign chemicals, cell disruption or infective 
agents. We provide evidence which suggests that, by means of 
this DNA carrier system, the exogenous gene neo from the 
bacterial transposon Tn5 has been inserted through the insulin 
receptor endocytotic pathway into the HepG2 hepatoma cell line 
and stabl y expressed. 
In keeping with our proposed model (Fig. 1.), the gel filtration 
fraction of insulin-[N-acylurea albumin] used for transfection 
was selec ted in order to achieve an optimal combination of 
protein c oncentr ation, DNA binding capacity and insulin content 
(Figs. 2 and 3.). Measuring DNA binding reactions by means of 
nitrocel l ulose f ilter and band shift assays, and using an 
equivalen t frac t ion of insulin-albumin conjugate as control, we 
have shown that binding takes place exclusively as a result of 
interact i on of DNA with N-acylurea moieties belonging to the 
modified albumin component of the conjugate (Figs. 3,4 and 5). 
In addit i on, we have shown that insulin-albumin conjugates bind 
specifica lly to insulin receptor sites on HepG2 cells, 
recognit i on being due to the insulin component of the conjugate, 
and that the presence of N-acylurea substituents does not 
adversely affec t conjugate-receptor binding characteristics 
(Fig. 7B . ). Fur thermore, we have demonstrated that 
conjugate -DNA binding does not interfere with conjugate-receptor 
binding (Fig. 7C.). 
The compl ex which arises when DNA is mixed with insulin-
[N-acylur ea albumin] is soluble under certain titration 
condition s as suggested by (i) reversibility of binding in the 
presence of high monovalent ion concentration (result not 
shown), a nd (ii) electrophoretic mobility of the complex (Figure 
5, wells 5 and 6). However, as the ratio of conjugate to DNA in 
the mixture is raised, large electrophoretically inert complexes 
which may be insoluble are formed (Figure 5, wells 7 and 8). In 
our trans fection protocol, therefore, we were careful to avoid 
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the possibility of insoluble material being precipitated in the 
medium. We achieved this by establishing conjugate-receptor 
binding during a pre-incubation period, following this with 
removal o f unbound conjugate, and only then adding expression 
vector DNA for attachment to the receptor-bound carrier. 
Receptor cycling was inhibited by temperature control until the 
DNA bindi ng step was complete. This approach to binding allows 
the addition of excess amounts of conjugate and DNA at each 
step, max imises binding and possibly increases transfection 
efficienc y. The alternative would be to ensure removal of 
particula te material by membrane filtration of the complex 
before a ddition to cells . This might be a suitable approach for 
in vivo gene transfer studies, but further investigation into 
the inter actions of soluble I-[A-DI]-DNA complex and components 
of the me dium would be a desirable prerequisite. 
A clear demonstration of stable expression of the neo gene 
following ptkNEO and pAL-8 transfer to HepG2 cells is provided 
by (i) t h e appearance of distinct clones among I-[A-CDI]-vector 
treated c ells g r own for 28 days on a G418 regime lethal to 
untreated cells (Figure 8.), and (ii) identification of the 
exogenous neo sequence in DNA extracted after clone populations 
produced in parallel to those shown in Figure 8. had been grown 
for 44 d a ys, thr ough a number of subculture steps, on the 
antibiot i c (Figure 9.). Complete lack of survivors in control 
flasks in which cells were provided with vector in the presence 
of no pro tein, I + A, I + A-CDI and I-A respectively (Figure 8.) 
constitut es evidence that these gene transfer events depended on 
an agent capable of binding to both DNA and insulin receptor. 
Furthermore, free A-CDI, present at a concentration equivalent 
to that i n the I-[A-CDI] conjugate, does not bring about 
transformation, indicating that non-specific cation-induced 
uptake is not i nvolved. On these premises we suggest that gene 
transfer has tak en place under the direction of insulin via the 
endocytot ic pathway. 
The size of the G418-resistant clones developed (Figure 8 . ) 
varied g r eatly within each treated population regardless of 
vector. The phenomenon has measurable parallels in plant 
genetics: individual neo-positive plantlets grown up from Ti 
plasmid- t ransformed tissue show wide quantitative difference in 
resistanc e to kanamycin; this is generally thought to indicate 
that expr ession of inserted genes is enhanced or suppressed 
according to genomic position, which varies as a result of 
random integration [40]. In enumerating clones we ignored those 
which wer e particularly small, thereby estimating transformation 
frequencies conservatively. Our results show I-[A-CDI]-induced 
stable gene transfer to be approximately 20 times (ptkNEO) and 
55 times (pAL-8) greater than typical stable transformation of 
HepG2 cells brought about by the calcium phosphate procedure 
[41 ] . 
Ligand-directed passage of DNA across the plasma membrane is 
likely to be efficient. During subsequent intracellular 
processing, however, the route of DNA is less controlled, and 
numerous hazards in the form of enzymatic or membrane barriers 
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are encountered. Ultimate delivery to the nucleus must still be 
a rare event. The use of insulin as ligand might offer an 
advantage in this respect. In contrast with some ligand 
proteins which are delivered via membrane-bound vesicles to 
lysosomes, it is increasingly evident that insulin degradation 
inside the cell takes place in endosomal rather than lysosomal 
compartments [42]; thus DNA still associated with the I-[A-CDI] 
complex after entry may not be directed actively towards 
lysosomal nucleases. 
Exploitation of the efficiency and specificity of cell entry 
afforded by receptor-mediated endocytosis has been suggested in 
various ways previously. For example, Poznansky et al have 
achieved delivery of a-1,4-glucosidase to muscle cells and 
hepatocytes using a covalently conjugated enzyme-albumin-insulin 
complex [31], and Cheng et al have devised a mechanism of 
covalent attachment between nucleic acid and protein with the 
purpose in view of genetic correction via endocytosis [43]. The 
method of gene transfer presented here combines the elegance of 
ligand-directed carrier insertion with non-covalent reversible 
binding of the DNA to the carrier [23], a possible advantage in 
the cell interior. Recent work by Wu and Wu published during 
the course of our investigations illustrates use of a parallel 
approach: by employing as carrier a conjugate of asialo-
orosomucoid and high molecular weight cationic poly-L-Iysine, 
which binds DNA electrostatically in much the same manner as 
N-acylurea protein, those workers have demonstrated transient 
expression of the bacterial cat gene in HepG2 hepatoma cells in 
culture [44, 45 ] and in rat liver in vivo [46]. The work we 
describe in the present communication adds to the growing body 
of evidence that receptor mediated endocytosis provides a 
pathway by which exogenous molecules, including DNA, may be 
directed into the interior of target cells, and in particular 
shows that stable gene transformation may result from the use of 
this facility. 
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LEGENDS 
Figure 1 . (Figure 1.1 in thesis) 
Binding i nteractions of a conjugate consisting of a small 
polypepti de ligand such as insulin covalently cross-linked to 
N-acylurea albumin. The ligand component retains its facility 
for specific receptor binding. The N-acylurea albumin 
component, produced by carbodiimide modification of serum 
albumin, bears numerous positively charged N-acylurea moieties 
( @ ) in place of acidic amino acid side chain carboxyl groups 
(aspartat e and glutamate residues) and readily interacts 
electros t atically with negatively charged DNA phophodiester 
backbone ( 8). I, insulin; A-CDI, N-acylurea albumin; a and 
B, insul i n receptor subunits. 
Figure 2 . (Figure 2.6 in thesis) 
Gel filtration chromatography of insulin, albumin and 
derivatives. Proteins were purified and characterised by gel 
filtration through Sephadex G-100 in a 7 X 1500mm column using 
10mM acetate buffer, pH 4.0, containing 5%v/v DMSO as eluant at 
a flow rate of 6.0ml/h. Absorption at 280nm was determined as a 
continuous trace, and fractions of 1ml collected. A. Unmodified 
insulin (I), unmodified albumin (A) and N-acylurea albumin 
(A-CDI). B. Insulin-albumin (I-A) and insulin-[N-acylurea 
albumin] (I-[A-CDI]). Reaction mixtures were dialysed 
exhaustively prior to loading on to the column; reaction 
mixtures containing insulin were dialysed in low molecular 
weight cut-off dialysis tubing. The horizontal bar shows those 
conjugate fractions containing the highest proportions of 
insulin to total p~otein as estimated by immuno-dot-blot 
analysis. 
Figure 3. (Figure 3.3 in thesis) 
DNA binding capacity of insulin-albumin conjugates fractionated 
by gel filtration. DNA binding was assayed by the 
nitrocellulose filtration technique. Each assay mixture 
contained 4.5ng [3H]pBR322, 5.5ng unlabelled pBR322 and 1 .5~g 
protein conjugate. Absorption at 280nm of I-A and I-[A-CDI] 
(----); DNA bound by I-A (heavy hatching); DNA bound by 
I-[A-CDI] (light hatching). The horizontal bar indicates those 
fractions pooled for use in subsequent binding and transfection 
experiments. 
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Figure 4. (Figure 3.4B in thesis) 
Binding of DNA to insulin-fH-acylurea albumin] at varying 
protein concentration. DNA binding was assayed by the 
nitrocel l ulose filtration technique. Each assay mixture 
contained 4.5ng [3H]pBR322 and 5.5ng unlabelled pBR322. Each 
protein conjugate was added in the form of a pooled gel 
filtration peak component as indicated in Figure 3. I-[A-CDI] ( • 
); I-A control ( 0 ). 
Figure 5 . (Figure 3.2B in thesis) 
Band shift assay of binding interactions between insulin-albumin 
conjugates and DNA. pBR322 was incubated with protein conjugate 
at 20°C for 30min prior to agarose gel electrophoresis. Each 
incubation mixture contained 50mM NaCl, 20mM Tris-HCl (pH 7.0), 
1mM EDTA , 0.45~g pBR322, and a variable amount of protein 
conjugate as indicated, in a final volume of 10~l. 1, pBR322 
control (no protein); 2 and 3, pBR322 plus I-A (2.0~g and 3.3~g 
respectively); 4-8, pBR322 plus I-[A-CDI] (0.4~g, 1 .O~g, 1 .66~g, 
2.66~g, and 3.3~g respectively). 
Figure 6. (Figure 4.1 in thesis) 
Binding of human insulin to HepG2 insulin receptors. 
Semi-confluent monolayers of HepG2 cells were grown and prepared 
for binding as described in Materials and Methods. A. 
[125I _TyrA14] human insulin (2~l, 0.4ng, 2.36 X 105 cpm) was added 
to each well and the incubation period at 10°C varied. B. 
Variable amounts of [125I _TyrA14] human insulin were added to the 
wells and incubation at 10°C allowed to continue for 18 hours. 
After incubation each well was processed as described in 
Materials and Methods. 
Figure 7. (Figure 4.2 in thesis) 
Competitive displacement of human insulin from HepG2 insulin 
receptors by porcine insulin and its conjugated derivatives. 
Semi-confluent monolayers of HepG2 cells were grown and prepared 
for binding as described in Materials and Methods. [125I _TyrA14] 
human insulin (2~l, 0.4ng, 2.36 X 10 5 cpm) was added to each 
well together with variable amounts of unlabelled competitor 
protein as shown. A. Porcine insulin. B. (Porcine) 
insulin-albumin conjugates I-A ( ~ ) and I-[A-CDI] ( • ), 
plus albumin controls ( 0 ). C. I-[A-CDI] which had been 
incubated with pBR322 DNA in binding buffer at 20°C for 30 
minutes prior to addition ( • ), plus DNA controls ( 0 ); 
DNA values underlined. Incubation was at 10°C for 18 hours. 
Subsequent processing was as described in Materials and Methods. 
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Figure 8. (Figu re 5.7 in thesis) 
Appearance of c l ones resistant to G418 following 
insulin-{N-acylurea albumin] mediated transfer of the expression 
vectors ptkNEO and pAL-8 to HepG2 cells. Cells were subjected 
to transfection and G418 selection as described in Materials and 
Methods. After 28 days of G418 treatment, one complete 
experimental set of flasks was stained for the visualisation of 
clones as follows: medium was removed, cells rinsed twice with 
PBS (Sml), fixed with redistilled methanol (Sml, 2min), stained 
with a 1/10 aqueous dilution of standard Giemsa (Sml, 2-Smin), 
then rinsed generously with water several times. Flasks were 
drained and air-dried. 
TRANSFECTION FLASKS: E1 and E2, I-[A-CDIl (40~g) plus ptkNEO 
(4~g); E3 and E4, I-[A-CDIl (40~g) plus pAL-8 (4~g). 
TRANSFECTION CONTROL FLASKS: Qi, no protein, no vector; C2, no 
protein, pAL-8 ( 4~g); C3, unconjugated I (18.2S~g) and A 
(21 .7S~g) plus pAL-8 (4~g); C4, unconjugated I (18.2S~g) and 
A-CDI (21.7S~g) plus pAL-8 (4~g); CS, I-A (40~g) plus pAL-8 
(4~g). 
Figure 9. (Figure 5.8 in thesis) 
Genomic Southern hybridisation: detection of the neo sequence in 
stably G418 resistant HepG2 cells following insulin-{N-acylurea 
albumin] mediated transfection. Cells were subjected to 
transfection and G418 selection as described in Materials and 
Methods. After 28 days of G418 treatment, one complete 
experimental set of flasks was stained for the visualisation of 
clones (Figure 8.). Flasks of the duplicate set containing 
surviving cells (E1 - E4) were trypsinised and each of the cell 
populations propagated through several passages on a G418 
maintenance regime for a further 16 days until there were 
sufficient cells for genomic DNA extraction. DNA was analysed 
for the neo sequence using as probe a 923bp PstI fragment of 
ptkNEO within t h e neo gene. 
A. MINI GEL BLOT: 1, PstI digested ptkNEO (2ng) plus salmon 
sperm carrier DNA (3~g); 3, neo fragment excised from Pst I 
digested ptkNEO (923bp) (2ng) plus carrier DNA (3~g); 5, PstI 
digested HepG2 cell line DNA (12~g); 6, PstI digested HeLa cell 
line DNA (12~g). 
B. LARGE GEL BLOT: 1, undigested ptkNEO (4913bp) (1ng) plus 
carrier DNA (7~g); 3, undigested pAL-8 (>10000bp) (1ng) plus 
carrier DNA (7~g); 5, neo fragment excised from PstI digested 
ptkNEO (923bp) (1ng) plus carrier DNA (7~g); 7-10, PstI digested 
DNAs from G418 resistant HepG2 cell populations E1 - E4 
respectively (28~g per well). 
252 
THE BRIGHT FIELD 
I have seen the sun break through 
to illuminate a small field 
for a while, and gone my way 
and forgot t en it. But that was the pearl 
of great pr ice, the one field that had 
the treasur e in it. I realise now 
that I mus t give all that I have 
to possess it. Life is not hurrying 
on to a receding future, nor hankering after 
an imagined past. It is the turning 
aside like Moses to the miracle 
of the lit bush, to a brightness 
that seemed as transitory as your youth 
once, but is the eternity that awaits you. 
R.S. Thomas 
From Laboratories of the Spirit 
In Later Poems 1972-1982 
Macmillan, London, 1983. 
